| S.no |
Heading Name |
Date |
Edit |
Delete |
| 1 |
Challenges and Limitations |
2026-08-10 |
|
|
| 2 |
Funding/Support Statement |
2026-07-17 |
|
|
| 3 |
Highlight |
2026-06-10 |
|
|
| 4 |
Information Sharing Statement |
2026-06-04 |
|
|
| 5 |
Data and/or Code Availability |
2026-06-04 |
|
|
| 6 |
Permissions |
2026-05-13 |
|
|
| 7 |
Support |
2026-05-13 |
|
|
| 8 |
Prior publication |
2026-05-13 |
|
|
| 9 |
Sponsorship And Support |
2026-04-20 |
|
|
| 10 |
Implications and Suggestions |
2026-04-17 |
|
|
| 11 |
Declaration of Computing Interest |
2026-04-08 |
|
|
| 12 |
Ethical Consideration and Consent to Participation |
2026-04-07 |
|
|
| 13 |
Availability Data and Privacy Regulations |
2026-04-07 |
|
|
| 14 |
Overview of Experts Discussion |
2026-03-09 |
|
|
| 15 |
Conclusions, Implications and Avenues for Future Research |
2026-02-11 |
|
|
| 16 |
Note on the Use of Artificial Intelligence |
2026-02-07 |
|
|
| 17 |
Strength and Limitation of the Study |
2026-02-03 |
|
|
| 18 |
Financial or Non-Financial Interests |
2026-01-28 |
|
|
| 19 |
Criteria for Author Inclusion |
2026-01-06 |
|
|
| 20 |
Key Words |
2026-01-05 |
|
|
| 21 |
Advances in Molecular Biology Approaches for Understanding Gene Regulation in Higher Plants |
2025-12-23 |
|
|
| 22 |
Acknowledgement/Funding |
2025-12-23 |
|
|
| 23 |
Statement of Declaration |
2025-12-22 |
|
|
| 24 |
Contribution Of Our Study To Knowledge |
2025-12-18 |
|
|
| 25 |
Current State Of Knowledge On The Subject |
2025-12-18 |
|
|
| 26 |
Management and Outcome |
2025-11-25 |
|
|
| 27 |
Discussion and Data Analysis |
2025-11-25 |
|
|
| 28 |
Availability of Datasets |
2025-11-05 |
|
|
| 29 |
Declaration Statement |
2025-11-04 |
|
|
| 30 |
Ethical Committee |
2025-10-24 |
|
|
| 31 |
Results, Literature Analysis and Discussion |
2025-10-22 |
|
|
| 32 |
Ethics Declarations |
2025-10-14 |
|
|
| 33 |
Other Relationships |
2025-09-29 |
|
|
| 34 |
Financial Relationships |
2025-09-29 |
|
|
| 35 |
Payment/Services Info |
2025-09-29 |
|
|
| 36 |
Human Subjects |
2025-09-29 |
|
|
| 37 |
Ethical Approval and Informed Consent |
2025-09-19 |
|
|
| 38 |
Conclusion |
2025-09-08 |
|
|
| 39 |
Human and Animal Rights |
2025-09-04 |
|
|
| 40 |
Gratitude |
2025-08-11 |
|
|
| 41 |
Ethical Consideration |
2025-08-01 |
|
|
| 42 |
Environmental Considerations |
2025-07-31 |
|
|
| 43 |
Bioactive Compounds and their Impact on Aging |
2025-07-28 |
|
|
| 44 |
Glossary |
2025-07-28 |
|
|
| 45 |
Availability of Material and Data |
2025-07-21 |
|
|
| 46 |
Consent and Ethical Approval |
2025-07-21 |
|
|
| 47 |
Data Avaliablity |
2025-07-19 |
|
|
| 48 |
Acknowledgement |
2025-07-17 |
|
|
| 49 |
Limitation and Future look |
2025-07-16 |
|
|
| 50 |
Disscusion |
2025-07-10 |
|
|
| 51 |
Availability of Data and Material/Data Availability |
2025-06-24 |
|
|
| 52 |
Research Highlights |
2025-05-26 |
|
|
| 53 |
Limitation and Future Implications |
2025-05-26 |
|
|
| 54 |
Disclosures of Interest |
2025-04-03 |
|
|
| 55 |
Contribution to Knowledge |
2025-04-01 |
|
|
| 56 |
Contributuion to Knowledge |
2025-04-01 |
|
|
| 57 |
Disclaimer (Artificial Intelligence) |
2025-01-17 |
|
|
| 58 |
Conclusions and Study Implication |
2025-01-17 |
|
|
| 59 |
Analysis and Interpretation of Findings |
2025-01-17 |
|
|
| 60 |
Empirical Literature |
2025-01-16 |
|
|
| 61 |
Antecedents of Authentic Leadership |
2025-01-16 |
|
|
| 62 |
Value of the Study |
2025-01-16 |
|
|
| 63 |
Contribution of the Study |
2025-01-16 |
|
|
| 64 |
Suggestions for Further Research |
2025-01-16 |
|
|
| 65 |
Definitions of Variables and Hypothesis |
2025-01-16 |
|
|
| 66 |
Model Specification |
2025-01-16 |
|
|
| 67 |
Approval of The Medical Ethics Committee |
2024-12-19 |
|
|
| 68 |
Study Approval |
2024-12-17 |
|
|
| 69 |
Originality-significance statement |
2024-12-12 |
|
|
| 70 |
Case Detail |
2024-12-10 |
|
|
| 71 |
Ethical Committee Consent |
2024-11-25 |
|
|
| 72 |
Section E |
2024-11-08 |
|
|
| 73 |
Section D |
2024-11-08 |
|
|
| 74 |
Section C |
2024-11-08 |
|
|
| 75 |
Section B |
2024-11-08 |
|
|
| 76 |
Section A |
2024-11-08 |
|
|
| 77 |
Questionnaire |
2024-11-08 |
|
|
| 78 |
Follow-up and Outcomes |
2024-11-06 |
|
|
| 79 |
Therapeutic Intervention |
2024-11-06 |
|
|
| 80 |
Clinical Findings and Diagnostic Assessment |
2024-11-06 |
|
|
| 81 |
Timeline |
2024-11-06 |
|
|
| 82 |
Authors Declaration |
2024-11-06 |
|
|
| 83 |
Future |
2024-10-29 |
|
|
| 84 |
7.References |
2024-10-15 |
|
|
| 85 |
6.Conflict of Interest |
2024-10-15 |
|
|
| 86 |
5.Author Contributions |
2024-10-15 |
|
|
| 87 |
4.Conclusion |
2024-10-15 |
|
|
| 88 |
3.Discussion |
2024-10-15 |
|
|
| 89 |
2.Literature Review |
2024-10-15 |
|
|
| 90 |
1.Introduction |
2024-10-15 |
|
|
| 91 |
Assistance with the Study |
2024-10-08 |
|
|
| 92 |
Methodology and Analysis |
2024-10-08 |
|
|
| 93 |
Author Disclosure |
2024-10-07 |
|
|
| 94 |
Publication Consent |
2024-09-30 |
|
|
| 95 |
Mass moves from Faster Time to Slower Time (Section 3.1) |
2024-09-12 |
|
|
| 96 |
Schemes Under Startup India |
2024-09-06 |
|
|
| 97 |
Analysis and Evaluation |
2024-09-02 |
|
|
| 98 |
Our Approach |
2024-09-02 |
|
|
| 99 |
Overview of Algorithms |
2024-09-02 |
|
|
| 100 |
Electromagnetic Analysis |
2024-08-30 |
|
|
| 101 |
About the clinical case |
2024-08-23 |
|
|
| 102 |
Contributorshisip |
2024-08-13 |
|
|
| 103 |
Supplementary Information |
2024-08-13 |
|
|
| 104 |
Limitations and Future Work |
2024-08-12 |
|
|
| 105 |
Results and Statistical Analysis |
2024-08-12 |
|
|
| 106 |
MSC codes |
2024-07-31 |
|
|
| 107 |
Authorship Contribution Statement |
2024-07-30 |
|
|
| 108 |
Results and Discussion (Experimental section) |
2024-07-30 |
|
|
| 109 |
Future Recommendations |
2024-07-30 |
|
|
| 110 |
Analysis Results |
2024-07-29 |
|
|
| 111 |
Disadvantages |
2024-07-26 |
|
|
| 112 |
Conclusion (Section 9) |
2024-07-05 |
|
|
| 113 |
Strong Force (Section 8) |
2024-07-05 |
|
|
| 114 |
Energy Time Dilation (Section 7) |
2024-07-05 |
|
|
| 115 |
Theoretical Idea for the Interior of a 3HE Atom. (Section 6.1) |
2024-07-05 |
|
|
| 116 |
Weak Force (Section 6) |
2024-07-05 |
|
|
| 117 |
Electromagnetism is Similar to Gravity (Section 5.1) |
2024-07-05 |
|
|
| 118 |
EM Force for Similar Charges (Section 5) |
2024-07-05 |
|
|
| 119 |
Time Dilation: Why Two Dissimilar Charges Attract (Section 4) |
2024-07-05 |
|
|
| 120 |
The Proposed Gravity Equation (PGE) is Expressed as Follows: (Section 3) |
2024-07-05 |
|
|
| 121 |
Proposed Gravity Equation (Section 2) |
2024-07-05 |
|
|
| 122 |
Understanding Time (Section 1) |
2024-07-05 |
|
|
| 123 |
Ethical Disclousre |
2024-07-04 |
|
|
| 124 |
Experimental Results and Discussion |
2024-06-29 |
|
|
| 125 |
Disclousre |
2024-06-19 |
|
|
| 126 |
Bibliografia |
2024-06-17 |
|
|
| 127 |
Ethical Consent |
2024-06-05 |
|
|
| 128 |
Methodology and Tools |
2024-05-30 |
|
|
| 129 |
Classifications |
2024-05-30 |
|
|
| 130 |
Use of AI tools declaration |
2024-05-30 |
|
|
| 131 |
Finding and Research Challenges |
2024-05-25 |
|
|
| 132 |
Ethical Agreement |
2024-05-25 |
|
|
| 133 |
The Nutritional Secrets and Cultural Significance of Honey |
2024-05-23 |
|
|
| 134 |
Acronyms |
2024-05-10 |
|
|
| 135 |
Data Analysis, Presentation and Interpretation, Demographic Profile of Respondents |
2024-05-10 |
|
|
| 136 |
Media and Branding |
2024-05-10 |
|
|
| 137 |
Brand Loyalty |
2024-05-10 |
|
|
| 138 |
E-Mail Marketing |
2024-05-10 |
|
|
| 139 |
Search Engine Optimization (SEO) |
2024-05-10 |
|
|
| 140 |
Specific Objectives |
2024-05-10 |
|
|
| 141 |
Reporting Checklist |
2024-05-03 |
|
|
| 142 |
Key Findings |
2024-05-03 |
|
|
| 143 |
Supplementary Data |
2024-05-01 |
|
|
| 144 |
Declarations Conflict of Interest |
2024-04-29 |
|
|
| 145 |
Bibliography |
2024-04-26 |
|
|
| 146 |
Limitations and Scope |
2024-04-11 |
|
|
| 147 |
Conclusion and Future Scope |
2024-04-10 |
|
|
| 148 |
Proposed Results and Analysis |
2024-04-10 |
|
|
| 149 |
An Introduction |
2024-03-30 |
|
|
| 150 |
Guarantor |
2024-03-25 |
|
|
| 151 |
Results and Main Findings |
2024-03-13 |
|
|
| 152 |
Research Involvement |
2024-03-04 |
|
|
| 153 |
Notes on Patient Consent |
2024-03-01 |
|
|
| 154 |
IRB Approval |
2024-03-01 |
|
|
| 155 |
Data Sources |
2024-03-01 |
|
|
| 156 |
Approach and Methodology |
2024-02-16 |
|
|
| 157 |
Background and the Objective of the Study |
2024-02-16 |
|
|
| 158 |
Suggestion and Findings |
2024-02-13 |
|
|
| 159 |
Declarations Ethics Approval and Consent to Participate |
2024-02-05 |
|
|
| 160 |
Informed Patient Consent for Publication |
2024-02-03 |
|
|
| 161 |
Conflict of Interest Disclosures |
2024-02-02 |
|
|
| 162 |
Ethical Issues |
2024-01-30 |
|
|
| 163 |
Policy Implications and Regulatory Challenges |
2024-01-30 |
|
|
| 164 |
Qualitative Insights: Impact On Urban Housing Markets |
2024-01-30 |
|
|
| 165 |
The Airbnb Business Model |
2024-01-30 |
|
|
| 166 |
Contribution of Authors |
2024-01-26 |
|
|
| 167 |
Data Availability/Availability of Data and Materials |
2024-01-25 |
|
|
| 168 |
Data Availability/Availability of Data and Materials |
2024-01-25 |
|
|
| 169 |
Martials and Methods |
2024-01-10 |
|
|
| 170 |
Expected Benefits/Implications of the Study |
2023-12-20 |
|
|
| 171 |
Limitations and Future Scope |
2023-12-05 |
|
|
| 172 |
Clinical-Medical Image |
2023-12-04 |
|
|
| 173 |
Future Direction and Conclusion |
2023-12-04 |
|
|
| 174 |
Works Cited |
2023-12-01 |
|
|
| 175 |
Introduction and importance |
2023-12-01 |
|
|
| 176 |
Safety and Ethical Considerations |
2023-12-01 |
|
|
| 177 |
Ethical and Legal Consideration |
2023-11-30 |
|
|
| 178 |
Proposed System |
2023-11-29 |
|
|
| 179 |
Research Location |
2023-11-21 |
|
|
| 180 |
Conclusion and Future Design Plan |
2023-11-20 |
|
|
| 181 |
Declaration of Generative AI in Scientific Writing |
2023-11-04 |
|
|
| 182 |
Research Limitations/Implications |
2023-11-02 |
|
|
| 183 |
Informed Consent Statements |
2023-10-17 |
|
|
| 184 |
Implications for Clinical Practice and Future Research |
2023-10-10 |
|
|
| 185 |
Hypothesis around AT Synaesthesia |
2023-10-10 |
|
|
| 186 |
Occurrences in the Present-day World |
2023-10-10 |
|
|
| 187 |
Associated Cognitive and Perceptual Effects |
2023-10-10 |
|
|
| 188 |
Phenomenology |
2023-10-10 |
|
|
| 189 |
Genetic and Environmental Factors |
2023-10-10 |
|
|
| 190 |
Neurological Basis |
2023-10-10 |
|
|
| 191 |
Strength of The Study |
2023-10-09 |
|
|
| 192 |
Ethics approval and Consent for Participation |
2023-10-04 |
|
|
| 193 |
HCA Healthcare Disclaimer |
2023-10-04 |
|
|
| 194 |
Finding Statement |
2023-09-21 |
|
|
| 195 |
Future Recommendation |
2023-09-19 |
|
|
| 196 |
Availability Statement |
2023-09-14 |
|
|
| 197 |
Statement of Ethics Data |
2023-09-14 |
|
|
| 198 |
Preface of the book |
2023-09-12 |
|
|
| 199 |
Limitations & Future Advancements |
2023-09-12 |
|
|
| 200 |
Findings and Discussions |
2023-09-12 |
|
|
| 201 |
Literature Review and Theoretical Framework |
2023-09-12 |
|
|
| 202 |
Limitations and Strengths |
2023-09-05 |
|
|
| 203 |
Economic Considerations |
2023-09-05 |
|
|
| 204 |
Ethical Approval and Consent to Participants |
2023-09-02 |
|
|
| 205 |
Availability of Supporting Data and Materials |
2023-09-02 |
|
|
| 206 |
Case Study 2 |
2023-08-31 |
|
|
| 207 |
Case Study 1 |
2023-08-31 |
|
|
| 208 |
Financial Disclaimer |
2023-08-30 |
|
|
| 209 |
Declaration of Significance |
2023-08-30 |
|
|
| 210 |
Classification of Paint |
2023-08-28 |
|
|
| 211 |
Competing Interest |
2023-08-26 |
|
|
| 212 |
Design of the Study |
2023-08-21 |
|
|
| 213 |
Funding Disclosures |
2023-08-17 |
|
|
| 214 |
Suggestion for Further Study |
2023-08-17 |
|
|
| 215 |
Procedure and Outcomes |
2023-08-14 |
|
|
| 216 |
Informant Consent |
2023-08-11 |
|
|
| 217 |
Follow-up and Outcome |
2023-08-11 |
|
|
| 218 |
Conclusions & Future Scope |
2023-08-08 |
|
|
| 219 |
Further Scope of Research |
2023-08-04 |
|
|
| 220 |
Consent Statement |
2023-08-03 |
|
|
| 221 |
Conclusions and Future Efforts |
2023-08-03 |
|
|
| 222 |
Recent Issues in Optimal Management and Future Direction |
2023-08-01 |
|
|
| 223 |
Entities of PTCL with Recent Advances |
2023-08-01 |
|
|
| 224 |
Recommendations for further studies |
2023-07-28 |
|
|
| 225 |
Main Body |
2023-07-28 |
|
|
| 226 |
Ayurveda in Management of Motor Neuron Disease |
2023-07-28 |
|
|
| 227 |
Induces Antioxidant Activities |
2023-07-28 |
|
|
| 228 |
Response of Plants to PBZ |
2023-07-28 |
|
|
| 229 |
Mode of Action |
2023-07-28 |
|
|
| 230 |
Traditional Uses |
2023-07-24 |
|
|
| 231 |
Interversion |
2023-07-24 |
|
|
| 232 |
Preparation of Ginger Tea Powder & Hibiscus Tea Powder At Home |
2023-07-24 |
|
|
| 233 |
The Present Study |
2023-07-20 |
|
|
| 234 |
Review of the Related Literature |
2023-07-20 |
|
|
| 235 |
Supplementary Material |
2023-07-19 |
|
|
| 236 |
Implications and Conclusions |
2023-07-18 |
|
|
| 237 |
Future Directions and Conclusion |
2023-07-18 |
|
|
| 238 |
Trial Registration Number |
2023-07-17 |
|
|
| 239 |
Ethics Standarts |
2023-07-01 |
|
|
| 240 |
Limitations of Current Study |
2023-06-30 |
|
|
| 241 |
Ethical Committee Approval |
2023-06-30 |
|
|
| 242 |
Declarations Ethical Statement |
2023-06-30 |
|
|
| 243 |
Source of Financial Grant |
2023-06-28 |
|
|
| 244 |
Data Flow |
2023-06-24 |
|
|
| 245 |
Patient Consent Statement |
2023-06-23 |
|
|
| 246 |
Ethical Consideration and Confidentiality |
2023-06-22 |
|
|
| 247 |
Policy Recommendation |
2023-06-20 |
|
|
| 248 |
Limitations of Review |
2023-06-16 |
|
|
| 249 |
Future research directions |
2023-06-08 |
|
|
| 250 |
Privacy-Preserving Techniques |
2023-06-08 |
|
|
| 251 |
Authenticity Declaration |
2023-06-07 |
|
|
| 252 |
Ethical Clearance and Consent for Participants |
2023-06-05 |
|
|
| 253 |
Disclosure of Potential Conflict of Interest |
2023-06-05 |
|
|
| 254 |
Data Availability Statement for this Work |
2023-06-03 |
|
|
| 255 |
Limitations of the Study and Suggestions for Future Research |
2023-06-01 |
|
|
| 256 |
Acknowledgment |
2023-06-01 |
|
|
| 257 |
DISCUSSION |
2023-06-01 |
|
|
| 258 |
Declaration of Interestsâ?? Statement |
2023-06-01 |
|
|
| 259 |
Research Funding |
2023-05-31 |
|
|
| 260 |
Abbrivations |
2023-05-31 |
|
|
| 261 |
Data Presentation and Analysis and Interpretations |
2023-05-29 |
|
|
| 262 |
Variables |
2023-05-29 |
|
|
| 263 |
Data Management and Analysis Plan |
2023-05-29 |
|
|
| 264 |
Literature Review and Related Work |
2023-05-22 |
|
|
| 265 |
Subjects |
2023-05-10 |
|
|
| 266 |
CONCLUSION |
2023-05-10 |
|
|
| 267 |
Patents |
2023-05-08 |
|
|
| 268 |
Ethical Conduct of Research |
2023-05-06 |
|
|
| 269 |
DISCUSSION |
2023-05-05 |
|
|
| 270 |
Scope and Limitations Of The Study |
2023-05-04 |
|
|
| 271 |
PICTORIAL ABSTRACT |
2023-05-04 |
|
|
| 272 |
Recommendations for Future Research and Practice |
2023-05-03 |
|
|
| 273 |
Scope of Future Study |
2023-05-03 |
|
|
| 274 |
DISCUSSION |
2023-05-03 |
|
|
| 275 |
Herbal Soap Evaluation |
2023-04-29 |
|
|
| 276 |
Greeks |
2023-04-28 |
|
|
| 277 |
Subscripts |
2023-04-28 |
|
|
| 278 |
Nomenclature |
2023-04-28 |
|
|
| 279 |
Advantages and Disadvantages of Herbal Plants |
2023-04-27 |
|
|
| 280 |
Importance And Benefits of Medicinal Plants |
2023-04-27 |
|
|
| 281 |
Recent Insight Into Medicinal Plants and their Classes |
2023-04-27 |
|
|
| 282 |
Research Design and Methodology |
2023-04-27 |
|
|
| 283 |
Funding’s |
2023-04-26 |
|
|
| 284 |
Fundingâ??s |
2023-04-26 |
|
|
| 285 |
Fundingâ??s |
2023-04-26 |
|
|
| 286 |
Funding Info |
2023-04-11 |
|
|
| 287 |
Conclusion and Summary |
2023-04-07 |
|
|
| 288 |
Case Study and Data Collection |
2023-04-07 |
|
|
| 289 |
Case Note |
2023-04-06 |
|
|
| 290 |
Limitation and Future direction |
2023-04-05 |
|
|
| 291 |
Mathematical Methods |
2023-04-03 |
|
|
| 292 |
Statement of Ethics and Consent |
2023-03-28 |
|
|
| 293 |
Sources and References |
2023-03-28 |
|
|
| 294 |
Neurological Symptoms and Physical Examination |
2023-03-27 |
|
|
| 295 |
Materials and Methods |
2023-03-27 |
|
|
| 296 |
Limitation of Study |
2023-03-24 |
|
|
| 297 |
Results and Follow up |
2023-03-23 |
|
|
| 298 |
Considerations |
2023-03-21 |
|
|
| 299 |
Clinical Presentation |
2023-03-20 |
|
|
| 300 |
Technology-5G |
2023-03-20 |
|
|
| 301 |
Research Involving Human Participant and/or Animals |
2023-03-20 |
|
|
| 302 |
Research Involving Human Participant and/or Animals |
2023-03-20 |
|
|
| 303 |
Conclusions and Future Recommendations |
2023-03-18 |
|
|
| 304 |
Role of Authors |
2023-03-17 |
|
|
| 305 |
Addressing the Challenge |
2023-03-17 |
|
|
| 306 |
Limitations of this Study |
2023-03-13 |
|
|
| 307 |
Disclosures of Conflicts of Interest |
2023-03-06 |
|
|
| 308 |
Implications For Nursing Management |
2023-03-02 |
|
|
| 309 |
Does The Recall Process Initiate the DP? |
2023-02-28 |
|
|
| 310 |
The Recall Process and the Dopaminergic Pathway |
2023-02-28 |
|
|
| 311 |
The Dopaminergic Pathway |
2023-02-28 |
|
|
| 312 |
Human Addiction: An Explanation |
2023-02-28 |
|
|
| 313 |
Authors Consideration |
2023-02-28 |
|
|
| 314 |
Results & Discussion |
2023-02-28 |
|
|
| 315 |
Ethical Protocol |
2023-02-24 |
|
|
| 316 |
Publishers Note |
2023-02-23 |
|
|
| 317 |
Ethics and Patient Consent |
2023-02-23 |
|
|
| 318 |
Financing Source |
2023-02-16 |
|
|
| 319 |
Aim/Goal of the Study |
2023-02-15 |
|
|
| 320 |
Problem Definition |
2023-02-15 |
|
|
| 321 |
Declaration of Conflicting Interests Statement |
2023-02-15 |
|
|
| 322 |
Chemotherapy |
2023-02-07 |
|
|
| 323 |
Parameters |
2023-02-06 |
|
|
| 324 |
Authorsâ?? Information |
2023-01-24 |
|
|
| 325 |
Authorsâ?? Information |
2023-01-24 |
|
|
| 326 |
Authorsâ?? Information |
2023-01-24 |
|
|
| 327 |
Authors’ Information |
2023-01-24 |
|
|
| 328 |
Authorsâ?? Information |
2023-01-24 |
|
|
| 329 |
Authorsâ?? Information |
2023-01-24 |
|
|
| 330 |
Authorsâ?? Information |
2023-01-24 |
|
|
| 331 |
Abbrevation: |
2023-01-24 |
|
|
| 332 |
Treatment and Vaccines |
2023-01-24 |
|
|
| 333 |
Types of Leishmaniasis |
2023-01-24 |
|
|
| 334 |
Types of Eczema |
2023-01-23 |
|
|
| 335 |
Diagnosis of ALPS |
2023-01-23 |
|
|
| 336 |
Clinical and Laboratory Features |
2023-01-23 |
|
|
| 337 |
Inheritance and ALPS |
2023-01-23 |
|
|
| 338 |
Clinical Data |
2023-01-23 |
|
|
| 339 |
Judicial Precedents |
2023-01-20 |
|
|
| 340 |
Method/Design |
2023-01-19 |
|
|
| 341 |
Limitations of the review |
2023-01-13 |
|
|
| 342 |
Geographical disparities |
2023-01-13 |
|
|
| 343 |
Attitude |
2023-01-13 |
|
|
| 344 |
Poor communication |
2023-01-13 |
|
|
| 345 |
Infrastructure |
2023-01-13 |
|
|
| 346 |
Time |
2023-01-13 |
|
|
| 347 |
Skill deficit |
2023-01-13 |
|
|
| 348 |
The Development of Social Interaction in Early Children with Autism |
2023-01-13 |
|
|
| 349 |
Use of Learning Media in Developing Social Interaction |
2023-01-13 |
|
|
| 350 |
Instrument Reliability |
2023-01-13 |
|
|
| 351 |
Instrument Validity |
2023-01-12 |
|
|
| 352 |
Population and Sample |
2023-01-12 |
|
|
| 353 |
Ethical Review |
2023-01-07 |
|
|
| 354 |
Method and Materials |
2023-01-07 |
|
|
| 355 |
Declaration of Anonymity |
2023-01-06 |
|
|
| 356 |
Inference |
2023-01-04 |
|
|
| 357 |
Standard Curve of Fluconazole |
2023-01-03 |
|
|
| 358 |
Evaluation of Fluconazole Gel |
2023-01-03 |
|
|
| 359 |
Meterials and Methodology |
2023-01-03 |
|
|
| 360 |
Instruments |
2023-01-03 |
|
|
| 361 |
Life Satisfaction |
2023-01-03 |
|
|
| 362 |
Compulsive Buying Behaviour |
2023-01-03 |
|
|
| 363 |
Typical design of pv solar system |
2023-01-02 |
|
|
| 364 |
Marketing Implications |
2023-01-02 |
|
|
| 365 |
Discussion and Recommendations |
2023-01-02 |
|
|
| 366 |
Algorithm for Treatment |
2022-12-27 |
|
|
| 367 |
Antibiotic Associated Encephalopathy |
2022-12-27 |
|
|
| 368 |
Antibiotics Causing Aseptic Meningitis |
2022-12-27 |
|
|
| 369 |
Antibiotics and Dysguesia |
2022-12-27 |
|
|
| 370 |
Antibiotics and Idiopathic Intracranial Hypertension |
2022-12-27 |
|
|
| 371 |
Antibiotics and Movement Disorders |
2022-12-27 |
|
|
| 372 |
Antibiotics Causing Myopathy |
2022-12-27 |
|
|
| 373 |
Antibiotics Provoking Seizure |
2022-12-27 |
|
|
| 374 |
Tetracyclines |
2022-12-27 |
|
|
| 375 |
Sulphonamides |
2022-12-27 |
|
|
| 376 |
Rifabutins |
2022-12-27 |
|
|
| 377 |
Quinolones |
2022-12-27 |
|
|
| 378 |
Polymyxins |
2022-12-27 |
|
|
| 379 |
Penicillin |
2022-12-27 |
|
|
| 380 |
Nitrofurantoin |
2022-12-27 |
|
|
| 381 |
Metronidazole |
2022-12-27 |
|
|
| 382 |
Linezolid |
2022-12-27 |
|
|
| 383 |
Isoniazid |
2022-12-27 |
|
|
| 384 |
Fluoroquinolones |
2022-12-27 |
|
|
| 385 |
Ethambutol |
2022-12-27 |
|
|
| 386 |
Clioquinol |
2022-12-27 |
|
|
| 387 |
Clarithromycin Induced Neurotoxicity |
2022-12-27 |
|
|
| 388 |
Chloroquine |
2022-12-27 |
|
|
| 389 |
Chloramphenicol |
2022-12-27 |
|
|
| 390 |
Cephalosporin Induced Neurotoxicity |
2022-12-27 |
|
|
| 391 |
Beta Lactam Induced Neurotoxicity |
2022-12-27 |
|
|
| 392 |
Aminoglycosides (AG) |
2022-12-27 |
|
|
| 393 |
Authors and Affiliations |
2022-12-27 |
|
|
| 394 |
Availability of Supporting Data |
2022-12-27 |
|
|
| 395 |
Retrotransposon Association and Types of Neurological Disorders Diagnosed as a Consequence of SARS-CoV-2 mRNA Vaccination |
2022-12-27 |
|
|
| 396 |
DNA Break Repair Mechanisms: When RNA meets DNA |
2022-12-27 |
|
|
| 397 |
DNA Repair Mechanisms: An Active Role for Polymerase Theta |
2022-12-27 |
|
|
| 398 |
Spike Protein, Inflammation, Syncytia, DNA Damage and Senescence |
2022-12-27 |
|
|
| 399 |
Potential for Spike Protein Induction of Oncogenic Signaling via JAK/STAT3 Pathway |
2022-12-27 |
|
|
| 400 |
Potential for Inducing Oncogenesis and Metastasis: The Role of Stem Cells |
2022-12-27 |
|
|
| 401 |
mRNA SARS-CoV-2 Vaccination can Cause Interference with Human Genomic DNA like Other Viral RNAs |
2022-12-27 |
|
|
| 402 |
Does the Spike Protein Enhance Risk to Prion Disease via LINE-1? |
2022-12-27 |
|
|
| 403 |
The Mobile Genetic Elements and Neurological Disease Etiopathogenesis |
2022-12-27 |
|
|
| 404 |
Does Cancer Increase Risk of Retrotranscription of Spike mRNA? |
2022-12-27 |
|
|
| 405 |
LINE-1-Mediated Reverse Transcription of Vaccine mRNA |
2022-12-27 |
|
|
| 406 |
Challenges and Risk Mitigation |
2022-12-27 |
|
|
| 407 |
Benefits of Metaverse and Block chain in Medicine |
2022-12-27 |
|
|
| 408 |
Metaverse Physicians |
2022-12-27 |
|
|
| 409 |
Management and Data Collection |
2022-12-23 |
|
|
| 410 |
The Support for the Position of Minority Groups |
2022-12-23 |
|
|
| 411 |
Supporting Data for Cannabis Use |
2022-12-23 |
|
|
| 412 |
Developmental Trauma Evidence |
2022-12-23 |
|
|
| 413 |
|
2022-12-22 |
|
|
| 414 |
Future Directions |
2022-12-20 |
|
|
| 415 |
Recommendation for policy and practice |
2022-12-20 |
|
|
| 416 |
Experimental Technique |
2022-12-16 |
|
|
| 417 |
Data and Materials Requirements |
2022-12-14 |
|
|
| 418 |
Research Limitation and Future Studies |
2022-12-13 |
|
|
| 419 |
Budgeting |
2022-12-13 |
|
|
| 420 |
Limitations of the Literature Review |
2022-12-06 |
|
|
| 421 |
Database and Methods |
2022-11-29 |
|
|
| 422 |
Methods and Methodology |
2022-11-26 |
|
|
| 423 |
Recommendation for Future Study |
2022-11-26 |
|
|
| 424 |
Mathematical Derivation of the Model |
2022-11-24 |
|
|
| 425 |
Physical Derivation of the Model |
2022-11-24 |
|
|
| 426 |
Informed Consent and Patient Details |
2022-11-21 |
|
|
| 427 |
Funding Declaration |
2022-11-18 |
|
|
| 428 |
Author Contribution Statement |
2022-11-18 |
|
|
| 429 |
Analysis of Results |
2022-11-17 |
|
|
| 430 |
Statements & Declarations |
2022-11-17 |
|
|
| 431 |
Hypothetical Foundation |
2022-11-16 |
|
|
| 432 |
Social Media and Health |
2022-11-16 |
|
|
| 433 |
Orchid |
2022-11-16 |
|
|
| 434 |
Natural Disasters due to Climate Change |
2022-11-16 |
|
|
| 435 |
Impacts on Environment |
2022-11-16 |
|
|
| 436 |
Types of Microplastics |
2022-11-16 |
|
|
| 437 |
Impact on Human Health |
2022-11-16 |
|
|
| 438 |
Type of Program to Measure |
2022-11-15 |
|
|
| 439 |
Research Instrument |
2022-11-15 |
|
|
| 440 |
Applied Behavioral Analysis (ABA) |
2022-11-15 |
|
|
| 441 |
Five Dimensional Lie Algebras |
2022-11-14 |
|
|
| 442 |
The Canonical Lie Group Connection |
2022-11-14 |
|
|
| 443 |
Dedication |
2022-11-11 |
|
|
| 444 |
Undertaking |
2022-11-11 |
|
|
| 445 |
Meterials and Methods |
2022-11-10 |
|
|
| 446 |
Authors Contribution |
2022-11-09 |
|
|
| 447 |
Case Report 3 |
2022-11-09 |
|
|
| 448 |
Case Report 2 |
2022-11-09 |
|
|
| 449 |
Case Report 1 |
2022-11-09 |
|
|
| 450 |
General Symptoms |
2022-11-09 |
|
|
| 451 |
Scales of Measurement |
2022-11-08 |
|
|
| 452 |
Implications of the Findings |
2022-11-04 |
|
|
| 453 |
Recommendations and Suggestions |
2022-11-04 |
|
|
| 454 |
Study Question |
2022-11-04 |
|
|
| 455 |
Implications for Practice |
2022-11-03 |
|
|
| 456 |
Experimental Project Hypothesis |
2022-11-03 |
|
|
| 457 |
Research Questions and Hypothesis |
2022-11-02 |
|
|
| 458 |
Survey Instrument |
2022-11-01 |
|
|
| 459 |
Acknowledgements and Funding |
2022-10-31 |
|
|
| 460 |
Subjective Heading |
2022-10-29 |
|
|
| 461 |
Ethical Approval and Consent of Participate |
2022-10-28 |
|
|
| 462 |
Discussion and Literature Review |
2022-10-28 |
|
|
| 463 |
Methods/Design |
2022-10-25 |
|
|
| 464 |
Implications of the Study |
2022-10-21 |
|
|
| 465 |
Principles and Methods |
2022-10-20 |
|
|
| 466 |
Mdd and Brain Non-locality |
2022-10-20 |
|
|
| 467 |
Brain Non-locality |
2022-10-20 |
|
|
| 468 |
Mdd Affected Areas |
2022-10-20 |
|
|
| 469 |
Author's Contribution |
2022-10-20 |
|
|
| 470 |
Authors Ethical Approval |
2022-10-20 |
|
|
| 471 |
Human Ethics |
2022-10-18 |
|
|
| 472 |
Ethical Standard |
2022-10-18 |
|
|
| 473 |
Method and Methodology |
2022-10-17 |
|
|
| 474 |
Structural Characteristics |
2022-10-17 |
|
|
| 475 |
Humoral Immunity |
2022-10-14 |
|
|
| 476 |
Limitation of the Review |
2022-10-14 |
|
|
| 477 |
Investigations |
2022-10-13 |
|
|
| 478 |
Toxicology |
2022-10-13 |
|
|
| 479 |
Phytochemical Investigation |
2022-10-13 |
|
|
| 480 |
Traditional Uses Of Aegle Marmelos |
2022-10-13 |
|
|
| 481 |
Other Staining Techniques |
2022-10-13 |
|
|
| 482 |
Orcid |
2022-10-12 |
|
|
| 483 |
Dispatch marketing |
2022-10-12 |
|
|
| 484 |
Limitation and Future Research |
2022-10-12 |
|
|
| 485 |
Geomorphological and Climatic Conditions |
2022-10-11 |
|
|
| 486 |
Immunotherapeutic Strategies |
2022-10-07 |
|
|
| 487 |
Photodynamic Therapy |
2022-10-03 |
|
|
| 488 |
Institutional board review statement |
2022-09-30 |
|
|
| 489 |
Credit Author Statement |
2022-09-30 |
|
|
| 490 |
Conflicts of Interest and Source of Funding |
2022-09-29 |
|
|
| 491 |
Purpose of the Study |
2022-09-29 |
|
|
| 492 |
Case Reports |
2022-09-28 |
|
|
| 493 |
Materials and Preoperative Patient Preparation |
2022-09-27 |
|
|
| 494 |
Statement of Using Databases |
2022-09-26 |
|
|
| 495 |
Availability of Data and Material |
2022-09-26 |
|
|
| 496 |
Funding/Support |
2022-09-26 |
|
|
| 497 |
Design, Prisciple, and Speech Recogntition |
2022-09-24 |
|
|
| 498 |
Characteristics of Informal Education(IE) |
2022-09-24 |
|
|
| 499 |
Early Childhood Education Important |
2022-09-24 |
|
|
| 500 |
Purpose of Early Childhood Education |
2022-09-24 |
|
|
| 501 |
Characteristics of Adult Education |
2022-09-24 |
|
|
| 502 |
Percutaneous Anthropometry |
2022-09-23 |
|
|
| 503 |
Authors Contributions Statement |
2022-09-23 |
|
|
| 504 |
Recommendation for Future Studies |
2022-09-22 |
|
|
| 505 |
Results and Conclusion |
2022-09-22 |
|
|
| 506 |
Potential cellular and molecular mechanisms of AIH-induced plasticity |
2022-09-21 |
|
|
| 507 |
AIH improves motor functions in human patients with incomplete chronic SCI |
2022-09-21 |
|
|
| 508 |
AIH induces plasticity and improves functional recovery in SCI rats |
2022-09-21 |
|
|
| 509 |
Acute intermittent hypoxia (AIH) |
2022-09-21 |
|
|
| 510 |
Fraction Analysis |
2022-09-20 |
|
|
| 511 |
Column Chromatography |
2022-09-20 |
|
|
| 512 |
Different Extraction Methods |
2022-09-20 |
|
|
| 513 |
Chronic intermittent hypoxia (CIH) |
2022-09-20 |
|
|
| 514 |
Changes During Ripening |
2022-09-19 |
|
|
| 515 |
Factors Influencing Embryo Culture |
2022-09-19 |
|
|
| 516 |
Embryo Culture Methods |
2022-09-19 |
|
|
| 517 |
Treatment to Break Dormancy in Seeds |
2022-09-19 |
|
|
| 518 |
Methods of Breaking Seed Dormancy |
2022-09-19 |
|
|
| 519 |
Types of Seed Dormancy |
2022-09-19 |
|
|
| 520 |
Photorespiration Process |
2022-09-19 |
|
|
| 521 |
Plant Tissue Culture Technique |
2022-09-19 |
|
|
| 522 |
Principle of Plant Tissue Culture |
2022-09-19 |
|
|
| 523 |
Case Presentation of the Model |
2022-09-17 |
|
|
| 524 |
Trial Registration |
2022-09-16 |
|
|
| 525 |
Recommendations and Implications |
2022-09-15 |
|
|
| 526 |
Limitations and Opportunities for Future Research |
2022-09-15 |
|
|
| 527 |
Limitations and Opportunities for FuÂture Research |
2022-09-15 |
|
|
| 528 |
Literature Review and Theoretical Foundation |
2022-09-15 |
|
|
| 529 |
Biological Applications |
2022-09-15 |
|
|
| 530 |
Vitamin Content Determination |
2022-09-15 |
|
|
| 531 |
Empirical Results |
2022-09-15 |
|
|
| 532 |
Comparison |
2022-09-15 |
|
|
| 533 |
Authors’ Contributions Statement |
2022-09-14 |
|
|
| 534 |
Authors' Contributions |
2022-09-14 |
|
|
| 535 |
Authorsâ?? Contributions Statement |
2022-09-14 |
|
|
| 536 |
Credit Authorship Contribution Statement |
2022-09-14 |
|
|
| 537 |
Properties of Petroleum |
2022-09-14 |
|
|
| 538 |
Chemical Composition |
2022-09-14 |
|
|
| 539 |
Environmental Impacts |
2022-09-14 |
|
|
| 540 |
Disadvantages of Fossil Fuel |
2022-09-14 |
|
|
| 541 |
Advantages of Fossil Fuel |
2022-09-14 |
|
|
| 542 |
Types of Fossil Fuels |
2022-09-14 |
|
|
| 543 |
Transparent Electrode Materials |
2022-09-13 |
|
|
| 544 |
The Electrodynamic Screen (EDS) |
2022-09-13 |
|
|
| 545 |
Permission to Publish |
2022-09-13 |
|
|
| 546 |
Limitations and Future Prospects |
2022-09-13 |
|
|
| 547 |
Types of Alternative Fuels |
2022-09-13 |
|
|
| 548 |
Future Scope of the Study |
2022-09-13 |
|
|
| 549 |
Performance Results of Optimized Pump Designs |
2022-09-13 |
|
|
| 550 |
Design Optimization Methodology |
2022-09-13 |
|
|
| 551 |
Miniature Axial-Centrifugal Flow Pump Design |
2022-09-13 |
|
|
| 552 |
Integration of Theoretical Models into a Meta-Framework |
2022-09-13 |
|
|
| 553 |
The Scientific Payoffs of w-phase |
2022-09-13 |
|
|
| 554 |
The Scientific Payoffs of Ï?-phase |
2022-09-13 |
|
|
| 555 |
Classification of w-phases |
2022-09-13 |
|
|
| 556 |
Classification of Ï?-phases |
2022-09-13 |
|
|
| 557 |
Ethical Publication Statement |
2022-09-12 |
|
|
| 558 |
Additional File |
2022-09-12 |
|
|
| 559 |
Achievements |
2022-09-12 |
|
|
| 560 |
Progress |
2022-09-12 |
|
|
| 561 |
Previous Studies |
2022-09-12 |
|
|
| 562 |
History of Animal Biotechnology in Ethiopia |
2022-09-12 |
|
|
| 563 |
Sponsor-None |
2022-09-06 |
|
|
| 564 |
Direction for Future Research |
2022-09-05 |
|
|
| 565 |
Patient Perspective |
2022-09-02 |
|
|
| 566 |
Clinical Findings |
2022-09-02 |
|
|
| 567 |
Limitations and Recommendations |
2022-08-27 |
|
|
| 568 |
Scope and Limitation of the Study |
2022-08-27 |
|
|
| 569 |
Dataset and Methodology |
2022-08-26 |
|
|
| 570 |
Decision and reasons |
2022-08-25 |
|
|
| 571 |
Outcomes |
2022-08-23 |
|
|
| 572 |
Root length and shoot length |
2022-08-22 |
|
|
| 573 |
Measurements |
2022-08-20 |
|
|
| 574 |
Conclusion, Recommendations and Limitations |
2022-08-20 |
|
|
| 575 |
Literature and hypothesis |
2022-08-20 |
|
|
| 576 |
Case Discussion |
2022-08-19 |
|
|
| 577 |
Case |
2022-08-19 |
|
|
| 578 |
Study population |
2022-08-19 |
|
|
| 579 |
Conclsuion |
2022-08-19 |
|
|
| 580 |
Declaration of Conflicts of Interest |
2022-08-18 |
|
|
| 581 |
Statistics |
2022-08-18 |
|
|
| 582 |
Plant-friendly Microorganisms |
2022-08-17 |
|
|
| 583 |
Digitalization Opportunities |
2022-08-17 |
|
|
| 584 |
Source of Support |
2022-08-17 |
|
|
| 585 |
Case Presentation and Therapy |
2022-08-17 |
|
|
| 586 |
Categorization |
2022-08-11 |
|
|
| 587 |
Data Set Description |
2022-08-11 |
|
|
| 588 |
Case Image |
2022-08-11 |
|
|
| 589 |
Medications |
2022-08-10 |
|
|
| 590 |
Body Composition Assessment |
2022-08-09 |
|
|
| 591 |
Association between Insulin and Body Composition |
2022-08-09 |
|
|
| 592 |
Correlations |
2022-08-09 |
|
|
| 593 |
Recommendations for Further Research |
2022-08-09 |
|
|
| 594 |
Neuro Protective Herbal Plants |
2022-08-08 |
|
|
| 595 |
Neurodegenerative Treatment Targets |
2022-08-08 |
|
|
| 596 |
History Background Of Reforms |
2022-08-04 |
|
|
| 597 |
Patients & Methods |
2022-08-03 |
|
|
| 598 |
Multidisciplinary Obesity Clinic |
2022-08-03 |
|
|
| 599 |
Clinical Applications |
2022-08-03 |
|
|
| 600 |
Statement of Funding Information |
2022-08-02 |
|
|
| 601 |
Delivery Systems |
2022-08-02 |
|
|
| 602 |
Operational Definitions |
2022-08-02 |
|
|
| 603 |
Future study and scope |
2022-08-02 |
|
|
| 604 |
Forensic transcription |
2022-08-01 |
|
|
| 605 |
Purpose of Forensic Odontology |
2022-08-01 |
|
|
| 606 |
Future Direction |
2022-08-01 |
|
|
| 607 |
Implications and Recommendations |
2022-08-01 |
|
|
| 608 |
Study Strengths and Limitations |
2022-08-01 |
|
|
| 609 |
Solitary Sclerosis as a Connectomopathy |
2022-08-01 |
|
|
| 610 |
Evidence of Extensive Brain Involvement in Solitary Sclerosis |
2022-08-01 |
|
|
| 611 |
Solitary Sclerosis |
2022-08-01 |
|
|
| 612 |
Scope for Future Work |
2022-07-30 |
|
|
| 613 |
Advantages and Disadvantages |
2022-07-30 |
|
|
| 614 |
Book Review |
2022-07-28 |
|
|
| 615 |
Supplemental Analysis |
2022-07-28 |
|
|
| 616 |
Annexes |
2022-07-28 |
|
|
| 617 |
Conflicting Interests |
2022-07-27 |
|
|
| 618 |
Antibacterial assay |
2022-07-27 |
|
|
| 619 |
Declaration of Authorship, Good Practices and Assignment of Rights |
2022-07-27 |
|
|
| 620 |
Clinical Report |
2022-07-27 |
|
|
| 621 |
MICROBIOLOGY |
2022-07-27 |
|
|
| 622 |
Description of Research |
2022-07-27 |
|
|
| 623 |
Psychotic Disorders |
2022-07-27 |
|
|
| 624 |
Use of bioinformatics in SARS CoV-2 infection in intestine |
2022-07-27 |
|
|
| 625 |
Application of SWOT-Analytic Hierarchy Process Method |
2022-07-26 |
|
|
| 626 |
SWOT Analysis Method |
2022-07-26 |
|
|
| 627 |
Multiple Linear Correlation |
2022-07-26 |
|
|
| 628 |
ACUTE GASTROENTERITIS |
2022-07-26 |
|
|
| 629 |
DEFENSINS AS ANTIMICROBIAL PEPTIDES |
2022-07-26 |
|
|
| 630 |
INFLAMMATORY BOWEL DISEASES |
2022-07-26 |
|
|
| 631 |
WHY TO ATTEND DIABETE SUMMIT 2021 CONFERENCE? |
2022-07-26 |
|
|
| 632 |
GUEST EDITOR BENEFITS |
2022-07-26 |
|
|
| 633 |
ROLES AND RESPONSIBILITY |
2022-07-26 |
|
|
| 634 |
Regional Insights |
2022-07-26 |
|
|
| 635 |
WHY SHOULD ATTEND? |
2022-07-26 |
|
|
| 636 |
N-linked Glycosylation and Its Potential within Different Rat Strain´S Pharmacology Basic Research |
2022-07-26 |
|
|
| 637 |
In Adequacy of Specialists and its Importance |
2022-07-26 |
|
|
| 638 |
Discussion of Results |
2022-07-25 |
|
|
| 639 |
Material and Study Methods |
2022-07-25 |
|
|
| 640 |
Sources |
2022-07-23 |
|
|
| 641 |
Referencias Bibliograficas |
2022-07-22 |
|
|
| 642 |
Disclosures and Declarations |
2022-07-21 |
|
|
| 643 |
Areas for Further Studies |
2022-07-21 |
|
|
| 644 |
Literature of the Study |
2022-07-21 |
|
|
| 645 |
Interventions |
2022-07-19 |
|
|
| 646 |
Biomass Conversion Methods |
2022-07-18 |
|
|
| 647 |
Types of Biomass |
2022-07-18 |
|
|
| 648 |
Mitigation Measures of Volcanic Eruption |
2022-07-18 |
|
|
| 649 |
Main Cause of A Volcano |
2022-07-18 |
|
|
| 650 |
Risk Mitigation Measures |
2022-07-18 |
|
|
| 651 |
Cause of An Earthquake |
2022-07-18 |
|
|
| 652 |
Types of Groundwater Contamination |
2022-07-18 |
|
|
| 653 |
Ground Water Quality |
2022-07-18 |
|
|
| 654 |
Effect of Groundwater Usage |
2022-07-18 |
|
|
| 655 |
Ethics Approval and Consent to the Study |
2022-07-16 |
|
|
| 656 |
Statements and Declarations |
2022-07-15 |
|
|
| 657 |
Disclosure of Interest Statement |
2022-07-12 |
|
|
| 658 |
Recommendation for Further Research |
2022-07-12 |
|
|
| 659 |
Finding of the Study |
2022-07-12 |
|
|
| 660 |
Model of Respiratory Rehabilitation and Recovery |
2022-07-06 |
|
|
| 661 |
Review Findings and Discussion |
2022-07-05 |
|
|
| 662 |
Patient and Methods |
2022-07-04 |
|
|
| 663 |
Risk Factors |
2022-07-04 |
|
|
| 664 |
Screening |
2022-07-04 |
|
|
| 665 |
Disclaimer Statement |
2022-07-02 |
|
|
| 666 |
Expected Outcomes |
2022-07-02 |
|
|
| 667 |
Reproducibility of Results |
2022-07-02 |
|
|
| 668 |
Dissemination Policy |
2022-07-02 |
|
|
| 669 |
Ancillary and Post Trial Care |
2022-07-02 |
|
|
| 670 |
Open Access to Data |
2022-07-02 |
|
|
| 671 |
Confidentiality |
2022-07-02 |
|
|
| 672 |
Informed Consent Process |
2022-07-02 |
|
|
| 673 |
Clinical Trial Registry |
2022-07-02 |
|
|
| 674 |
Research Ethics Approval |
2022-07-02 |
|
|
| 675 |
Auditing |
2022-07-02 |
|
|
| 676 |
Availability for Supporting Data |
2022-07-01 |
|
|
| 677 |
Human and Animal Ethics |
2022-07-01 |
|
|
| 678 |
Limitation of this Study |
2022-07-01 |
|
|
| 679 |
Discussion of the Findings |
2022-07-01 |
|
|
| 680 |
Microbial analysis |
2022-06-30 |
|
|
| 681 |
Case Narrative |
2022-06-28 |
|
|
| 682 |
Educational Disabilities |
2022-06-27 |
|
|
| 683 |
Educational Services |
2022-06-27 |
|
|
| 684 |
Production and transport of plasma |
2022-06-27 |
|
|
| 685 |
Cellulose |
2022-06-27 |
|
|
| 686 |
Biomedical Materials |
2022-06-27 |
|
|
| 687 |
Funding or Support |
2022-06-27 |
|
|
| 688 |
Post-traumatic Feedback-loop |
2022-06-27 |
|
|
| 689 |
Galanin with the Stress Response |
2022-06-27 |
|
|
| 690 |
Information and Communication |
2022-06-27 |
|
|
| 691 |
Digital Literacy |
2022-06-27 |
|
|
| 692 |
Statements and Declaration |
2022-06-25 |
|
|
| 693 |
Future Prospects for Applying Muricibased Products From Supercritical Technology |
2022-06-25 |
|
|
| 694 |
Sequential Supercritical Extractions |
2022-06-25 |
|
|
| 695 |
Murici Biological/Bioactive Properties |
2022-06-25 |
|
|
| 696 |
Bioactive Compounds of Murici Pulp |
2022-06-25 |
|
|
| 697 |
Murici (Byrsonima crassifolia) |
2022-06-25 |
|
|
| 698 |
Sample Preparation |
2022-06-24 |
|
|
| 699 |
Anti-nutritional Factors |
2022-06-24 |
|
|
| 700 |
Data Sharing Statement |
2022-06-23 |
|
|
| 701 |
General Review |
2022-06-23 |
|
|
| 702 |
Principle of Justice |
2022-06-22 |
|
|
| 703 |
Ethical Principles |
2022-06-22 |
|
|
| 704 |
Importance of Ethics in Nursing Research |
2022-06-22 |
|
|
| 705 |
Specific Aims |
2022-06-22 |
|
|
| 706 |
Suggestions and Recommendations |
2022-06-22 |
|
|
| 707 |
Implication and Conclusion |
2022-06-22 |
|
|
| 708 |
Functional Properties |
2022-06-20 |
|
|
| 709 |
Research Context: Background |
2022-06-20 |
|
|
| 710 |
Authors' Information |
2022-06-18 |
|
|
| 711 |
Estimation Results |
2022-06-16 |
|
|
| 712 |
Model and Data |
2022-06-16 |
|
|
| 713 |
Consent to Publish Authors |
2022-06-16 |
|
|
| 714 |
Consent to Participate and Publish Participant |
2022-06-16 |
|
|
| 715 |
Availability of Date and Material |
2022-06-16 |
|
|
| 716 |
Abbreviation |
2022-06-16 |
|
|
| 717 |
Phytopharmaceutical Distinguishing Features |
2022-06-16 |
|
|
| 718 |
Summary and Concluding Remarks |
2022-06-15 |
|
|
| 719 |
Results of Model Evaluation |
2022-06-15 |
|
|
| 720 |
Cell Envelope |
2022-06-15 |
|
|
| 721 |
Concluding remarks and summary |
2022-06-15 |
|
|
| 722 |
Future Prespective |
2022-06-14 |
|
|
| 723 |
Nigerian Government Contributions |
2022-06-13 |
|
|
| 724 |
Portraying an Authentic Plot |
2022-06-13 |
|
|
| 725 |
The Oil Boom and Problems |
2022-06-13 |
|
|
| 726 |
History of Crude Oil In Nigeria |
2022-06-13 |
|
|
| 727 |
Formation of Crude Oil |
2022-06-13 |
|
|
| 728 |
Environmental Communication Theory |
2022-06-13 |
|
|
| 729 |
Information Technology and Environmental Communication |
2022-06-13 |
|
|
| 730 |
Authorâ??s Statements |
2022-06-13 |
|
|
| 731 |
Author’s Statements |
2022-06-13 |
|
|
| 732 |
Authorâ??s Statements |
2022-06-13 |
|
|
| 733 |
Scientific Evidence |
2022-06-13 |
|
|
| 734 |
Uses and Indications |
2022-06-10 |
|
|
| 735 |
Conclusion and Future Research Directions |
2022-06-10 |
|
|
| 736 |
The drivers of land use/land cover change in Ethiopia |
2022-06-10 |
|
|
| 737 |
Financial Disclosure Statement |
2022-06-09 |
|
|
| 738 |
Ethical Approval and Consent |
2022-06-09 |
|
|
| 739 |
Declaration of Non-duplication |
2022-06-09 |
|
|
| 740 |
Unconstrained Optimization vs. Constrained Optimization |
2022-06-08 |
|
|
| 741 |
Continuous Optimization vs. Discrete Optimization |
2022-06-08 |
|
|
| 742 |
Conclusion & Future Implications |
2022-06-08 |
|
|
| 743 |
Analysis of Survey Results and Discussion |
2022-06-08 |
|
|
| 744 |
Research |
2022-06-08 |
|
|
| 745 |
Pragmatic Disorder in ADHD |
2022-06-07 |
|
|
| 746 |
Pragmatic Assessment |
2022-06-07 |
|
|
| 747 |
Formalists vs. Functionalists in Speechlanguage Pathology |
2022-06-07 |
|
|
| 748 |
Pragmatic and Pragmatic Disorder |
2022-06-07 |
|
|
| 749 |
Methodology and Design |
2022-06-07 |
|
|
| 750 |
Literature Review and Methodology Concept of Discipline |
2022-06-07 |
|
|
| 751 |
Greenhouse Gases Effect on Earth |
2022-06-07 |
|
|
| 752 |
Consent for participation and publication |
2022-06-06 |
|
|
| 753 |
Pharmacological Evaluation |
2022-06-03 |
|
|
| 754 |
Declaration of Interest Statement |
2022-06-03 |
|
|
| 755 |
Future Works |
2022-06-02 |
|
|
| 756 |
Risk Mitigation Strategies |
2022-06-01 |
|
|
| 757 |
Supply Chain Risks |
2022-06-01 |
|
|
| 758 |
Supplier Loss and Provisory Plans |
2022-06-01 |
|
|
| 759 |
Facility Loss and Backup Plans |
2022-06-01 |
|
|
| 760 |
Suggestions for Future Researchers |
2022-06-01 |
|
|
| 761 |
Data Analysis and Discussion of Results |
2022-06-01 |
|
|
| 762 |
Types of Corporate Social Responsibility |
2022-06-01 |
|
|
| 763 |
Roles of Ngo’s |
2022-06-01 |
|
|
| 764 |
Roles of Ngoâ??s |
2022-06-01 |
|
|
| 765 |
Roles of Ngoâ??s |
2022-06-01 |
|
|
| 766 |
Roles of Ngoâ??s |
2022-06-01 |
|
|
| 767 |
Funding Disclosure |
2022-05-28 |
|
|
| 768 |
Limitations of the Study and Future Research |
2022-05-26 |
|
|
| 769 |
Discussing the results |
2022-05-26 |
|
|
| 770 |
Presentation and discussion of results |
2022-05-26 |
|
|
| 771 |
Research methodology and field procedures |
2022-05-26 |
|
|
| 772 |
Definitions |
2022-05-25 |
|
|
| 773 |
Impact of Soil Degradation on Food Productivity |
2022-05-25 |
|
|
| 774 |
Future Perspective |
2022-05-24 |
|
|
| 775 |
Conclusion and Findings |
2022-05-24 |
|
|
| 776 |
Conflict Statement |
2022-05-23 |
|
|
| 777 |
Statements of Ethics |
2022-05-21 |
|
|
| 778 |
Funding Support |
2022-05-21 |
|
|
| 779 |
Availability and Requirements |
2022-05-20 |
|
|
| 780 |
Impacts On Human Health |
2022-05-20 |
|
|
| 781 |
Advantages |
2022-05-20 |
|
|
| 782 |
Significance |
2022-05-20 |
|
|
| 783 |
Consent of the patient |
2022-05-17 |
|
|
| 784 |
LITERATURE REVIEW |
2022-05-13 |
|
|
| 785 |
About the Case Study |
2022-05-11 |
|
|
| 786 |
MOLECULAR DOCKING STUDY |
2022-05-10 |
|
|
| 787 |
Brayton Cycle Innovation in Atomic Designing Applications |
2022-05-10 |
|
|
| 788 |
On the Oxidation Instrument of Mishap Lenient Atomic Fuel |
2022-05-10 |
|
|
| 789 |
Supplementary Materials |
2022-05-09 |
|
|
| 790 |
Author Declarations |
2022-05-09 |
|
|
| 791 |
Credit Authors Contribution |
2022-05-09 |
|
|
| 792 |
Abbrevations |
2022-05-09 |
|
|
| 793 |
Declaration Section |
2022-05-09 |
|
|
| 794 |
Conclusion and Implications of the Research Findings for Practice |
2022-05-05 |
|
|
| 795 |
Prediction of Hot Keywords in Information Science Journals |
2022-05-05 |
|
|
| 796 |
Comparative Analysis of Keyword Characteristics between Information Discipline and the Whole Discipline |
2022-05-05 |
|
|
| 797 |
Analysis on the Evolution Track of Hot Keywords in Domestic Information Science Journals |
2022-05-05 |
|
|
| 798 |
Review of Research Work |
2022-05-05 |
|
|
| 799 |
Effect of nixtamalization on aflatoxins, functional and acceptability of maize |
2022-04-29 |
|
|
| 800 |
Effects on Aquatic Ecosytem |
2022-04-28 |
|
|
| 801 |
Impacts on Vegetation |
2022-04-28 |
|
|
| 802 |
Health Effects from Specific Pollutants |
2022-04-28 |
|
|
| 803 |
Impact on Human Health |
2022-04-28 |
|
|
| 804 |
Environmental Impact |
2022-04-28 |
|
|
| 805 |
Microplastics: Reductions and Solutions |
2022-04-28 |
|
|
| 806 |
Microplastics: In Wastewater Treatment |
2022-04-28 |
|
|
| 807 |
Microplastics: Through Air |
2022-04-28 |
|
|
| 808 |
Microplastics: Health Problems to Organisms |
2022-04-28 |
|
|
| 809 |
Microplastics: Concentration at Different Trophic Levels |
2022-04-28 |
|
|
| 810 |
Microplastics: Exposure to Food Chain or Food Web |
2022-04-28 |
|
|
| 811 |
Microplastics: Journey Through Food Chain or Food Web |
2022-04-28 |
|
|
| 812 |
Microplastics: Classification and Sources |
2022-04-28 |
|
|
| 813 |
Relevance |
2022-04-28 |
|
|
| 814 |
Key Objective |
2022-04-28 |
|
|
| 815 |
Expert Opinion |
2022-04-27 |
|
|
| 816 |
New timelines of medical device regulations |
2022-04-27 |
|
|
| 817 |
The Role of the Workload on the Computing Efficiency |
2022-04-26 |
|
|
| 818 |
The Importance of Imitating the Timely Behaviour |
2022-04-26 |
|
|
| 819 |
Limitations Due to Technical Implementation |
2022-04-26 |
|
|
| 820 |
Issues with Large Scale Computing |
2022-04-26 |
|
|
| 821 |
Terminology of Neuron Morphic Computing |
2022-04-26 |
|
|
| 822 |
Challenges and Opportunities Ethical Values |
2022-04-26 |
|
|
| 823 |
Modes of Establishing International Business |
2022-04-26 |
|
|
| 824 |
Advantages of Globalization |
2022-04-26 |
|
|
| 825 |
Globalization of International Business |
2022-04-26 |
|
|
| 826 |
Protein Evolution Analysis Service |
2022-04-26 |
|
|
| 827 |
Protein Structure Analysis Service |
2022-04-26 |
|
|
| 828 |
Protein Sequencing Analysis Services |
2022-04-26 |
|
|
| 829 |
Protein Sequencing |
2022-04-26 |
|
|
| 830 |
Emergent Therapies |
2022-04-25 |
|
|
| 831 |
Limitations to Current CAD Therapies |
2022-04-25 |
|
|
| 832 |
Current Diagnosis and Treatment of CAD |
2022-04-25 |
|
|
| 833 |
Health Promotion and Disease Prevention |
2022-04-25 |
|
|
| 834 |
Adjustment on Products by Agronomic Techniques |
2022-04-25 |
|
|
| 835 |
Analytical Techniques on Product Standardization |
2022-04-25 |
|
|
| 836 |
Phyto-Cannabinoids |
2022-04-25 |
|
|
| 837 |
Geographic Information |
2022-04-25 |
|
|
| 838 |
Taxonomy |
2022-04-25 |
|
|
| 839 |
Clinical Manifestations of Psychosis |
2022-04-25 |
|
|
| 840 |
COVID-19: Emerging Infection with Emerging Sequels |
2022-04-22 |
|
|
| 841 |
Benefits of Algae on Skin, Oral and Vision of Pets |
2022-04-21 |
|
|
| 842 |
Benefits of Algae on Skin, Oral and Vision of Pets< |
2022-04-21 |
|
|
| 843 |
Micro-Algal Immune Modulators in Pets |
2022-04-21 |
|
|
| 844 |
Algae With Immunomodulatory Activity |
2022-04-21 |
|
|
| 845 |
Role of Algae in Gut Health |
2022-04-21 |
|
|
| 846 |
Algae As Protein Ingredients in Pets |
2022-04-21 |
|
|
| 847 |
Future Prospective |
2022-04-21 |
|
|
| 848 |
Microalgae As A Potential Immune Modulator and Its Role in Gut Health Improvement in Poultry |
2022-04-21 |
|
|
| 849 |
Types of Immune Modulators |
2022-04-21 |
|
|
| 850 |
Immune Modulators and Mode of Action |
2022-04-21 |
|
|
| 851 |
Research Methodology |
2022-04-21 |
|
|
| 852 |
REFERENCES |
2022-04-20 |
|
|
| 853 |
Structure and Functions of Emmprin |
2022-04-19 |
|
|
| 854 |
Funding and Financial Disclosure |
2022-04-19 |
|
|
| 855 |
Prospects for the Future |
2022-04-19 |
|
|
| 856 |
Clinical Implications |
2022-04-19 |
|
|
| 857 |
Contributors |
2022-04-18 |
|
|
| 858 |
Review Article |
2022-04-18 |
|
|
| 859 |
Civic Solid Waste Management as a Luxury Element |
2022-04-18 |
|
|
| 860 |
Limited Research, Treatment, and Services |
2022-04-16 |
|
|
| 861 |
Diagnostic Ambiguity |
2022-04-16 |
|
|
| 862 |
Historical Overview of Schizophrenia Terminology |
2022-04-16 |
|
|
| 863 |
Anchoring |
2022-04-15 |
|
|
| 864 |
Common Treatments |
2022-04-12 |
|
|
| 865 |
Learning Points/Take Home Messages |
2022-04-12 |
|
|
| 866 |
Authors’ Information |
2022-04-11 |
|
|
| 867 |
Authorsâ?? Information |
2022-04-11 |
|
|
| 868 |
Authorsâ?? Information |
2022-04-11 |
|
|
| 869 |
Authors’ Information |
2022-04-11 |
|
|
| 870 |
Authorsâ?? Information |
2022-04-11 |
|
|
| 871 |
Authorsâ?? Information |
2022-04-11 |
|
|
| 872 |
Recovery |
2022-04-11 |
|
|
| 873 |
Authorsâ?? Information |
2022-04-11 |
|
|
| 874 |
Authorsâ?? Information |
2022-04-11 |
|
|
| 875 |
Symptoms and Types |
2022-04-11 |
|
|
| 876 |
Authorsâ?? Information |
2022-04-11 |
|
|
| 877 |
Availability of Data and Materials |
2022-04-11 |
|
|
| 878 |
Consent for Publication |
2022-04-11 |
|
|
| 879 |
Diagnosis and Treatment |
2022-04-11 |
|
|
| 880 |
Strengths and Limitations of this Study |
2022-04-11 |
|
|
| 881 |
Metal Compound Nanoparticles |
2022-04-11 |
|
|
| 882 |
Some nanoparticles and their Bactericidals action |
2022-04-11 |
|
|
| 883 |
Nanosystems role in overcoming Antibiotic resistance |
2022-04-11 |
|
|
| 884 |
Multidrug resistance (mdr) and Nanoparticles |
2022-04-11 |
|
|
| 885 |
Organic Nanosystems |
2022-04-11 |
|
|
| 886 |
Classification of Nanosystems |
2022-04-11 |
|
|
| 887 |
Nanoparticles |
2022-04-11 |
|
|
| 888 |
Concern Against The Amendment Act |
2022-04-11 |
|
|
| 889 |
Types of Criminal Laws |
2022-04-11 |
|
|
| 890 |
Elements of Criminal Law |
2022-04-11 |
|
|
| 891 |
Benefits and Drawbacks |
2022-04-11 |
|
|
| 892 |
Research Limitations |
2022-04-08 |
|
|
| 893 |
Research Tools |
2022-04-08 |
|
|
| 894 |
Sampling |
2022-04-08 |
|
|
| 895 |
Adaptive Immune Response |
2022-04-07 |
|
|
| 896 |
Innate Immune Response |
2022-04-07 |
|
|
| 897 |
Immune Responses to Infection |
2022-04-07 |
|
|
| 898 |
The Types of COVID-19 That Have Been Labelled as Variants of Concern are: |
2022-04-07 |
|
|
| 899 |
Variants of COVID-19 |
2022-04-07 |
|
|
| 900 |
Current Day and Moving Forward |
2022-04-06 |
|
|
| 901 |
Advances in Neurosurgery in the 1980S and 90S |
2022-04-06 |
|
|
| 902 |
Body Imaging Technology in the 1960S and 70S |
2022-04-06 |
|
|
| 903 |
Symptoms and Signs |
2022-04-06 |
|
|
| 904 |
Food Additives and Bioactive Food Chemicals |
2022-04-05 |
|
|
| 905 |
Funding Details |
2022-04-05 |
|
|
| 906 |
Appreciation |
2022-04-04 |
|
|
| 907 |
Psychiatric Disorders Found in other Neurocutaneous Syndrome |
2022-03-31 |
|
|
| 908 |
Research Problems |
2022-03-31 |
|
|
| 909 |
Author Contributions Statement |
2022-03-31 |
|
|
| 910 |
Pharmacological Levels of RA Alter Synaptic Plasticity |
2022-03-31 |
|
|
| 911 |
Research problem |
2022-03-30 |
|
|
| 912 |
Materiales y metodos |
2022-03-30 |
|
|
| 913 |
Material y metodos |
2022-03-30 |
|
|
| 914 |
Material y métodos |
2022-03-30 |
|
|
| 915 |
Material y métodos |
2022-03-30 |
|
|
| 916 |
Research Limitations and Suggestions |
2022-03-30 |
|
|
| 917 |
Conclusions/Concluding comments |
2022-03-30 |
|
|
| 918 |
Contact Information for Authors |
2022-03-29 |
|
|
| 919 |
Assessment of Problem |
2022-03-28 |
|
|
| 920 |
Summary and Prospect |
2022-03-23 |
|
|
| 921 |
Tax Subsidy for Local Buyers and Analysis of Equilibrium Situation |
2022-03-23 |
|
|
| 922 |
Analysis of Tax Collection of Non-resident Enterprises of Amazon Overseas Sellers in the United States |
2022-03-23 |
|
|
| 923 |
The Necessity of Taxing Non-resident Enterprises of Amazon Overseas Sellers in the United States |
2022-03-23 |
|
|
| 924 |
Operation of Amazon Overseas Sellers on Amazon Platform in USA |
2022-03-23 |
|
|
| 925 |
Operation of Amazon Overseas Sellers on Amazon Platform in USA |
2022-03-23 |
|
|
| 926 |
Tax Situation of Native American Enterprises |
2022-03-23 |
|
|
| 927 |
Types of Phytochemicals |
2022-03-22 |
|
|
| 928 |
Screening of Phytochemicals |
2022-03-22 |
|
|
| 929 |
Theory of Phytochemicals Analysis |
2022-03-22 |
|
|
| 930 |
Editoral |
2022-03-21 |
|
|
| 931 |
Drug Interactions |
2022-03-18 |
|
|
| 932 |
Indications |
2022-03-18 |
|
|
| 933 |
Results Interpretation and Discussion |
2022-03-17 |
|
|
| 934 |
Suggestion for Further Research |
2022-03-15 |
|
|
| 935 |
Literature of Review |
2022-03-11 |
|
|
| 936 |
Household Dependency Ratio |
2022-03-07 |
|
|
| 937 |
Role of Funding Source |
2022-03-04 |
|
|
| 938 |
Cloud Computing Migration Literature Review |
2022-03-03 |
|
|
| 939 |
Cloud Computing: A New Paradigm |
2022-03-03 |
|
|
| 940 |
Current State of Air Force Expeditionary Healthcare Information Technology |
2022-03-03 |
|
|
| 941 |
Current State of Air Force Expeditionary Healthcare Information Technology |
2022-03-03 |
|
|
| 942 |
Other Extrapulmonary Manifestations |
2022-03-03 |
|
|
| 943 |
Implementation |
2022-03-02 |
|
|
| 944 |
Proposed Approach |
2022-03-02 |
|
|
| 945 |
Comparative Study |
2022-03-02 |
|
|
| 946 |
Algorithm |
2022-03-02 |
|
|
| 947 |
Assumption |
2022-03-02 |
|
|
| 948 |
Experimental setup |
2022-03-02 |
|
|
| 949 |
Simulation |
2022-03-02 |
|
|
| 950 |
Mathematical Concept |
2022-03-02 |
|
|
| 951 |
Related Work |
2022-03-01 |
|
|
| 952 |
Challenges/Strategies |
2022-03-01 |
|
|
| 953 |
Local or national perspective |
2022-03-01 |
|
|
| 954 |
Global perspective |
2022-03-01 |
|
|
| 955 |
Conflicts of Interest/Competing Interest |
2022-02-28 |
|
|
| 956 |
Prevalence Rates of Child Maltreatment in High Income Countries |
2022-02-28 |
|
|
| 957 |
International Study of Cancer with Full Genotyping for Cervical Screening |
2022-02-28 |
|
|
| 958 |
Bio Fluid Mechanisms of Biological Flows and their Interrelationships |
2022-02-28 |
|
|
| 959 |
Bio International Society on Thrombosis and Haemostasis |
2022-02-26 |
|
|
| 960 |
Key Message |
2022-02-26 |
|
|
| 961 |
Brief Review on Clinical Pharmacology |
2022-02-26 |
|
|
| 962 |
Efforts to Promote Appropriate Transfusions and Avoid Unnecessary Transfusions |
2022-02-25 |
|
|
| 963 |
Simulation and Discussion |
2022-02-24 |
|
|
| 964 |
Results and Disscussion |
2022-02-24 |
|
|
| 965 |
Authorâ??s Contributions |
2022-02-24 |
|
|
| 966 |
Conclusion and Future Perspective |
2022-02-24 |
|
|
| 967 |
Limitation Statement |
2022-02-24 |
|
|
| 968 |
Beneficiary Effect of TEFF of Human Health |
2022-02-23 |
|
|
| 969 |
Antioxidant Properties of TEFF |
2022-02-23 |
|
|
| 970 |
Phyto Chemicals in TEFF |
2022-02-23 |
|
|
| 971 |
Nutritional Importance of TEFF |
2022-02-23 |
|
|
| 972 |
Safekeeping of Pediatric Diseases |
2022-02-23 |
|
|
| 973 |
Glossary of Abbreviations |
2022-02-23 |
|
|
| 974 |
Summary and Discussion |
2022-02-22 |
|
|
| 975 |
Advanced Neural Networks for All-Terminal Network Reliability Prediction |
2022-02-22 |
|
|
| 976 |
Multilingual Terminological E-Dictionary |
2022-02-22 |
|
|
| 977 |
Additional Information |
2022-02-22 |
|
|
| 978 |
Effects |
2022-02-22 |
|
|
| 979 |
Approach |
2022-02-22 |
|
|
| 980 |
Factors Affecting Consumer Loyalty |
2022-02-22 |
|
|
| 981 |
Importance of Consumer Satisfaction |
2022-02-22 |
|
|
| 982 |
Measurement of Consumer Satisfaction |
2022-02-22 |
|
|
| 983 |
Factors Affecting Consumer Satisfaction |
2022-02-22 |
|
|
| 984 |
Trust and Commitment |
2022-02-22 |
|
|
| 985 |
Managing Consumer Relationship |
2022-02-22 |
|
|
| 986 |
Editorial Note on New Form of Brain Surgery |
2022-02-21 |
|
|
| 987 |
Pollution |
2022-02-21 |
|
|
| 988 |
Modern Hazard |
2022-02-21 |
|
|
| 989 |
Traditional Hazard |
2022-02-21 |
|
|
| 990 |
Effects of Unemployment |
2022-02-21 |
|
|
| 991 |
Causes of Unemployment |
2022-02-21 |
|
|
| 992 |
Availability of Data and Materials Interests |
2022-02-21 |
|
|
| 993 |
Authors’ Contributions |
2022-02-21 |
|
|
| 994 |
Authorâ??s Information |
2022-02-21 |
|
|
| 995 |
Patient Information |
2022-02-21 |
|
|
| 996 |
Future Work Recommendations |
2022-02-21 |
|
|
| 997 |
Descriptive |
2022-02-18 |
|
|
| 998 |
Case Presentaion |
2022-02-17 |
|
|
| 999 |
Biotic Factors |
2022-02-17 |
|
|
| 1000 |
Physiographic Factors |
2022-02-17 |
|
|
| 1001 |
Climatic Factors |
2022-02-17 |
|
|
| 1002 |
Study Framework and Methods |
2022-02-17 |
|
|
| 1003 |
Impacts |
2022-02-16 |
|
|
| 1004 |
Importance |
2022-02-16 |
|
|
| 1005 |
Opinion Article |
2022-02-16 |
|
|
| 1006 |
Editorial on New Techniques in Forensic Toxicology |
2022-02-16 |
|
|
| 1007 |
Detecting the Synthetic Cannabinoid Drug by using New Biomarkers |
2022-02-16 |
|
|
| 1008 |
Principles of Fluid Mechanical to Reveal Forensics Puzzle |
2022-02-16 |
|
|
| 1009 |
A Novel Technique for Retrieving Fingerprint on Curved Objects |
2022-02-16 |
|
|
| 1010 |
Clustering |
2022-02-11 |
|
|
| 1011 |
Discretization of the fractional thermal diffusion equation |
2022-02-11 |
|
|
| 1012 |
Future Work |
2022-02-11 |
|
|
| 1013 |
Methods and Implementation |
2022-02-10 |
|
|
| 1014 |
Classification of Nutraceuticals |
2022-02-10 |
|
|
| 1015 |
Biotechnology and Nutraceuticals |
2022-02-10 |
|
|
| 1016 |
Biomedical Activities |
2022-02-10 |
|
|
| 1017 |
An Editorial on Hereditary Endometrial Cancer |
2022-02-10 |
|
|
| 1018 |
Architecture |
2022-02-09 |
|
|
| 1019 |
Visualization Results |
2022-02-09 |
|
|
| 1020 |
Module and Methods |
2022-02-09 |
|
|
| 1021 |
2019 Conference Awards |
2022-02-08 |
|
|
| 1022 |
Competiting Interests |
2022-02-08 |
|
|
| 1023 |
Respiratory Acidosis |
2022-02-05 |
|
|
| 1024 |
Types of Acidosis |
2022-02-05 |
|
|
| 1025 |
Discuss the results |
2022-02-04 |
|
|
| 1026 |
Literature Review and Hypothesis Development |
2022-02-04 |
|
|
| 1027 |
Results and Findings |
2022-02-03 |
|
|
| 1028 |
Changes of Coagulation-Related Biomarkers |
2022-02-03 |
|
|
| 1029 |
Misleading Advertisement |
2022-02-02 |
|
|
| 1030 |
The Legal Framework of Medicine and Food Advertisement in the EU and UK Post Brexit |
2022-02-02 |
|
|
| 1031 |
Cell Biology |
2022-02-02 |
|
|
| 1032 |
Clinical Case |
2022-02-02 |
|
|
| 1033 |
Declaration of Potential Conflict of Interest |
2022-02-02 |
|
|
| 1034 |
Commentary Article |
2022-02-01 |
|
|
| 1035 |
Complications |
2022-02-01 |
|
|
| 1036 |
Conclusion, Limitations and Future Research |
2022-01-29 |
|
|
| 1037 |
Methodology of Research |
2022-01-29 |
|
|
| 1038 |
Conclusion and Recommendation for Future Research |
2022-01-28 |
|
|
| 1039 |
Breif Review of Literature |
2022-01-28 |
|
|
| 1040 |
Library Activity |
2022-01-28 |
|
|
| 1041 |
Types of Libraries Today |
2022-01-28 |
|
|
| 1042 |
Community Center Libraries |
2022-01-28 |
|
|
| 1043 |
Environmental |
2022-01-27 |
|
|
| 1044 |
PDNPS in Cancer Drug Delivery |
2022-01-27 |
|
|
| 1045 |
Current Cancer Treatment Regimen and Its Limitations |
2022-01-27 |
|
|
| 1046 |
Physicochemical Properties and Characteristics of PDNPS |
2022-01-27 |
|
|
| 1047 |
Plant-Derived Edible Nanoparticles (PDNPs) |
2022-01-27 |
|
|
| 1048 |
Treatment Strategies |
2022-01-22 |
|
|
| 1049 |
Treatment of Anemia |
2022-01-22 |
|
|
| 1050 |
Causes of Anemia |
2022-01-22 |
|
|
| 1051 |
Symptoms of Anemia |
2022-01-22 |
|
|
| 1052 |
Summary of Therapeutic Intervention |
2022-01-21 |
|
|
| 1053 |
Case Formulation |
2022-01-21 |
|
|
| 1054 |
Quantitative Analysis |
2022-01-21 |
|
|
| 1055 |
Background Information |
2022-01-21 |
|
|
| 1056 |
Characteristics of Nanoparticles |
2022-01-20 |
|
|
| 1057 |
Nanoparticles and its Applications |
2022-01-20 |
|
|
| 1058 |
Alcohol |
2022-01-13 |
|
|
| 1059 |
Types of TBI |
2022-01-13 |
|
|
| 1060 |
Experimental Methods and Materials |
2022-01-12 |
|
|
| 1061 |
Determinants of Urban Housing Choice |
2022-01-12 |
|
|
| 1062 |
Theoretical Analysis |
2022-01-11 |
|
|
| 1063 |
Symptoms of Nervous System |
2022-01-11 |
|
|
| 1064 |
Research Ethics |
2022-01-11 |
|
|
| 1065 |
Code Availability |
2022-01-10 |
|
|
| 1066 |
The Competing Interests |
2022-01-10 |
|
|
| 1067 |
Reports |
2022-01-10 |
|
|
| 1068 |
Laser Resonator |
2022-01-05 |
|
|
| 1069 |
Dielectric Waveguide |
2022-01-05 |
|
|
| 1070 |
Hartree Fock guess |
2022-01-05 |
|
|
| 1071 |
Free Carrier Model |
2022-01-05 |
|
|
| 1072 |
Gain Medium |
2022-01-05 |
|
|
| 1073 |
Sugaring |
2022-01-04 |
|
|
| 1074 |
Heating |
2022-01-04 |
|
|
| 1075 |
Boiling |
2022-01-04 |
|
|
| 1076 |
Freezing |
2022-01-04 |
|
|
| 1077 |
Cooling |
2022-01-04 |
|
|
| 1078 |
Curing |
2022-01-04 |
|
|
| 1079 |
Animal Ethics Approval |
2022-01-04 |
|
|
| 1080 |
Opndv Vaccine Experiment |
2022-01-04 |
|
|
| 1081 |
Challenge Experiment |
2022-01-04 |
|
|
| 1082 |
Indirect Elisa for Iga |
2022-01-04 |
|
|
| 1083 |
Experimental Design and Sample Collection |
2022-01-04 |
|
|
| 1084 |
Samples |
2022-01-04 |
|
|
| 1085 |
Birds |
2022-01-04 |
|
|
| 1086 |
Vaccine |
2022-01-04 |
|
|
| 1087 |
Literature Sources |
2022-01-03 |
|
|
| 1088 |
Discussion and Future Research |
2022-01-03 |
|
|
| 1089 |
Future Investigation |
2022-01-03 |
|
|
| 1090 |
Impact of Covid-19 in Worsening the Condition of Patients with Prostate Cancer |
2021-12-31 |
|
|
| 1091 |
Treatments to Disentangle New Therapeutic Targets: Cancer Stem Cells, Cellular Markers |
2021-12-31 |
|
|
| 1092 |
The Role of Hyperhomocysteinemia in the Development of Endothelial Dysfunction |
2021-12-31 |
|
|
| 1093 |
Marketing Dispatches |
2021-12-31 |
|
|
| 1094 |
Disclaimer |
2021-12-31 |
|
|
| 1095 |
Editorial Note on Sensitivity Analysis |
2021-12-31 |
|
|
| 1096 |
A Brief Notes on Viral Gastroenteritis |
2021-12-31 |
|
|
| 1097 |
About Periodontal Disease |
2021-12-31 |
|
|
| 1098 |
Respiratory Tract Infections, Effects and Medical Conditions |
2021-12-31 |
|
|
| 1099 |
An Overview on Babesiosis |
2021-12-31 |
|
|
| 1100 |
Laser Technology |
2021-12-30 |
|
|
| 1101 |
Optical Imaging |
2021-12-30 |
|
|
| 1102 |
Conveyed Sensing |
2021-12-30 |
|
|
| 1103 |
Optical Communications |
2021-12-30 |
|
|
| 1104 |
Fiber Optical Sensing |
2021-12-30 |
|
|
| 1105 |
Viremia: Outcome and Causes |
2021-12-30 |
|
|
| 1106 |
Quantum Mechanics and General Relativity |
2021-12-30 |
|
|
| 1107 |
Current Applications and Developments |
2021-12-30 |
|
|
| 1108 |
Mode Locking |
2021-12-30 |
|
|
| 1109 |
Pumping |
2021-12-30 |
|
|
| 1110 |
Solid-State Media |
2021-12-30 |
|
|
| 1111 |
Benefits of Optical Fiber |
2021-12-30 |
|
|
| 1112 |
Evidence of Clinical Utility: An Investigator Assessment of a Novel Blood-Based Biomarker of Liver Transplant Rejection to Guide Immunosuppression Decisions |
2021-12-30 |
|
|
| 1113 |
Marketing Strategy and Development of SME |
2021-12-30 |
|
|
| 1114 |
Association between Intellectual Capital and Cost Characteristics |
2021-12-30 |
|
|
| 1115 |
Editorial note on Business development |
2021-12-30 |
|
|
| 1116 |
Editorial note on Journal of Accounting & Marketing |
2021-12-30 |
|
|
| 1117 |
Author Information |
2021-12-29 |
|
|
| 1118 |
Conclusions and Implications |
2021-12-29 |
|
|
| 1119 |
INTRODUCTION |
2021-12-29 |
|
|
| 1120 |
Resumen |
2021-12-29 |
|
|
| 1121 |
Resumo |
2021-12-29 |
|
|
| 1122 |
The Governance of 5G-Based Big Data Virtual Networks |
2021-12-24 |
|
|
| 1123 |
Case Examples |
2021-12-23 |
|
|
| 1124 |
Methodologies |
2021-12-23 |
|
|
| 1125 |
Multi-Sourcing Obstacles |
2021-12-22 |
|
|
| 1126 |
2020 Awards Announcement |
2021-12-22 |
|
|
| 1127 |
2020 Young Researchers Forum |
2021-12-22 |
|
|
| 1128 |
An Overview and Cause of Head Transplantation |
2021-12-20 |
|
|
| 1129 |
Conclusion and Evaluation |
2021-12-20 |
|
|
| 1130 |
A New Technique of Arm Transplantation |
2021-12-20 |
|
|
| 1131 |
An Outlook of Lung Transplantation |
2021-12-20 |
|
|
| 1132 |
An Overview and Mechanism of Face Transplantation |
2021-12-20 |
|
|
| 1133 |
A brief Introduction of Brain Transplantation |
2021-12-20 |
|
|
| 1134 |
Practical Implications |
2021-12-18 |
|
|
| 1135 |
Future Scenarios |
2021-12-18 |
|
|
| 1136 |
Nanomaterials for Heavy Metals Removal |
2021-12-18 |
|
|
| 1137 |
Role of Nanoscience In Detecting Plant Diseases |
2021-12-18 |
|
|
| 1138 |
Nanoparticles Produced By Yeast And Fungi |
2021-12-18 |
|
|
| 1139 |
Nanoparticles Produced By Bacteria |
2021-12-18 |
|
|
| 1140 |
Nanoparticles Produced By Plants |
2021-12-18 |
|
|
| 1141 |
Biogenic Production of Various NanopartiÂcles |
2021-12-18 |
|
|
| 1142 |
Biogenic Production of Various NanopartiÂcles |
2021-12-18 |
|
|
| 1143 |
Synthesis of Nanoparticles |
2021-12-18 |
|
|
| 1144 |
Unique Properties of Nanoparticles And Their Contribution To Plant Production And Growth |
2021-12-18 |
|
|
| 1145 |
Nano Particles |
2021-12-18 |
|
|
| 1146 |
Uses of Raloxifene |
2021-12-17 |
|
|
| 1147 |
Social Entrepreneurship: An Overview |
2021-12-14 |
|
|
| 1148 |
Relationship between Small Business and Entrepreneurship |
2021-12-14 |
|
|
| 1149 |
Real Estate Entrepreneurship and Its Key Challenges |
2021-12-14 |
|
|
| 1150 |
A Short Note on Entrepreneurial Networks |
2021-12-14 |
|
|
| 1151 |
A Short Note on Economic Development Goals |
2021-12-14 |
|
|
| 1152 |
Risk of COVID-19: Mental and Neurological Disorders |
2021-12-14 |
|
|
| 1153 |
Ethical Issue |
2021-12-14 |
|
|
| 1154 |
Funding and Conflict of Interest |
2021-12-14 |
|
|
| 1155 |
Therapeutic Strategy for Apocrine-Type TNBC |
2021-12-14 |
|
|
| 1156 |
Period-Shortening (de-escalation) of NAC in Basal-Like TNBC with High Ki-67 Labeling Index |
2021-12-13 |
|
|
| 1157 |
Evaluation of the Prognosis of Patients |
2021-12-13 |
|
|
| 1158 |
Ki-67 Labeling Index in Good and Poor Responders |
2021-12-13 |
|
|
| 1159 |
AR Expression in TNBC |
2021-12-13 |
|
|
| 1160 |
Results and Discusssion |
2021-12-10 |
|
|
| 1161 |
Variation in the Loss of Soil Nutrients between Control |
2021-12-10 |
|
|
| 1162 |
Renewable Energy |
2021-12-10 |
|
|
| 1163 |
Determination of Potassium in Soil |
2021-12-10 |
|
|
| 1164 |
Total Microbial Counting |
2021-12-10 |
|
|
| 1165 |
Electrometric Method |
2021-12-10 |
|
|
| 1166 |
Neuro pathological Features and COVID-19 Infection |
2021-12-10 |
|
|
| 1167 |
Editorial on Allergy and Asthma |
2021-12-10 |
|
|
| 1168 |
Recent Advances in Stem Cell Biology |
2021-12-10 |
|
|
| 1169 |
Metastasis and Cell Migration of Tumours |
2021-12-10 |
|
|
| 1170 |
Tidal Power |
2021-12-10 |
|
|
| 1171 |
BioMass Energy |
2021-12-10 |
|
|
| 1172 |
Wind Energy |
2021-12-10 |
|
|
| 1173 |
Hydro-Power |
2021-12-10 |
|
|
| 1174 |
GeoThermal Energy |
2021-12-10 |
|
|
| 1175 |
Solar Energy |
2021-12-10 |
|
|
| 1176 |
Expression of p53, EGFR, CK5/6, CK14 and GCDFP15 |
2021-12-09 |
|
|
| 1177 |
Conclusion and Future Research |
2021-12-09 |
|
|
| 1178 |
Performing Strategic Group Analysis |
2021-12-09 |
|
|
| 1179 |
Autism Diagnostic Observation Schedule Analysis |
2021-12-09 |
|
|
| 1180 |
Conclusions and Policy Recommendations |
2021-12-09 |
|
|
| 1181 |
Types of Markets |
2021-12-09 |
|
|
| 1182 |
Looking Ahead: Research and Practice |
2021-12-08 |
|
|
| 1183 |
Method Description |
2021-12-08 |
|
|
| 1184 |
The BvgASR regulon of Bordetella pertussis |
2021-12-08 |
|
|
| 1185 |
Applications of Geophysics |
2021-12-07 |
|
|
| 1186 |
2020 Conference Awards |
2021-12-07 |
|
|
| 1187 |
2020 Conference Market Analysis |
2021-12-07 |
|
|
| 1188 |
Population and Methods |
2021-12-06 |
|
|
| 1189 |
Measures Of Economic Inequality |
2021-12-06 |
|
|
| 1190 |
Recommendations and Conclusion |
2021-12-04 |
|
|
| 1191 |
Clinical Trials Registration |
2021-12-03 |
|
|
| 1192 |
Plant Reproducibility |
2021-12-03 |
|
|
| 1193 |
Animal Research |
2021-12-03 |
|
|
| 1194 |
Clinical Manifestation |
2021-12-02 |
|
|
| 1195 |
Risk Stratification |
2021-12-02 |
|
|
| 1196 |
Reverse Takeover and its benefits |
2021-12-01 |
|
|
| 1197 |
Reconciliation and its types |
2021-12-01 |
|
|
| 1198 |
Accounts receivable and its terms |
2021-12-01 |
|
|
| 1199 |
A Short Note on Refinancing |
2021-12-01 |
|
|
| 1200 |
Role of Operation Management in this era of Globalization |
2021-12-01 |
|
|
| 1201 |
Microscopic Characterizations of Apocrine- and Basal-Like Phenotypes |
2021-12-01 |
|
|
| 1202 |
Enumeration / Result |
2021-12-01 |
|
|
| 1203 |
Immunohistochemical Evaluation |
2021-11-30 |
|
|
| 1204 |
Histopathological Evaluation |
2021-11-30 |
|
|
| 1205 |
Evaluation of Effects of NAC |
2021-11-30 |
|
|
| 1206 |
Submission Declaration |
2021-11-30 |
|
|
| 1207 |
Author Contribution |
2021-11-30 |
|
|
| 1208 |
IGBT Samples and Experimental Procedure |
2021-11-30 |
|
|
| 1209 |
Tools |
2021-11-30 |
|
|
| 1210 |
Conclusion and Future Prospective |
2021-11-30 |
|
|
| 1211 |
Discussion & Conclusion |
2021-11-29 |
|
|
| 1212 |
Cyber Security Measures of Bems |
2021-11-29 |
|
|
| 1213 |
The Syberattacks Threats of Bems |
2021-11-29 |
|
|
| 1214 |
Network and Communication Protocol |
2021-11-29 |
|
|
| 1215 |
Network Structure of Bems |
2021-11-29 |
|
|
| 1216 |
Discussions and Conclusions |
2021-11-29 |
|
|
| 1217 |
Causes of Fatal Accidents by Electric Shock |
2021-11-29 |
|
|
| 1218 |
Method and Results |
2021-11-29 |
|
|
| 1219 |
Principles for a Desirable Electromagnetic Environment |
2021-11-29 |
|
|
| 1220 |
Electromagnetic Environmental Issues in Medical Facilities |
2021-11-29 |
|
|
| 1221 |
Electromagnetic Environment Guidelines for Advanced Electronic Medical Facilities |
2021-11-29 |
|
|
| 1222 |
Standards for ME Equipment and Medical Facilities in Japan |
2021-11-29 |
|
|
| 1223 |
Broadband Folded Antenna as a Far-field Sensor |
2021-11-29 |
|
|
| 1224 |
Optical Electric-Field Sensor as a Near-field Sensor |
2021-11-29 |
|
|
| 1225 |
Waveform Reproduction by Signal Processing for Transient Electromagnetic Field |
2021-11-29 |
|
|
| 1226 |
Measurement Principle and Typical Results |
2021-11-29 |
|
|
| 1227 |
Experimental Results & Consideration |
2021-11-29 |
|
|
| 1228 |
Experimental Methods |
2021-11-29 |
|
|
| 1229 |
Declaration of Interest |
2021-11-29 |
|
|
| 1230 |
Anti-Malarial Strategies |
2021-11-27 |
|
|
| 1231 |
Elements of Culture |
2021-11-26 |
|
|
| 1232 |
Characteristics of Culture |
2021-11-26 |
|
|
| 1233 |
Clinical Recommendation |
2021-11-26 |
|
|
| 1234 |
Case Synopsis |
2021-11-26 |
|
|
| 1235 |
Editorial Note on Transplantation of Bone Marrow |
2021-11-26 |
|
|
| 1236 |
Pharmacological Significance |
2021-11-24 |
|
|
| 1237 |
Organocatalysts in the Biginelli Reaction |
2021-11-24 |
|
|
| 1238 |
Disclosure of Potential Conflicts of Interest |
2021-11-23 |
|
|
| 1239 |
Editorial Notes |
2021-11-23 |
|
|
| 1240 |
Types of Fish Farming |
2021-11-23 |
|
|
| 1241 |
Conclusion /recommendation |
2021-11-23 |
|
|
| 1242 |
WES Data Citation |
2021-11-22 |
|
|
| 1243 |
Potential Competing Interests |
2021-11-22 |
|
|
| 1244 |
Conflict of Interest Disclosure |
2021-11-22 |
|
|
| 1245 |
Litrature Review |
2021-11-22 |
|
|
| 1246 |
List of Abbreviations |
2021-11-22 |
|
|
| 1247 |
New Horizons |
2021-11-22 |
|
|
| 1248 |
Role of Cerebellum in Psychopathology of Disorders |
2021-11-22 |
|
|
| 1249 |
Hormones in Relation to Cerebellum |
2021-11-22 |
|
|
| 1250 |
Extra-Motor Functions |
2021-11-22 |
|
|
| 1251 |
Tax Accounting and its Basics |
2021-11-22 |
|
|
| 1252 |
Short Notes on Job Costing |
2021-11-22 |
|
|
| 1253 |
Cost Accounting and its Origins |
2021-11-22 |
|
|
| 1254 |
Accounts Receivable and Its Payment Terms: An Overview |
2021-11-22 |
|
|
| 1255 |
A short Note on General Ledger |
2021-11-22 |
|
|
| 1256 |
A short notes on Real Estate Entrepreneurship |
2021-11-20 |
|
|
| 1257 |
Short Notes on Social Entrepreneurship |
2021-11-20 |
|
|
| 1258 |
Economic Development and its Goals |
2021-11-20 |
|
|
| 1259 |
Ethical Compliance Statement |
2021-11-20 |
|
|
| 1260 |
Funding Sources and Conflicts of Interest |
2021-11-20 |
|
|
| 1261 |
2020 Market Analysis |
2021-11-20 |
|
|
| 1262 |
Descriptors |
2021-11-19 |
|
|
| 1263 |
Results, Analysis and Discussion |
2021-11-19 |
|
|
| 1264 |
Common Excavation Methods |
2021-11-19 |
|
|
| 1265 |
Funding Organization Name |
2021-11-18 |
|
|
| 1266 |
Results and Laboratory work |
2021-11-18 |
|
|
| 1267 |
The Study |
2021-11-18 |
|
|
| 1268 |
Remaining Issues |
2021-11-18 |
|
|
| 1269 |
The Changes of Administrative Law Towards An Open Market Economy |
2021-11-18 |
|
|
| 1270 |
Introduction of Administrative of Reform in Vietnam |
2021-11-18 |
|
|
| 1271 |
Apparatus and Stimuli |
2021-11-17 |
|
|
| 1272 |
Conceptual Framework and Methodology |
2021-11-17 |
|
|
| 1273 |
Introduction and Problem Statement |
2021-11-17 |
|
|
| 1274 |
Network Defense Approaches |
2021-11-17 |
|
|
| 1275 |
Network Vulnerabilities |
2021-11-17 |
|
|
| 1276 |
Network Security Architecture Issues |
2021-11-17 |
|
|
| 1277 |
Pharmacokinetics of Flavonoids |
2021-11-16 |
|
|
| 1278 |
Medication and Diagnosis |
2021-11-16 |
|
|
| 1279 |
Treatment for PHT |
2021-11-16 |
|
|
| 1280 |
Classification of PHT |
2021-11-16 |
|
|
| 1281 |
Diagnostic Ways for PHT |
2021-11-16 |
|
|
| 1282 |
Medical Care for COAD |
2021-11-16 |
|
|
| 1283 |
Preventive Measures for COAD |
2021-11-16 |
|
|
| 1284 |
Symptoms of COAD |
2021-11-16 |
|
|
| 1285 |
2020 Young Research Forum |
2021-11-16 |
|
|
| 1286 |
Clinical Use |
2021-11-15 |
|
|
| 1287 |
2020 Awards |
2021-11-15 |
|
|
| 1288 |
2020 Conference Announcement |
2021-11-15 |
|
|
| 1289 |
The Psychological Construct of Self, Between Anthropology and Sociology |
2021-11-15 |
|
|
| 1290 |
The Application of Psychoanalysis to Socio-Humanities: the Case of Sublimation |
2021-11-15 |
|
|
| 1291 |
A Possible, Current Evaluation of Mythology |
2021-11-15 |
|
|
| 1292 |
A Psychoanalytic Anthropology Remark on the Work of C. Lévi-Strauss |
2021-11-15 |
|
|
| 1293 |
The Religious Matrix of Society: A Brief Remark |
2021-11-15 |
|
|
| 1294 |
Revisiting the Theory of Moral Development according to L. Kohlberg |
2021-11-15 |
|
|
| 1295 |
From Anthropological Epistemology to Sociology of Law: A Case-Study |
2021-11-15 |
|
|
| 1296 |
The Sense of Subjective Time, Between So-ciology and Anthropology |
2021-11-15 |
|
|
| 1297 |
Religion |
2021-11-15 |
|
|
| 1298 |
Workplace |
2021-11-15 |
|
|
| 1299 |
School |
2021-11-15 |
|
|
| 1300 |
Neighbourhoods |
2021-11-15 |
|
|
| 1301 |
Family |
2021-11-15 |
|
|
| 1302 |
Hydrochlorothiazide Tablets |
2021-11-15 |
|
|
| 1303 |
Ethical Aspects |
2021-11-12 |
|
|
| 1304 |
Compliance of Ethical Standard |
2021-11-12 |
|
|
| 1305 |
Data and Methods |
2021-11-12 |
|
|
| 1306 |
Tracking Algorithm for Working |
2021-11-12 |
|
|
| 1307 |
Literature survey |
2021-11-12 |
|
|
| 1308 |
Statements |
2021-11-11 |
|
|
| 1309 |
Way Forward: The Need For Multifaceted Programming |
2021-11-11 |
|
|
| 1310 |
Leveraging Positive Forces Among Adolescent Boys |
2021-11-11 |
|
|
| 1311 |
Surveying of Adolescent Male Students |
2021-11-11 |
|
|
| 1312 |
Habitat |
2021-11-10 |
|
|
| 1313 |
Biodiversity |
2021-11-10 |
|
|
| 1314 |
Histopathological Results |
2021-11-10 |
|
|
| 1315 |
Overview of Lean Elements |
2021-11-10 |
|
|
| 1316 |
Miniaturization Prospect |
2021-11-10 |
|
|
| 1317 |
Basic Principle |
2021-11-10 |
|
|
| 1318 |
Internal Flow Choking: An Overview |
2021-11-10 |
|
|
| 1319 |
Types of Receptors |
2021-11-09 |
|
|
| 1320 |
Pathophysiology of Neuropathic Pain |
2021-11-09 |
|
|
| 1321 |
Steps in Neuronal Signal Processing |
2021-11-09 |
|
|
| 1322 |
Nociceptive Versus Neuropathic Pain |
2021-11-09 |
|
|
| 1323 |
Neuropsychology in therapy |
2021-11-09 |
|
|
| 1324 |
Challenges of Competition In The Energy Market And Arrangements |
2021-11-09 |
|
|
| 1325 |
The Possibility of Competition In The Energy Market And The Opportunities Ahead |
2021-11-09 |
|
|
| 1326 |
Leaving The Monopoly And Entering The Competition In The Energy Market |
2021-11-09 |
|
|
| 1327 |
Energy Market, Competition, and Monopoly |
2021-11-09 |
|
|
| 1328 |
Energy Market, Competition, and Monopoly |
2021-11-09 |
|
|
| 1329 |
Dominance of Monopoly In The Energy Market |
2021-11-09 |
|
|
| 1330 |
Difference between Alzheimer's and Dementia |
2021-11-09 |
|
|
| 1331 |
Supporting Information |
2021-11-09 |
|
|
| 1332 |
Ongoing Research Activities, Application Projects and Recent Advances |
2021-11-09 |
|
|
| 1333 |
Major Types of Smart Materials and Their Known and Emerging Applications |
2021-11-09 |
|
|
| 1334 |
Mitigation of Sexual Challenges |
2021-11-05 |
|
|
| 1335 |
Popular Perception of Sexuality |
2021-11-05 |
|
|
| 1336 |
Human sexuality and its manifestation |
2021-11-05 |
|
|
| 1337 |
commentry |
2021-11-02 |
|
|
| 1338 |
Materials and Methodologies |
2021-11-02 |
|
|
| 1339 |
Macrophages |
2021-11-01 |
|
|
| 1340 |
Lymphokine-Activated Killer Cells |
2021-11-01 |
|
|
| 1341 |
Natural Killer Cells |
2021-11-01 |
|
|
| 1342 |
Systemic Lupus Erythematosus |
2021-11-01 |
|
|
| 1343 |
Psoriasis |
2021-11-01 |
|
|
| 1344 |
Disorders of the Thyroid |
2021-11-01 |
|
|
| 1345 |
Celiac Disease |
2021-11-01 |
|
|
| 1346 |
Composite |
2021-11-01 |
|
|
| 1347 |
Simulation Results |
2021-11-01 |
|
|
| 1348 |
Model Estimation |
2021-11-01 |
|
|
| 1349 |
Chemical Constituents |
2021-10-30 |
|
|
| 1350 |
Herbal Plants Used for Covid-19 |
2021-10-30 |
|
|
| 1351 |
Mechanism of Action |
2021-10-30 |
|
|
| 1352 |
Survey And Feedback |
2021-10-29 |
|
|
| 1353 |
Memberships and Reprints |
2021-10-29 |
|
|
| 1354 |
Advertisement Platform |
2021-10-29 |
|
|
| 1355 |
Article Types |
2021-10-29 |
|
|
| 1356 |
Informed Consent Statement |
2021-10-29 |
|
|
| 1357 |
Institutional Review Board Statement |
2021-10-29 |
|
|
| 1358 |
Layers of Controller Operation |
2021-10-29 |
|
|
| 1359 |
Eyenet Model |
2021-10-29 |
|
|
| 1360 |
Convolution Neural Network |
2021-10-29 |
|
|
| 1361 |
Blood Vessel Extraction |
2021-10-29 |
|
|
| 1362 |
Ethical Standards Disclosure |
2021-10-29 |
|
|
| 1363 |
The Eventual Fate of Online Schooling |
2021-10-28 |
|
|
| 1364 |
Positive and Negative Impacts of Online Learning |
2021-10-28 |
|
|
| 1365 |
Reason for Considering Online Education |
2021-10-28 |
|
|
| 1366 |
Extracorporeal Membrane Oxygenation (ECMO) or Extracorporeal Life Support (ECLS) |
2021-10-28 |
|
|
| 1367 |
Autophagy: Molecular Mechanisms in Human Disease |
2021-10-28 |
|
|
| 1368 |
Methods of soil stabilization |
2021-10-28 |
|
|
| 1369 |
Data Access and Format |
2021-10-28 |
|
|
| 1370 |
Discription |
2021-10-28 |
|
|
| 1371 |
Calibration |
2021-10-28 |
|
|
| 1372 |
Algae as Fish Feed Additives |
2021-10-28 |
|
|
| 1373 |
Different Algae and their Compounds Responsible for their Antioxidative Property |
2021-10-28 |
|
|
| 1374 |
Prespective |
2021-10-28 |
|
|
| 1375 |
Facility Specific Indicators |
2021-10-27 |
|
|
| 1376 |
Patient Care Indicators |
2021-10-27 |
|
|
| 1377 |
Business Associations |
2021-10-27 |
|
|
| 1378 |
Main part |
2021-10-27 |
|
|
| 1379 |
Calcium Deficiency in Body: Hypocalcemia |
2021-10-27 |
|
|
| 1380 |
Vitamin Bâ?? is One of the B vitamins: An Essential Nutrient |
2021-10-27 |
|
|
| 1381 |
Vitamin Bâ?? is One of the B vitamins: An Essential Nutrient |
2021-10-27 |
|
|
| 1382 |
Women and Her Oral Healthcare: Overview |
2021-10-27 |
|
|
| 1383 |
Should Access to Dental Healthcare be a Fundamental Human Right? |
2021-10-27 |
|
|
| 1384 |
Effects of Global Climate Change on Oral Health: Overview |
2021-10-27 |
|
|
| 1385 |
Significance of Dental Care in Elderly: Overview |
2021-10-27 |
|
|
| 1386 |
Pregnancy and Oral Health Care Complications: Overview |
2021-10-27 |
|
|
| 1387 |
Mineral Deficiencies Can Cause a Number of Health Issues |
2021-10-27 |
|
|
| 1388 |
Vitamins and Minerals are Essential Nutrients Because they Perform Hundreds of Roles in the Body |
2021-10-27 |
|
|
| 1389 |
Fat Soluble Vitamins and its Significance |
2021-10-27 |
|
|
| 1390 |
Important Assumptions |
2021-10-26 |
|
|
| 1391 |
Reliability model (Safety profile) |
2021-10-26 |
|
|
| 1392 |
Spatial variability modelling |
2021-10-26 |
|
|
| 1393 |
The propagation stage |
2021-10-26 |
|
|
| 1394 |
Buying Process |
2021-10-26 |
|
|
| 1395 |
Policy Recommendations and Future Outlook |
2021-10-26 |
|
|
| 1396 |
Summary, Conclusion and Recommendations |
2021-10-26 |
|
|
| 1397 |
Study Objectives |
2021-10-26 |
|
|
| 1398 |
Results and evaluation |
2021-10-26 |
|
|
| 1399 |
Proposed Unified Network Pruning and Architecture Search (NPAS) Framework |
2021-10-26 |
|
|
| 1400 |
Ethics Committee Approval |
2021-10-26 |
|
|
| 1401 |
Artificial Intelligence |
2021-10-25 |
|
|
| 1402 |
Nanoplastics |
2021-10-25 |
|
|
| 1403 |
Aims of the Study |
2021-10-25 |
|
|
| 1404 |
Role and Responsibilities |
2021-10-23 |
|
|
| 1405 |
Editorial Invitation |
2021-10-23 |
|
|
| 1406 |
Heart Disease Datasets |
2021-10-23 |
|
|
| 1407 |
Proposed Methods |
2021-10-23 |
|
|
| 1408 |
Datasets |
2021-10-22 |
|
|
| 1409 |
Conceptual Model and Hypotheses |
2021-10-22 |
|
|
| 1410 |
A Report on Basal Cell Carcinoma |
2021-10-22 |
|
|
| 1411 |
Overview of Sebaceous Glands |
2021-10-22 |
|
|
| 1412 |
System Description |
2021-10-22 |
|
|
| 1413 |
Mechanisms Involved in Bipolar Disorder |
2021-10-22 |
|
|
| 1414 |
Celebrating Microbial Diversity: The Many Cell Cycles of Eukaryotic Microbes |
2021-10-21 |
|
|
| 1415 |
Drug Targets, Chemical Matter and Approaches |
2021-10-21 |
|
|
| 1416 |
Short Communication.. |
2021-10-21 |
|
|
| 1417 |
Traditional Immunology |
2021-10-21 |
|
|
| 1418 |
Discharge Plan |
2021-10-21 |
|
|
| 1419 |
Histopathology |
2021-10-21 |
|
|
| 1420 |
Repeated Ct After 6 Days |
2021-10-21 |
|
|
| 1421 |
Upper Abdomen Us Showed |
2021-10-21 |
|
|
| 1422 |
Situations in Medical Imaging |
2021-10-21 |
|
|
| 1423 |
Expectations of Artificial Intelligence(AI) |
2021-10-21 |
|
|
| 1424 |
Positive Identifications using “Biological Fingerprints” in Advanced Imaging |
2021-10-21 |
|
|
| 1425 |
Positive Identifications using “Biological Fingerprints” in Digital Radiography |
2021-10-21 |
|
|
| 1426 |
Positive Identifications using â??Biological Fingerprintsâ? in Digital Radiography |
2021-10-21 |
|
|
| 1427 |
Repositioning of Head Postmortem Computed Tomography (PMCT) |
2021-10-21 |
|
|
| 1428 |
The Need for Databases in Countries |
2021-10-21 |
|
|
| 1429 |
Batch Fermentation |
2021-10-21 |
|
|
| 1430 |
Back to Our Patient |
2021-10-20 |
|
|
| 1431 |
Causes of Recurrent and Breakthrough Thrombosis |
2021-10-20 |
|
|
| 1432 |
Recurrent VTE versus Breakthrough VTE |
2021-10-20 |
|
|
| 1433 |
Introduction to the Case |
2021-10-20 |
|
|
| 1434 |
Editorial Note on Erythroplakia: Hazards and Treatment |
2021-10-20 |
|
|
| 1435 |
Editorial Note on Drug-induced Pigmentation |
2021-10-20 |
|
|
| 1436 |
Cutaneous T-cell lymphoma |
2021-10-20 |
|
|
| 1437 |
Challenges and Prospects |
2021-10-20 |
|
|
| 1438 |
Chromosomal Disorder |
2021-10-20 |
|
|
| 1439 |
Multifactorial disorder |
2021-10-20 |
|
|
| 1440 |
Mitochondrial |
2021-10-20 |
|
|
| 1441 |
Autosomal recessive |
2021-10-20 |
|
|
| 1442 |
Autosomal Dominant |
2021-10-20 |
|
|
| 1443 |
Single Gene |
2021-10-20 |
|
|
| 1444 |
Predictive |
2021-10-20 |
|
|
| 1445 |
Medicine |
2021-10-20 |
|
|
| 1446 |
Conclusion/Recommendation |
2021-10-20 |
|
|
| 1447 |
Poliovirus |
2021-10-20 |
|
|
| 1448 |
Prevention of Zoonosis |
2021-10-19 |
|
|
| 1449 |
Zoonosis |
2021-10-19 |
|
|
| 1450 |
Evidence Examination |
2021-10-19 |
|
|
| 1451 |
Examination of Biological Evidence: Current Prospective of DNA Profiling |
2021-10-19 |
|
|
| 1452 |
Result and Conclusion |
2021-10-19 |
|
|
| 1453 |
Hypertension and Blood Pressure |
2021-10-19 |
|
|
| 1454 |
Results and Analysis |
2021-10-19 |
|
|
| 1455 |
Detailed Description |
2021-10-18 |
|
|
| 1456 |
Results and Comparative Analysis |
2021-10-18 |
|
|
| 1457 |
Capillary electrophoresis |
2021-10-18 |
|
|
| 1458 |
Analytical techniques for detection of chemical adulterants |
2021-10-18 |
|
|
| 1459 |
Marine Litter |
2021-10-18 |
|
|
| 1460 |
Scope of Future Research |
2021-10-14 |
|
|
| 1461 |
Observations |
2021-10-14 |
|
|
| 1462 |
Micromorphology of the Rhizosphere: Methodology and Findings |
2021-10-14 |
|
|
| 1463 |
Primary Immunodeficiency |
2021-10-14 |
|
|
| 1464 |
Secondary Immunodeficiency |
2021-10-14 |
|
|
| 1465 |
Cytotoxic T Lymphocytes |
2021-10-14 |
|
|
| 1466 |
Limitation of Research |
2021-10-13 |
|
|
| 1467 |
Growth Media for Bacteria: Types of Culture Media |
2021-10-13 |
|
|
| 1468 |
Industrial Fermentation Procedures |
2021-10-13 |
|
|
| 1469 |
Molecular Docking: Bioinformatics Tool |
2021-10-13 |
|
|
| 1470 |
Nano Materials: Emerging Trend in Microbiology |
2021-10-13 |
|
|
| 1471 |
Education Quality in Economic Growth |
2021-10-13 |
|
|
| 1472 |
Visual Perception |
2021-10-13 |
|
|
| 1473 |
Medication |
2021-10-12 |
|
|
| 1474 |
Biochemical Properties of Channa punctatus |
2021-10-12 |
|
|
| 1475 |
Breast Reconstruction |
2021-10-12 |
|
|
| 1476 |
Experimental Determination of Mechanical Properties of Aluminum Sheet Metal |
2021-10-12 |
|
|
| 1477 |
Pharmacotherapy |
2021-10-12 |
|
|
| 1478 |
Blood pressure-fast Facts |
2021-10-12 |
|
|
| 1479 |
High Vital Sign Increases Your Risk of Stroke |
2021-10-12 |
|
|
| 1480 |
Ocular Hypertension Causes |
2021-10-12 |
|
|
| 1481 |
Role of Aldosterone in Hypertension Patients |
2021-10-12 |
|
|
| 1482 |
Measures to Prevent High Blood Pressure |
2021-10-12 |
|
|
| 1483 |
Movement Exploration and Information Holes |
2021-10-09 |
|
|
| 1484 |
Local Bodies and Drives |
2021-10-09 |
|
|
| 1485 |
Movement Related Strategies in India, Bangladesh and Nepal |
2021-10-09 |
|
|
| 1486 |
Sexual Orientation and Movement |
2021-10-09 |
|
|
| 1487 |
Transient Status and Medical Care Access and Usage |
2021-10-09 |
|
|
| 1488 |
Term of Stay as a Traveler and Wellbeing Results |
2021-10-09 |
|
|
| 1489 |
Switching the Impacts of Movement: Metropolitan to Country Relocation |
2021-10-09 |
|
|
| 1490 |
Heftiness and Cardiovascular Medical Issues |
2021-10-09 |
|
|
| 1491 |
Movement: Advantages and Settlements |
2021-10-09 |
|
|
| 1492 |
New Insights on Child Epilepsy |
2021-10-08 |
|
|
| 1493 |
Cross-Line Relocation |
2021-10-07 |
|
|
| 1494 |
Business Development and Ethics |
2021-10-07 |
|
|
| 1495 |
Small Businesses and Its Advantages |
2021-10-07 |
|
|
| 1496 |
Income Smoothing and Causes |
2021-10-07 |
|
|
| 1497 |
Chief Marketing Officer: Roles and Responsibilities |
2021-10-07 |
|
|
| 1498 |
Education Quality in Economic Growth |
2021-10-07 |
|
|
| 1499 |
Methods in Economic Protection |
2021-10-07 |
|
|
| 1500 |
Plant Hormones |
2021-10-07 |
|
|
| 1501 |
Sources of Groundwater Pollution |
2021-10-07 |
|
|
| 1502 |
Technique for Determining Earth's Surface Evaporation |
2021-10-07 |
|
|
| 1503 |
Role of Aquatic Plants in Water Treatment |
2021-10-07 |
|
|
| 1504 |
Hydrology and Water Resources |
2021-10-07 |
|
|
| 1505 |
Conservation of Water |
2021-10-07 |
|
|
| 1506 |
Type 2 Diabetes |
2021-10-06 |
|
|
| 1507 |
Type 1 Diabetes |
2021-10-06 |
|
|
| 1508 |
Role of Industrial Development in Economic Growth |
2021-10-06 |
|
|
| 1509 |
Contributions from Authors |
2021-10-06 |
|
|
| 1510 |
Microchimerism in Triggering Thyroid Pathology |
2021-10-06 |
|
|
| 1511 |
oloy Microchimerism in Triggering Thyroid Pa |
2021-10-06 |
|
|
| 1512 |
Chromosomal Disorder in Peripheral White Blood Cells in Turner Syndrome |
2021-10-06 |
|
|
| 1513 |
Thyrotoxicosis-induced Anemia in Patient with Painless Thyroiditis |
2021-10-06 |
|
|
| 1514 |
Hashimoto Redness is Most Prevailing Response Thyroid Disorder |
2021-10-06 |
|
|
| 1515 |
Hashimoto Inflammation is Associate in Nursing Disease |
2021-10-06 |
|
|
| 1516 |
Coronovirus |
2021-10-06 |
|
|
| 1517 |
Influenza And Coronavirus |
2021-10-06 |
|
|
| 1518 |
Association of Malaria Transmission |
2021-10-04 |
|
|
| 1519 |
Epstein–Barr Infection Related lymphoproliferative illnesses |
2021-10-04 |
|
|
| 1520 |
Non-Hodgkin Lymphomas |
2021-10-04 |
|
|
| 1521 |
Hodgkin Lymphoma |
2021-10-04 |
|
|
| 1522 |
Mouth |
2021-10-04 |
|
|
| 1523 |
Signs and Indications |
2021-10-04 |
|
|
| 1524 |
Other vitamin B-12 deficiency anemia vs. pernicious anemia |
2021-10-04 |
|
|
| 1525 |
Small intestinal conditions |
2021-10-04 |
|
|
| 1526 |
Lack of Intrinsic Factor in the Body |
2021-10-04 |
|
|
| 1527 |
Symptoms for Pernicious Anemia |
2021-10-04 |
|
|
| 1528 |
Data Statement |
2021-10-04 |
|
|
| 1529 |
Arthrodesis |
2021-10-04 |
|
|
| 1530 |
Spinal Surgeries |
2021-10-04 |
|
|
| 1531 |
Shoulder Replacement Surgery |
2021-10-04 |
|
|
| 1532 |
Knee Replacement Surgery |
2021-10-04 |
|
|
| 1533 |
Hip Replacement Surgery |
2021-10-04 |
|
|
| 1534 |
Knee Arthroscopy |
2021-10-04 |
|
|
| 1535 |
Perspective for a System Biology Framework |
2021-10-04 |
|
|
| 1536 |
The Challenges of JAK Inhibition Therapy |
2021-10-04 |
|
|
| 1537 |
The Role of JAK-STAT Pathway |
2021-10-04 |
|
|
| 1538 |
Limits |
2021-10-04 |
|
|
| 1539 |
Heartbeat |
2021-10-04 |
|
|
| 1540 |
Learning Rate |
2021-10-04 |
|
|
| 1541 |
Hyper-Boundary |
2021-10-04 |
|
|
| 1542 |
Engendering Capacity |
2021-10-04 |
|
|
| 1543 |
Association |
2021-10-04 |
|
|
| 1544 |
Spread Capacity |
2021-10-04 |
|
|
| 1545 |
Performance |
2021-10-04 |
|
|
| 1546 |
Wellbeing Designing |
2021-10-04 |
|
|
| 1547 |
Editoral Note |
2021-10-04 |
|
|
| 1548 |
Review Literature |
2021-10-04 |
|
|
| 1549 |
Storage and Execution |
2021-10-04 |
|
|
| 1550 |
Programming languages |
2021-10-04 |
|
|
| 1551 |
Real View of The Automatic Board Cleaner(Figure 5) |
2021-10-04 |
|
|
| 1552 |
Related Literatures |
2021-10-04 |
|
|
| 1553 |
Organic Nutrition For Orchids |
2021-10-01 |
|
|
| 1554 |
Fertilizing Orchids At Flowering Stage |
2021-10-01 |
|
|
| 1555 |
Fertilizing Orchids Before Flowering Stage |
2021-10-01 |
|
|
| 1556 |
Fertilizing In Orchids |
2021-10-01 |
|
|
| 1557 |
Minerals Content of Orchids |
2021-10-01 |
|
|
| 1558 |
Conclusion and Policies Indication |
2021-10-01 |
|
|
| 1559 |
Time Series and Statistical Tests |
2021-10-01 |
|
|
| 1560 |
Economic Indicators |
2021-10-01 |
|
|
| 1561 |
Baby |
2021-10-01 |
|
|
| 1562 |
Oil Price |
2021-10-01 |
|
|
| 1563 |
Childbirth Education |
2021-10-01 |
|
|
| 1564 |
Pregnancy |
2021-10-01 |
|
|
| 1565 |
Risk of Pregnancy |
2021-10-01 |
|
|
| 1566 |
Contraception |
2021-10-01 |
|
|
| 1567 |
Diseases |
2021-10-01 |
|
|
| 1568 |
Sex |
2021-10-01 |
|
|
| 1569 |
Maternal Age |
2021-10-01 |
|
|
| 1570 |
Crop Water Requirement |
2021-10-01 |
|
|
| 1571 |
Literate Review |
2021-10-01 |
|
|
| 1572 |
Grain Yield of Crops |
2021-09-30 |
|
|
| 1573 |
Hypothesis Summary |
2021-09-30 |
|
|
| 1574 |
Marketing Mix |
2021-09-30 |
|
|
| 1575 |
Methodology of research: Case study analysis |
2021-09-30 |
|
|
| 1576 |
Accountancy |
2021-09-30 |
|
|
| 1577 |
Formulation and Evaluation of Press Coated Tablets for Pulsatile Drug Delivery |
2021-09-30 |
|
|
| 1578 |
Discussion and Implications |
2021-09-30 |
|
|
| 1579 |
Data Analysis and Results |
2021-09-30 |
|
|
| 1580 |
What Is Developmental And Epileptic Encephalopathy (DEE) and How Does It Affect You? |
2021-09-29 |
|
|
| 1581 |
Management of epilepsy |
2021-09-29 |
|
|
| 1582 |
Epilepsy in the Developing Brain: Neurobiology and Consequences |
2021-09-29 |
|
|
| 1583 |
Consent |
2021-09-29 |
|
|
| 1584 |
Cosent |
2021-09-29 |
|
|
| 1585 |
Therapeutic Uses of Stem Cells |
2021-09-29 |
|
|
| 1586 |
Mode of Information Acquire |
2021-09-29 |
|
|
| 1587 |
Aging and Development |
2021-09-29 |
|
|
| 1588 |
Childhood Obesity and Consequences |
2021-09-29 |
|
|
| 1589 |
Strengths |
2021-09-28 |
|
|
| 1590 |
Background and Justification |
2021-09-27 |
|
|
| 1591 |
Effects of Deforestation |
2021-09-25 |
|
|
| 1592 |
World Deforestation |
2021-09-25 |
|
|
| 1593 |
Types of Spectrometry |
2021-09-25 |
|
|
| 1594 |
Orcid Id |
2021-09-25 |
|
|
| 1595 |
Emerging Technologies, Innovation, and Volatility |
2021-09-24 |
|
|
| 1596 |
Ethical Consideration |
2021-09-24 |
|
|
| 1597 |
Evaluation |
2021-09-23 |
|
|
| 1598 |
STOIC |
2021-09-23 |
|
|
| 1599 |
Antioxidants in Red Wine |
2021-09-23 |
|
|
| 1600 |
Importance of Antioxidants to Skin Aging |
2021-09-23 |
|
|
| 1601 |
Antioxidants and Skin Aging |
2021-09-23 |
|
|
| 1602 |
The Effect of Various Doses and Forms of Selenium on the Expression of Selenoprotein Genes, Productivity, Metabolic and Immune Processes in Fish |
2021-09-23 |
|
|
| 1603 |
Selenoproteome and Selenoproteins |
2021-09-23 |
|
|
| 1604 |
Analytical Framework |
2021-09-20 |
|
|
| 1605 |
Conclusion and Suggestions |
2021-09-20 |
|
|
| 1606 |
Challenges Faced by Women Entrepreneurs in India |
2021-09-20 |
|
|
| 1607 |
Important Problems Faced by Women Entrepreneurs in India |
2021-09-20 |
|
|
| 1608 |
Aims and Objectives |
2021-09-20 |
|
|
| 1609 |
Cash Flow |
2021-09-20 |
|
|
| 1610 |
Tax Deductions |
2021-09-20 |
|
|
| 1611 |
Business Relations |
2021-09-20 |
|
|
| 1612 |
Government Sectors |
2021-09-20 |
|
|
| 1613 |
Regression Analysis |
2021-09-20 |
|
|
| 1614 |
Agricultural Robots |
2021-09-18 |
|
|
| 1615 |
Bernoulli's Standard |
2021-09-17 |
|
|
| 1616 |
Statement of Funding |
2021-09-16 |
|
|
| 1617 |
Ethical Clearance |
2021-09-16 |
|
|
| 1618 |
A Brief History of Memory Research |
2021-09-16 |
|
|
| 1619 |
Irrigation Schedule |
2021-09-15 |
|
|
| 1620 |
Estimation of Evapotranspiration ETO |
2021-09-15 |
|
|
| 1621 |
Location of Study Area |
2021-09-15 |
|
|
| 1622 |
Disclosure of funding |
2021-09-15 |
|
|
| 1623 |
Disclosure of financial support |
2021-09-15 |
|
|
| 1624 |
Charter |
2021-09-15 |
|
|
| 1625 |
Development |
2021-09-15 |
|
|
| 1626 |
Physical and Chemical Inactivation Methods |
2021-09-15 |
|
|
| 1627 |
Patient Consent for Publication |
2021-09-14 |
|
|
| 1628 |
Key Clinical Message |
2021-09-14 |
|
|
| 1629 |
Availability of Data |
2021-09-14 |
|
|
| 1630 |
Role of Hypertension in Aneurysms |
2021-09-13 |
|
|
| 1631 |
General Discussion |
2021-09-13 |
|
|
| 1632 |
Result Analysis |
2021-09-13 |
|
|
| 1633 |
The Presentation of Findings |
2021-09-13 |
|
|
| 1634 |
Supplementary Methods |
2021-09-09 |
|
|
| 1635 |
DNA Binding Studies |
2021-09-08 |
|
|
| 1636 |
Contribution Statement |
2021-09-08 |
|
|
| 1637 |
Consent to Participate |
2021-09-08 |
|
|
| 1638 |
Author Contributions and Recognitions |
2021-09-08 |
|
|
| 1639 |
Experimental Details |
2021-09-07 |
|
|
| 1640 |
Exclusion Criteria |
2021-09-07 |
|
|
| 1641 |
Inclusion Criteria |
2021-09-07 |
|
|
| 1642 |
Anxiety disorders have certain characteristics |
2021-09-06 |
|
|
| 1643 |
Mental Retardation is Caused by a Combination of Genetic and Environmental |
2021-09-06 |
|
|
| 1644 |
Inheritance |
2021-09-06 |
|
|
| 1645 |
Asperger Syndrome Affects |
2021-09-06 |
|
|
| 1646 |
Model |
2021-09-06 |
|
|
| 1647 |
Photography |
2021-09-06 |
|
|
| 1648 |
Painting |
2021-09-06 |
|
|
| 1649 |
Drawing |
2021-09-06 |
|
|
| 1650 |
Calculated Workmanship |
2021-09-06 |
|
|
| 1651 |
Earthenware Production |
2021-09-06 |
|
|
| 1652 |
20th century |
2021-09-06 |
|
|
| 1653 |
Late modern |
2021-09-06 |
|
|
| 1654 |
Early modern |
2021-09-06 |
|
|
| 1655 |
Continuous Extrusion Printing |
2021-09-06 |
|
|
| 1656 |
The Right to Secession in the Fdre Constitution |
2021-09-06 |
|
|
| 1657 |
The Right to Self-Determination Under the Fdre Constitution |
2021-09-06 |
|
|
| 1658 |
The right to self-determination in international human rights law |
2021-09-06 |
|
|
| 1659 |
Ethnic Federalism in Ethiopia |
2021-09-06 |
|
|
| 1660 |
Analysis and Discussion |
2021-09-03 |
|
|
| 1661 |
Conclusions and Future Perspectives |
2021-09-03 |
|
|
| 1662 |
Nanomaterials Based Techniques for the Detection of OP Pesticides |
2021-09-03 |
|
|
| 1663 |
Results Discussion |
2021-09-03 |
|
|
| 1664 |
SGLT2 inhibitors |
2021-09-03 |
|
|
| 1665 |
Possible Relation of Pharmacotherapy to Gut Microbiota |
2021-09-03 |
|
|
| 1666 |
Insulin Resistance and β-cell Dysfunction |
2021-09-03 |
|
|
| 1667 |
Low-Grade Inflammatory Changes |
2021-09-03 |
|
|
| 1668 |
Metabolic Endotoxemia |
2021-09-03 |
|
|
| 1669 |
Intestinal Permeability |
2021-09-03 |
|
|
| 1670 |
Gut Dysbiosis and its Implications |
2021-09-03 |
|
|
| 1671 |
Use of Agrochemicals |
2021-09-02 |
|
|
| 1672 |
Overgrazing |
2021-09-02 |
|
|
| 1673 |
Deforestation |
2021-09-02 |
|
|
| 1674 |
Management of hypertension and methods |
2021-09-02 |
|
|
| 1675 |
Summary and Conclusion |
2021-09-01 |
|
|
| 1676 |
Crop Improvement |
2021-09-01 |
|
|
| 1677 |
Conservation and Conclusion |
2021-09-01 |
|
|
| 1678 |
Deep History of Ancestral Pandemics |
2021-09-01 |
|
|
| 1679 |
Fat Soluble Vitamins: Vitamins A, D, E, and K |
2021-09-01 |
|
|
| 1680 |
Evidence from Geology |
2021-09-01 |
|
|
| 1681 |
The Role of Viruses-Evidence from DNA |
2021-09-01 |
|
|
| 1682 |
A Brief Note Deficiency of Iron in Body |
2021-09-01 |
|
|
| 1683 |
A Mini Review on Vitamin Deficiency |
2021-09-01 |
|
|
| 1684 |
A Review on Minerals Deficiency in Body |
2021-09-01 |
|
|
| 1685 |
A Mini Review on Vitamins and Minerals |
2021-09-01 |
|
|
| 1686 |
Techniques |
2021-09-01 |
|
|
| 1687 |
Recognizing disease |
2021-08-31 |
|
|
| 1688 |
Acknowledgements/Funding |
2021-08-31 |
|
|
| 1689 |
Surgery |
2021-08-31 |
|
|
| 1690 |
Minimally Invasive Surgery |
2021-08-31 |
|
|
| 1691 |
Coronary Artery Bypass Grafting (CABG) |
2021-08-31 |
|
|
| 1692 |
Modern-Day Beating-Heart Surgical Procedure |
2021-08-31 |
|
|
| 1693 |
Open-Heart Surgery |
2021-08-31 |
|
|
| 1694 |
WHO and Surgical Safety |
2021-08-31 |
|
|
| 1695 |
Why Secure Surgical Procedure is Vital |
2021-08-31 |
|
|
| 1696 |
Research Approach and Methods |
2021-08-31 |
|
|
| 1697 |
Public policies |
2021-08-31 |
|
|
| 1698 |
Results of the Empirical Analyses |
2021-08-31 |
|
|
| 1699 |
BJP and Hyper-Nationalism |
2021-08-31 |
|
|
| 1700 |
Hyper-Nationalism and the Indian Press |
2021-08-31 |
|
|
| 1701 |
Nationalism in India |
2021-08-31 |
|
|
| 1702 |
The New Trends in Industrial Business Change and Its Effects in Indian Economics |
2021-08-31 |
|
|
| 1703 |
The Line of DisciplineFollowed by the Business house in the Ever- changing Modern Era |
2021-08-31 |
|
|
| 1704 |
Financial Institutes and their New Ways to Fight Financial Frauds |
2021-08-31 |
|
|
| 1705 |
The Change in Corporate Finance Sector in the Everchanging Modern Era |
2021-08-31 |
|
|
| 1706 |
Research Question |
2021-08-30 |
|
|
| 1707 |
Scope for Further Research |
2021-08-30 |
|
|
| 1708 |
Alternative Medicine for Diabetes: Beyond Stem Cell Approach |
2021-08-30 |
|
|
| 1709 |
Clinical Trials Use Comparison Groups to Compare Medical Strategies and Treatments |
2021-08-30 |
|
|
| 1710 |
Biostatistics is a Subset of Statistics that Deals with Biological Data |
2021-08-30 |
|
|
| 1711 |
Behavioral Patterns, not Physical Characteristics, are the Emphasis of Behavioral Metrics |
2021-08-30 |
|
|
| 1712 |
Biometrics are Measurements and Calculations of the Human Body |
2021-08-30 |
|
|
| 1713 |
Protein Analysis of Thyroid Cancer Cells |
2021-08-30 |
|
|
| 1714 |
ASSOCIATED FACTORS OF ALCOHOL USE DISORDER AMONG MEN WHO HAVE SEX WITH MEN |
2021-08-30 |
|
|
| 1715 |
The Use of Networks to Investigate Social Systems |
2021-08-30 |
|
|
| 1716 |
Thyroid Tissue-Organotypic Culture System |
2021-08-30 |
|
|
| 1717 |
T3 Therapy: Animal Models and Translational |
2021-08-30 |
|
|
| 1718 |
Function of the Medical Examiner |
2021-08-30 |
|
|
| 1719 |
Thyroid-Associated Ophthalmopathy Autoimmune Disorder |
2021-08-30 |
|
|
| 1720 |
The Vulnerabilities Related with Bloodstain Design Investigation are Colossal |
2021-08-30 |
|
|
| 1721 |
Thyroid Function Fluctuaated Animal for Thyroid Associated Ophthalmopathy |
2021-08-30 |
|
|
| 1722 |
Post-mortems are performed to legitimate or clinical purposes |
2021-08-30 |
|
|
| 1723 |
Phonological and Orthographic Adjustments between a Base Word |
2021-08-30 |
|
|
| 1724 |
The Effect of Sex in the Storage Capacity of Red Blood Cell Concentrates in CPD/SAGM |
2021-08-30 |
|
|
| 1725 |
Childhood Cancer - A Silent Killer of Children in Low and Middle-Income Countries |
2021-08-30 |
|
|
| 1726 |
Potential of Recombinant Protein (ULLB-0005) in Different Cancer |
2021-08-30 |
|
|
| 1727 |
Study of Epigenomic Changes (Noncoding -Tag. Oncogene) In Primary Cells of Cancer Patients than Biopsy Cells from Normal Tissue |
2021-08-30 |
|
|
| 1728 |
Mechanistic Studies on the Anti-Tumor Activities of Omega-3 Polyunsaturated Fatty Acids on the Human Neuroblastoma LA-N-1 Cells |
2021-08-30 |
|
|
| 1729 |
The Old and the New In Medical Cancer Therapy |
2021-08-30 |
|
|
| 1730 |
Marketing Management with Global Perspective |
2021-08-30 |
|
|
| 1731 |
An Overview on Marketing, Accounting and Finance Interface |
2021-08-30 |
|
|
| 1732 |
A Brief Note on Modern Business Effecting the Financial World |
2021-08-28 |
|
|
| 1733 |
The Investigation of Pathology |
2021-08-28 |
|
|
| 1734 |
Business Ethics: An overview |
2021-08-28 |
|
|
| 1735 |
Limitations and Future Studies |
2021-08-27 |
|
|
| 1736 |
Technological Developments |
2021-08-27 |
|
|
| 1737 |
Financial Management |
2021-08-27 |
|
|
| 1738 |
Corporate Governances |
2021-08-27 |
|
|
| 1739 |
Corporate Governance |
2021-08-27 |
|
|
| 1740 |
Statistical Results |
2021-08-27 |
|
|
| 1741 |
Consent Letter |
2021-08-26 |
|
|
| 1742 |
Microbial Indicators |
2021-08-26 |
|
|
| 1743 |
Cancer |
2021-08-26 |
|
|
| 1744 |
Chemical Analysis |
2021-08-26 |
|
|
| 1745 |
Green Solvents |
2021-08-25 |
|
|
| 1746 |
Phosphorylation of Glucose |
2021-08-25 |
|
|
| 1747 |
Conclusion and Outlook |
2021-08-25 |
|
|
| 1748 |
Prototypical Applications |
2021-08-25 |
|
|
| 1749 |
Declaration of Conflicting Interests |
2021-08-24 |
|
|
| 1750 |
Demands in Business |
2021-08-24 |
|
|
| 1751 |
Measuring Value in the Digital Economy is Difficult |
2021-08-24 |
|
|
| 1752 |
Review on Prostheses Development |
2021-08-24 |
|
|
| 1753 |
Overview of Prosthesis and Orthopedic Device |
2021-08-24 |
|
|
| 1754 |
Review Technique |
2021-08-24 |
|
|
| 1755 |
General Method of IGC Technique |
2021-08-24 |
|
|
| 1756 |
Principle Error Committed on the Dispersive Surface Energy of Solid Materials |
2021-08-24 |
|
|
| 1757 |
Actual Executions |
2021-08-23 |
|
|
| 1758 |
Summary of Studies |
2021-08-23 |
|
|
| 1759 |
Study Selection |
2021-08-23 |
|
|
| 1760 |
Missing Data |
2021-08-23 |
|
|
| 1761 |
Methodological Quality |
2021-08-23 |
|
|
| 1762 |
Information sources and search strategy |
2021-08-23 |
|
|
| 1763 |
Electrochemical Biosensors |
2021-08-23 |
|
|
| 1764 |
Results and Discussion |
2021-08-23 |
|
|
| 1765 |
Essentials of E-Retailing |
2021-08-21 |
|
|
| 1766 |
Bioassays for Microorganism |
2021-08-21 |
|
|
| 1767 |
Brief Note |
2021-08-21 |
|
|
| 1768 |
Brief Commentary |
2021-08-20 |
|
|
| 1769 |
Experimental Investigation |
2021-08-20 |
|
|
| 1770 |
Method Adopted |
2021-08-19 |
|
|
| 1771 |
Application of Proposed Method |
2021-08-19 |
|
|
| 1772 |
Scope |
2021-08-19 |
|
|
| 1773 |
Considering Market To Consumer Practices |
2021-08-19 |
|
|
| 1774 |
Hypertensive Encephalopathy |
2021-08-19 |
|
|
| 1775 |
Quality Management System |
2021-08-19 |
|
|
| 1776 |
Hypertensive Retinopathy |
2021-08-19 |
|
|
| 1777 |
Apparent Versus True |
2021-08-19 |
|
|
| 1778 |
Prevalence |
2021-08-19 |
|
|
| 1779 |
Refractory Hypertension |
2021-08-19 |
|
|
| 1780 |
Materials and Methods of Survey |
2021-08-19 |
|
|
| 1781 |
Competing Interests Competing Interests |
2021-08-19 |
|
|
| 1782 |
Hypertensive Emergency |
2021-08-19 |
|
|
| 1783 |
Cancer Biomarkers & Targeted Therapies |
2021-08-19 |
|
|
| 1784 |
Cancer Biomarkerâ??s & Targeted Therapies |
2021-08-19 |
|
|
| 1785 |
Cancer Biomarkerâ??s & Targeted Therapies |
2021-08-19 |
|
|
| 1786 |
Hypertensive Encephalopathy: Signs, Symptoms and Treatment |
2021-08-19 |
|
|
| 1787 |
Hypertensive Retinopathy: Physical examination, Symptoms and Management |
2021-08-19 |
|
|
| 1788 |
Refractory Hypertension: Prevalence, Apparent Versus True and Prognosis |
2021-08-19 |
|
|
| 1789 |
Corporate Governanceâ??s with Best Implementation |
2021-08-19 |
|
|
| 1790 |
Corporate Governanceâ??s with Best Implementation |
2021-08-19 |
|
|
| 1791 |
Corporate Governanceâ??s with Best Implementation |
2021-08-19 |
|
|
| 1792 |
Financial Management Importance for Financial Managers |
2021-08-19 |
|
|
| 1793 |
Hypertensive Emergency: Signs and Symptoms, Causes and Treatment |
2021-08-19 |
|
|
| 1794 |
Developing Business Goals |
2021-08-19 |
|
|
| 1795 |
Importance of Business Goals |
2021-08-19 |
|
|
| 1796 |
Key Points |
2021-08-19 |
|
|
| 1797 |
Competing of Interest |
2021-08-19 |
|
|
| 1798 |
Authors’ Contribution Statements |
2021-08-19 |
|
|
| 1799 |
Financial Backers |
2021-08-18 |
|
|
| 1800 |
Soil Management |
2021-08-18 |
|
|
| 1801 |
Authorship Statement |
2021-08-18 |
|
|
| 1802 |
Source of Financial Support |
2021-08-18 |
|
|
| 1803 |
The Case |
2021-08-18 |
|
|
| 1804 |
Limitations of Research |
2021-08-18 |
|
|
| 1805 |
Conclusion and Suggestion |
2021-08-18 |
|
|
| 1806 |
Data Collection Tools |
2021-08-18 |
|
|
| 1807 |
An Overview on Microbial Genetics |
2021-08-18 |
|
|
| 1808 |
Pathotypes of Enteropathogenic E. coli (EPEC) |
2021-08-18 |
|
|
| 1809 |
Microbial Assay |
2021-08-18 |
|
|
| 1810 |
Distribution of Estuarine Archaea |
2021-08-18 |
|
|
| 1811 |
Components of Histopathology Report |
2021-08-18 |
|
|
| 1812 |
Method of Preparation |
2021-08-18 |
|
|
| 1813 |
Different medicinal plants includes |
2021-08-17 |
|
|
| 1814 |
Announcement |
2021-08-17 |
|
|
| 1815 |
Terminal Area Calculation |
2021-08-17 |
|
|
| 1816 |
Electrical Carotid Sinus Stimulation |
2021-08-16 |
|
|
| 1817 |
Novel Biomarkers: Cardiovascular Risk |
2021-08-16 |
|
|
| 1818 |
Satisfactory Decongestion is still a Question in Heart Failure |
2021-08-16 |
|
|
| 1819 |
Cardiovascular Disease and Diabetes |
2021-08-16 |
|
|
| 1820 |
Use of Cardiac Biomarkers in Various Cardiovascular Conditions |
2021-08-16 |
|
|
| 1821 |
Seizures and epilepsy |
2021-08-16 |
|
|
| 1822 |
Photosensitive Seizures; its Causes and its Diagnosis |
2021-08-16 |
|
|
| 1823 |
Epilepsy Brain Responds to Nerve Stimulations |
2021-08-16 |
|
|
| 1824 |
Editorial Note on Focal Seizures |
2021-08-16 |
|
|
| 1825 |
Assessing the Risk of People with Epilepsy During the Covid-19 Pandemic |
2021-08-16 |
|
|
| 1826 |
Variable Gain Analog Buffer Amplifier |
2021-08-16 |
|
|
| 1827 |
Unity Gain OTA Buffer Using SG-RFET Inverter and GAAFET Inverter Circuit |
2021-08-16 |
|
|
| 1828 |
Method of Data Analysis |
2021-08-16 |
|
|
| 1829 |
Symptoms of Allergies |
2021-08-16 |
|
|
| 1830 |
Strain Improvement |
2021-08-16 |
|
|
| 1831 |
Opinion on Homeopathic Medicinal Products |
2021-08-13 |
|
|
| 1832 |
Editorial Note on Physical Exercise Induces Menstruation |
2021-08-13 |
|
|
| 1833 |
Editorial Note on Clinical Trials for Traditional Chinese Medicine |
2021-08-13 |
|
|
| 1834 |
Commentary on Parental Traditional Medicine |
2021-08-13 |
|
|
| 1835 |
A Brief Report on Psychiatric Disorder |
2021-08-13 |
|
|
| 1836 |
Additive Manufacturing (Am) Which Can Be a Suitable Technology to Personalize Wearableâ??s |
2021-08-13 |
|
|
| 1837 |
Additive Manufacturing (Am) Which Can Be a Suitable Technology to Personalize Wearableâ??s |
2021-08-13 |
|
|
| 1838 |
Data Availiability |
2021-08-13 |
|
|
| 1839 |
Stem Cell |
2021-08-13 |
|
|
| 1840 |
Post-Traumatic Stress Disorder |
2021-08-13 |
|
|
| 1841 |
About Conference |
2021-08-13 |
|
|
| 1842 |
Editorial on Plant Diversity Effects on Forage Quality |
2021-08-12 |
|
|
| 1843 |
Veterinary Medicine |
2021-08-12 |
|
|
| 1844 |
Materials, Software and Models to be used |
2021-08-11 |
|
|
| 1845 |
Authorship Contributions |
2021-08-11 |
|
|
| 1846 |
Ethical Standards |
2021-08-11 |
|
|
| 1847 |
Chemical engineering perspectives on vaccine production against COVID 19 |
2021-08-11 |
|
|
| 1848 |
Chemical engineering perspectives on vaccine production against COVID 19â?. |
2021-08-11 |
|
|
| 1849 |
Chemical engineering perspectives on vaccine production against COVID 19â?. |
2021-08-11 |
|
|
| 1850 |
Data extraction |
2021-08-10 |
|
|
| 1851 |
Cancer Biomarkerâ??s & Targeted Therapies |
2021-08-09 |
|
|
| 1852 |
Cancer Biomarkerâ??s & Targeted Therapies |
2021-08-09 |
|
|
| 1853 |
Cancer Biomarkerâ??s & Targeted Therapies |
2021-08-09 |
|
|
| 1854 |
Reproducibility |
2021-08-09 |
|
|
| 1855 |
Precision |
2021-08-09 |
|
|
| 1856 |
Exprimental |
2021-08-09 |
|
|
| 1857 |
Canine Transmissible Venereal Tumor: An Overview |
2021-08-09 |
|
|
| 1858 |
Oral Pathology and Its Role in Determining the Root of Dental Problems: An Overview |
2021-08-09 |
|
|
| 1859 |
Gingivitis: An Overview |
2021-08-09 |
|
|
| 1860 |
Focusing on Tumor Rejection Antigens in Melanoma with Tumor Infiltrating Lymphocytes |
2021-08-07 |
|
|
| 1861 |
Improving Outcomes in Children with High-Risk Neuroblastoma |
2021-08-07 |
|
|
| 1862 |
Fish Cytogenetics: Present / Future |
2021-08-07 |
|
|
| 1863 |
Short note on food nanotechnology |
2021-08-07 |
|
|
| 1864 |
no headings |
2021-08-07 |
|
|
| 1865 |
Survey |
2021-08-07 |
|
|
| 1866 |
Image Article |
2021-08-07 |
|
|
| 1867 |
Hypothesis for t-test |
2021-08-06 |
|
|
| 1868 |
Relating Two Measurement: Regression |
2021-08-06 |
|
|
| 1869 |
A Comment On Stating Null And Alternative Hypothesis |
2021-08-06 |
|
|
| 1870 |
Theoretical |
2021-08-06 |
|
|
| 1871 |
Signs and Symptoms |
2021-08-06 |
|
|
| 1872 |
Theory X and Y of Douglas McGregor |
2021-08-06 |
|
|
| 1873 |
Funding Sources |
2021-08-06 |
|
|
| 1874 |
Observation and Results |
2021-08-06 |
|
|
| 1875 |
Effect on Per Capita Gross Domestic Product |
2021-08-06 |
|
|
| 1876 |
Demography and Life-History Perspectives |
2021-08-06 |
|
|
| 1877 |
Patterns in Travel |
2021-08-06 |
|
|
| 1878 |
What are the Types of Soil Fertility? |
2021-08-06 |
|
|
| 1879 |
Environment Impact on Natural Ecosys- tems and Human Society |
2021-08-06 |
|
|
| 1880 |
Operative Procedure |
2021-08-06 |
|
|
| 1881 |
Molecular-Biology Applications In Rhetorical |
2021-08-05 |
|
|
| 1882 |
Plant Microbes Associated in Soil Microorganisms |
2021-08-05 |
|
|
| 1883 |
Carbon Sequestration |
2021-08-05 |
|
|
| 1884 |
Approaches of Clinical Veterinary Pathology |
2021-08-05 |
|
|
| 1885 |
Cell Pathology Techniques Concerned In Tissue Cultures |
2021-08-05 |
|
|
| 1886 |
Microbial Applications in Human Welfare |
2021-08-05 |
|
|
| 1887 |
Contemporary Correlation |
2021-08-05 |
|
|
| 1888 |
Techniques for Selection |
2021-08-05 |
|
|
| 1889 |
Disclosures |
2021-08-05 |
|
|
| 1890 |
Setting |
2021-08-05 |
|
|
| 1891 |
Functional applications |
2021-08-05 |
|
|
| 1892 |
Research style of the Study |
2021-08-04 |
|
|
| 1893 |
Policy Implications |
2021-08-04 |
|
|
| 1894 |
Study of the Period |
2021-08-04 |
|
|
| 1895 |
Statement of the Problems |
2021-08-04 |
|
|
| 1896 |
Favourable Conditions |
2021-08-04 |
|
|
| 1897 |
Discussion, Recommendation and Conclusion |
2021-08-04 |
|
|
| 1898 |
Results and Interpretation |
2021-08-04 |
|
|
| 1899 |
Objective of the Study |
2021-08-04 |
|
|
| 1900 |
Framework of Analysis |
2021-08-04 |
|
|
| 1901 |
Scope of the Study |
2021-08-04 |
|
|
| 1902 |
Suggestions for Future Research |
2021-08-04 |
|
|
| 1903 |
Model and methodology |
2021-08-04 |
|
|
| 1904 |
Hypotheses |
2021-08-04 |
|
|
| 1905 |
The Following Factors affect the Soil Fertility |
2021-08-04 |
|
|
| 1906 |
Definition |
2021-08-03 |
|
|
| 1907 |
Significance of the Study |
2021-08-03 |
|
|
| 1908 |
Need for the Study |
2021-08-03 |
|
|
| 1909 |
Statement of the Matter |
2021-08-03 |
|
|
| 1910 |
Pathophysiology |
2021-08-03 |
|
|
| 1911 |
Endometriosis |
2021-08-03 |
|
|
| 1912 |
Operation Process |
2021-08-02 |
|
|
| 1913 |
Procedure |
2021-08-02 |
|
|
| 1914 |
Discussions about Objectivity in Humanities |
2021-08-02 |
|
|
| 1915 |
Issues and Criticisms |
2021-08-02 |
|
|
| 1916 |
Observations and Results |
2021-07-31 |
|
|
| 1917 |
Test Results |
2021-07-31 |
|
|
| 1918 |
Description and Formulation of Model |
2021-07-31 |
|
|
| 1919 |
Data Findings and Analysis |
2021-07-30 |
|
|
| 1920 |
Scientific Contribution |
2021-07-30 |
|
|
| 1921 |
Methodology and Objective |
2021-07-29 |
|
|
| 1922 |
Institutional Response |
2021-07-29 |
|
|
| 1923 |
Social Implications |
2021-07-29 |
|
|
| 1924 |
Psychological Contract Theory |
2021-07-29 |
|
|
| 1925 |
Emotional Implications |
2021-07-29 |
|
|
| 1926 |
Control and Prevention |
2021-07-29 |
|
|
| 1927 |
Polymerase chain response |
2021-07-29 |
|
|
| 1928 |
Post-bio printing |
2021-07-29 |
|
|
| 1929 |
Bio-printing |
2021-07-29 |
|
|
| 1930 |
Pre-bio printing |
2021-07-29 |
|
|
| 1931 |
Uses |
2021-07-29 |
|
|
| 1932 |
Immunohistochemistry |
2021-07-28 |
|
|
| 1933 |
Proficient Commitment |
2021-07-28 |
|
|
| 1934 |
On Factory Automation |
2021-07-28 |
|
|
| 1935 |
On Telepresence Robots |
2021-07-28 |
|
|
| 1936 |
Crossing Scholarly Trains |
2021-07-28 |
|
|
| 1937 |
From 2-D to 3-D |
2021-07-28 |
|
|
| 1938 |
Method and Data Description |
2021-07-28 |
|
|
| 1939 |
Non-Associativity in M-theory |
2021-07-28 |
|
|
| 1940 |
Non-Associative Algebra |
2021-07-28 |
|
|
| 1941 |
The role of Einstein-Maxwell equations in Ads space-time |
2021-07-28 |
|
|
| 1942 |
Topological Black Hole |
2021-07-28 |
|
|
| 1943 |
Self-Care for a Stiff Neck |
2021-07-28 |
|
|
| 1944 |
Common Causes of Stiff Neck |
2021-07-28 |
|
|
| 1945 |
Metastases of the Bone |
2021-07-28 |
|
|
| 1946 |
Angiogenesis |
2021-07-28 |
|
|
| 1947 |
Treating Sinus Diseases |
2021-07-27 |
|
|
| 1948 |
Results of RAI Therapy Treatment |
2021-07-27 |
|
|
| 1949 |
Consumer Behaviour |
2021-07-27 |
|
|
| 1950 |
Limitaciones y perspectivas futuras de trabajo |
2021-07-24 |
|
|
| 1951 |
Comparison Of Clinical Trial Phases |
2021-07-24 |
|
|
| 1952 |
Monitoring Clinical Trials |
2021-07-24 |
|
|
| 1953 |
Types Of Cinical Trial |
2021-07-24 |
|
|
| 1954 |
Phases Of Clinical Trial |
2021-07-24 |
|
|
| 1955 |
Elimination of Malarial Grade |
2021-07-24 |
|
|
| 1956 |
Medical Care Development of Malaria |
2021-07-24 |
|
|
| 1957 |
Transcriptome Dynamics of CD4+ T cells during malaria |
2021-07-24 |
|
|
| 1958 |
Preventing the Reintroduction of Malaria |
2021-07-24 |
|
|
| 1959 |
Building the Nitrogen Consumption-Production Trade-Off |
2021-07-24 |
|
|
| 1960 |
Administration Ventures |
2021-07-23 |
|
|
| 1961 |
Sustenance and Sensitivity |
2021-07-23 |
|
|
| 1962 |
Conclusion and Key Points |
2021-07-23 |
|
|
| 1963 |
Radiosurgery with CyberKnife |
2021-07-22 |
|
|
| 1964 |
Criteria for Selection and Awards |
2021-07-22 |
|
|
| 1965 |
Young Researchers Forum Guideline |
2021-07-22 |
|
|
| 1966 |
Young Scientist Awards at Euro Structural Biology 2021 |
2021-07-22 |
|
|
| 1967 |
Various Specific Measures of Phylogenetic Diversity. |
2021-07-22 |
|
|
| 1968 |
Various Specific Measures of Phylogenetic Diversity |
2021-07-22 |
|
|
| 1969 |
Note on Electrochemical Biosensors |
2021-07-22 |
|
|
| 1970 |
Wearable chemistry Biosensors in Medical Applications |
2021-07-22 |
|
|
| 1971 |
Current Technologies of Immunosensors |
2021-07-22 |
|
|
| 1972 |
Nanosensors for Medical Specialty Applications |
2021-07-22 |
|
|
| 1973 |
Teacher Policy |
2021-07-22 |
|
|
| 1974 |
Cellulite |
2021-07-22 |
|
|
| 1975 |
Editorial Note on Black Hairy Tongue |
2021-07-22 |
|
|
| 1976 |
HBV and HIV |
2021-07-22 |
|
|
| 1977 |
Control of HBV |
2021-07-22 |
|
|
| 1978 |
HBV Serum Markers |
2021-07-22 |
|
|
| 1979 |
Customer Focused Process Improvement and the Performance Analysis Studies in Healthcare Systems |
2021-07-22 |
|
|
| 1980 |
Origin and Evolution |
2021-07-22 |
|
|
| 1981 |
Function |
2021-07-22 |
|
|
| 1982 |
NONINVASIVE PARENTAL TESTING : CLINICAL REVIEW |
2021-07-22 |
|
|
| 1983 |
A Review on Anti-Biotics (Anti- Bacterials) |
2021-07-22 |
|
|
| 1984 |
Removal of Pulp Tissue |
2021-07-22 |
|
|
| 1985 |
Dental Treatment |
2021-07-22 |
|
|
| 1986 |
Quality System Functionality Evaluation in Production Logistics |
2021-07-22 |
|
|
| 1987 |
Production and Trade |
2021-07-22 |
|
|
| 1988 |
Bioelectronics An Overview |
2021-07-21 |
|
|
| 1989 |
Electrochemical Sensor |
2021-07-21 |
|
|
| 1990 |
How Microelectrode Array-Based Chick Forebrain Neuron Biosensors Respond to Glutamate |
2021-07-21 |
|
|
| 1991 |
Electronic Devices Using Biosensors or Biochemical Products |
2021-07-21 |
|
|
| 1992 |
Prospective |
2021-07-21 |
|
|
| 1993 |
EDITORIAL NOTE ON PULMONARY DRUG DELIVERY TO OLDER PEOPLE |
2021-07-21 |
|
|
| 1994 |
RT-PCR BASICS |
2021-07-21 |
|
|
| 1995 |
HYPERPARATHYROIDISM |
2021-07-21 |
|
|
| 1996 |
EDITORIAL NOTE ON NONINVASIVE PARENTAL TESTING : CLINICAL REVIEW |
2021-07-20 |
|
|
| 1997 |
Antimicrobial Resistance in Clinical Studies |
2021-07-20 |
|
|
| 1998 |
Brief Report |
2021-07-20 |
|
|
| 1999 |
Short opinion |
2021-07-20 |
|
|
| 2000 |
Short opinon |
2021-07-20 |
|
|
| 2001 |
History and Interaction |
2021-07-20 |
|
|
| 2002 |
Transgenic |
2021-07-20 |
|
|
| 2003 |
Large-scale production |
2021-07-20 |
|
|
| 2004 |
Polyphenols in Health and Disease |
2021-07-20 |
|
|
| 2005 |
Polyphenol and its Mechanism of Action |
2021-07-20 |
|
|
| 2006 |
Understanding the Effect of Rainfall and Hydrology in Determining the Efficacy of Fluvial Erosion |
2021-07-19 |
|
|
| 2007 |
Hydrological Hypothesis Testing |
2021-07-19 |
|
|
| 2008 |
Surface and Subsurface Hydrology in Urban Residential Areas |
2021-07-19 |
|
|
| 2009 |
The Exact Distribution of Associated Extremes in Hydrology |
2021-07-19 |
|
|
| 2010 |
Hydrology of Hillslopes in Global Change Research Modelling of the Earth System |
2021-07-19 |
|
|
| 2011 |
Simulated Mountain Block Hydrology's Sensitivity to Subsurface |
2021-07-19 |
|
|
| 2012 |
Canadian and Chinese Mountain Hydrology: A Comparative Hydrology Case Study |
2021-07-19 |
|
|
| 2013 |
Water Resource Research Is Evolving in An Interdisciplinary Manner |
2021-07-19 |
|
|
| 2014 |
By using florigen, you can control how much water you need |
2021-07-19 |
|
|
| 2015 |
For mesotidal salt marshes, a basic, dynamic hydrological model was created |
2021-07-19 |
|
|
| 2016 |
Myocardial Infarction(MI) in Covid-19 Era |
2021-07-19 |
|
|
| 2017 |
Research Hypothesis |
2021-07-19 |
|
|
| 2018 |
Bacterial Cell: Coupling between Growth, Nucleoid Replication, Cell Division & Shape |
2021-07-17 |
|
|
| 2019 |
Bacterial Cell: Coupling between Growth, Nucleoid Replication, Cell Division and Shape |
2021-07-17 |
|
|
| 2020 |
Bacterial Cell: Coupling between Growth, Nucleoid Replication, Cell Division, and Shape |
2021-07-17 |
|
|
| 2021 |
Cell and Its Water |
2021-07-17 |
|
|
| 2022 |
EDITORIAL NOTE ON USE OF MHEALTH TO INCREASE PHYSICAL ACTIVITY IN OLDER PEOPLE |
2021-07-17 |
|
|
| 2023 |
EDITORIAL NOTE ONUSE OF MHEALTH TO INCREASE PHYSICAL ACTIVITY IN OLDER PEOPLE |
2021-07-17 |
|
|
| 2024 |
Editorial on Transcriptome Analysis |
2021-07-16 |
|
|
| 2025 |
Editorial on Genetic Marker System |
2021-07-16 |
|
|
| 2026 |
New Treatments |
2021-07-16 |
|
|
| 2027 |
Antiviral Drug Design |
2021-07-16 |
|
|
| 2028 |
The System of Cytogenetics |
2021-07-16 |
|
|
| 2029 |
The Disease of Prostate Cancer |
2021-07-16 |
|
|
| 2030 |
Measures |
2021-07-15 |
|
|
| 2031 |
Sample |
2021-07-15 |
|
|
| 2032 |
Rationale of the study |
2021-07-15 |
|
|
| 2033 |
Assessment Measures |
2021-07-15 |
|
|
| 2034 |
Editorial on DNA-Profiling |
2021-07-15 |
|
|
| 2035 |
Author’s Contributions |
2021-07-15 |
|
|
| 2036 |
Author's Contributions |
2021-07-15 |
|
|
| 2037 |
Green Buildings - A Step towards Environmental Protection |
2021-07-15 |
|
|
| 2038 |
Earthquake Engineering |
2021-07-15 |
|
|
| 2039 |
Types of Glaucoma |
2021-07-15 |
|
|
| 2040 |
Note on Pulmonary Hypertension and Pathophysiological Condition |
2021-07-14 |
|
|
| 2041 |
Hypertension: Its stages, Medication and Diet |
2021-07-14 |
|
|
| 2042 |
A Current Perspective on Global Prevalence of Hypertension |
2021-07-14 |
|
|
| 2043 |
Heart Diseases due to Hypertension |
2021-07-14 |
|
|
| 2044 |
Logistics in Entrepreneurship |
2021-07-14 |
|
|
| 2045 |
Logistic in Business |
2021-07-14 |
|
|
| 2046 |
Corporate Social Responsibility (CSR) vs. Corporate Accountability |
2021-07-14 |
|
|
| 2047 |
Corporate Accountability Reports |
2021-07-14 |
|
|
| 2048 |
Other Corporate Accountability Campaigns |
2021-07-14 |
|
|
| 2049 |
Corporate Accountability in History |
2021-07-14 |
|
|
| 2050 |
Cardiac Stroke: Causes, Types, Symptoms and Prevention |
2021-07-14 |
|
|
| 2051 |
Environmental Science - An Over Review |
2021-07-14 |
|
|
| 2052 |
Clinical Images |
2021-07-14 |
|
|
| 2053 |
Hypertension: Risk factors, prevention, and management |
2021-07-14 |
|
|
| 2054 |
Evaluation of Malaria Control and Prevention of Malaria Elimination |
2021-07-14 |
|
|
| 2055 |
Global Prospects and Strategies of Malaria Control & Elimination |
2021-07-14 |
|
|
| 2056 |
Quantifying Impact of Human Mobility on Malaria |
2021-07-14 |
|
|
| 2057 |
Cooperation Initiative in Malaria Control and Elimination |
2021-07-14 |
|
|
| 2058 |
Capital Market |
2021-07-14 |
|
|
| 2059 |
Corporate Governance Structure |
2021-07-14 |
|
|
| 2060 |
Hypertensive Heart Diseases |
2021-07-14 |
|
|
| 2061 |
Malaria Prevention and Public Health Issues |
2021-07-14 |
|
|
| 2062 |
Gestational Hypertension |
2021-07-14 |
|
|
| 2063 |
Extensive Aquaculture |
2021-07-13 |
|
|
| 2064 |
Intensive Aquaculture |
2021-07-13 |
|
|
| 2065 |
Immune System |
2021-07-13 |
|
|
| 2066 |
Therapies |
2021-07-13 |
|
|
| 2067 |
Triggers of Multiple Sclerosis |
2021-07-13 |
|
|
| 2068 |
Early Signs of Trouble |
2021-07-12 |
|
|
| 2069 |
The (Covid-19) Pandemic is Hitting Creating Economies at a Crucial Point in Time |
2021-07-12 |
|
|
| 2070 |
Model Development |
2021-07-12 |
|
|
| 2071 |
The Effect of COVID-19 on Shopper Conduct |
2021-07-12 |
|
|
| 2072 |
Ethical Declaration |
2021-07-10 |
|
|
| 2073 |
Measure |
2021-07-10 |
|
|
| 2074 |
Apprentices of Commercial Communication of SENA, Bogotá |
2021-07-09 |
|
|
| 2075 |
Prevention, Treatment, and Future |
2021-07-08 |
|
|
| 2076 |
Oxidative Stress in Brief |
2021-07-08 |
|
|
| 2077 |
Application of Phylogenetics |
2021-07-08 |
|
|
| 2078 |
Future Scope of Artificial Intelligence |
2021-07-08 |
|
|
| 2079 |
Application of AI in Pharmacy |
2021-07-08 |
|
|
| 2080 |
AI in Pharmacy |
2021-07-08 |
|
|
| 2081 |
AI in Science |
2021-07-08 |
|
|
| 2082 |
Devices Worked on Artificial Intelligence |
2021-07-08 |
|
|
| 2083 |
Types of AI |
2021-07-08 |
|
|
| 2084 |
History of AI |
2021-07-08 |
|
|
| 2085 |
Techniques and Applications |
2021-07-08 |
|
|
| 2086 |
Goals |
2021-07-08 |
|
|
| 2087 |
Overview |
2021-07-08 |
|
|
| 2088 |
Development of Social-media Platforms |
2021-07-08 |
|
|
| 2089 |
Early Computing |
2021-07-08 |
|
|
| 2090 |
Biological Profile of Benzimidazole |
2021-07-08 |
|
|
| 2091 |
Synthetic Strategies of Benzimidazole |
2021-07-08 |
|
|
| 2092 |
Pre-Current |
2021-07-08 |
|
|
| 2093 |
Foundation and Edges of the Field |
2021-07-08 |
|
|
| 2094 |
Issues in Policy Responses |
2021-07-08 |
|
|
| 2095 |
Policy Responses to COVID-19 |
2021-07-08 |
|
|
| 2096 |
Impact of Corona Virus in Health Industry |
2021-07-08 |
|
|
| 2097 |
Impact of Corona Virus on Global Education Industry |
2021-07-08 |
|
|
| 2098 |
Impact of Corona Virus on the Global Sports Industry |
2021-07-08 |
|
|
| 2099 |
Impact of Corona Virus on Global Hospitality Industry |
2021-07-08 |
|
|
| 2100 |
Impact on the Tourism Industry |
2021-07-08 |
|
|
| 2101 |
Impact of Corona Virus on World Economy |
2021-07-08 |
|
|
| 2102 |
Growing Importance of State Administration |
2021-07-08 |
|
|
| 2103 |
The States Reorganization Act,1956 |
2021-07-08 |
|
|
| 2104 |
Criticism of the SRC Report |
2021-07-08 |
|
|
| 2105 |
The Appointment and Report of the States Reorganization Commission |
2021-07-08 |
|
|
| 2106 |
The Creation of Andhra Pradesh |
2021-07-08 |
|
|
| 2107 |
History of the Demand for Redistribution of States |
2021-07-08 |
|
|
| 2108 |
State Setup at the Commencement of the Constitution |
2021-07-08 |
|
|
| 2109 |
Herbal Remedies |
2021-07-08 |
|
|
| 2110 |
Herbal Medicine |
2021-07-08 |
|
|
| 2111 |
Medicinal and Aromatic Plants |
2021-07-08 |
|
|
| 2112 |
Need for Herbal Therapy |
2021-07-08 |
|
|
| 2113 |
Hdl Cholesterol |
2021-07-08 |
|
|
| 2114 |
Triglycerides |
2021-07-08 |
|
|
| 2115 |
Going Even Lower |
2021-07-08 |
|
|
| 2116 |
Ldl-Lowering Strategies |
2021-07-08 |
|
|
| 2117 |
Other Pre-Analytical Considerations |
2021-07-08 |
|
|
| 2118 |
Lipid Profile |
2021-07-08 |
|
|
| 2119 |
Scheme of Cholesterol Formation |
2021-07-08 |
|
|
| 2120 |
Control |
2021-07-07 |
|
|
| 2121 |
Chemical Control |
2021-07-07 |
|
|
| 2122 |
Disease Cycle |
2021-07-07 |
|
|
| 2123 |
Causal Agent |
2021-07-07 |
|
|
| 2124 |
Management |
2021-07-07 |
|
|
| 2125 |
Treatment of Osteoarthritis |
2021-07-07 |
|
|
| 2126 |
Osteoarthritis Diagnosis |
2021-07-07 |
|
|
| 2127 |
Symptom of Osteoarthritis |
2021-07-07 |
|
|
| 2128 |
Causes of Osteoarthritis |
2021-07-07 |
|
|
| 2129 |
Editorial Note on Genetic Diseases |
2021-07-06 |
|
|
| 2130 |
Safety Regulations |
2021-07-05 |
|
|
| 2131 |
Dracunculiasis Diagnosis |
2021-07-05 |
|
|
| 2132 |
Adult vaccination schedule |
2021-07-05 |
|
|
| 2133 |
Adolescent Vaccine Schedule |
2021-07-05 |
|
|
| 2134 |
Editorial Note on Genetic Code |
2021-07-05 |
|
|
| 2135 |
Editorial Note on Molecular Genetics and Genomic Medicine |
2021-07-05 |
|
|
| 2136 |
Editorial Note on Genetic Screening |
2021-07-05 |
|
|
| 2137 |
Editorial Note on Different Types of Vaccines |
2021-07-05 |
|
|
| 2138 |
Editorial Note on COVID-19: Coronavirus Vaccines |
2021-07-05 |
|
|
| 2139 |
Discussion and Conclusions |
2021-07-05 |
|
|
| 2140 |
Methods of Biodiversity Analysis |
2021-07-02 |
|
|
| 2141 |
Data accessibility statement |
2021-07-01 |
|
|
| 2142 |
Participants and Procedures |
2021-07-01 |
|
|
| 2143 |
Results and Data Analysis |
2021-07-01 |
|
|
| 2144 |
Clinicocytological Analysis of Hepatic Neoplastic Lesions with Particular Reference to Morphological Pattern Assessment |
2021-06-30 |
|
|
| 2145 |
Changing Boundaries in Management of Head & Neck Oncology-Pathologist Role |
2021-06-30 |
|
|
| 2146 |
Diagnostic Histopathology |
2021-06-30 |
|
|
| 2147 |
Dataset |
2021-06-29 |
|
|
| 2148 |
Amaranthus spinosus, Amaranthus caudatus, and Amaranthus viridis |
2021-06-29 |
|
|
| 2149 |
Medicinal Plants of North East India Used in Hyperlipidemia |
2021-06-29 |
|
|
| 2150 |
Types of Hyperlipidemia |
2021-06-29 |
|
|
| 2151 |
Consent to Publish |
2021-06-26 |
|
|
| 2152 |
Limitations & Recommendations for Future Studies |
2021-06-26 |
|
|
| 2153 |
How to Extract Plasmid DNA |
2021-06-26 |
|
|
| 2154 |
Conclusion and Recommendation |
2021-06-26 |
|
|
| 2155 |
Empirical Review |
2021-06-26 |
|
|
| 2156 |
Theoretical Review |
2021-06-26 |
|
|
| 2157 |
Challenges |
2021-06-25 |
|
|
| 2158 |
Product Market Consolidation and Supply-Chain Structure |
2021-06-25 |
|
|
| 2159 |
The Determinants of Demand |
2021-06-25 |
|
|
| 2160 |
CRISPR |
2021-06-25 |
|
|
| 2161 |
Genetic Testing from 23 and Me |
2021-06-25 |
|
|
| 2162 |
Proposed System Overview |
2021-06-25 |
|
|
| 2163 |
Easier To Harvest Mature Plants |
2021-06-24 |
|
|
| 2164 |
Fewer Pest Problems |
2021-06-24 |
|
|
| 2165 |
Less Water Consumption |
2021-06-24 |
|
|
| 2166 |
Plants Can Grow Anywhere |
2021-06-24 |
|
|
| 2167 |
Higher Plant Density |
2021-06-24 |
|
|
| 2168 |
Improved Growth and Yield |
2021-06-24 |
|
|
| 2169 |
An Extended Growing Season |
2021-06-24 |
|
|
| 2170 |
Hi-Tech Nursery |
2021-06-24 |
|
|
| 2171 |
Forest Plant Nursery |
2021-06-24 |
|
|
| 2172 |
Medicinal and Aromatic Plant Nursery |
2021-06-24 |
|
|
| 2173 |
Vegetable Plant Nursery |
2021-06-24 |
|
|
| 2174 |
Fruit Plant Nursery |
2021-06-24 |
|
|
| 2175 |
Renovation Pruning |
2021-06-24 |
|
|
| 2176 |
Cordon Pruning |
2021-06-24 |
|
|
| 2177 |
Cane Pruning |
2021-06-24 |
|
|
| 2178 |
New Plantings |
2021-06-24 |
|
|
| 2179 |
Pest Control |
2021-06-24 |
|
|
| 2180 |
Compost |
2021-06-24 |
|
|
| 2181 |
Fertilizers |
2021-06-24 |
|
|
| 2182 |
Regulation |
2021-06-24 |
|
|
| 2183 |
Current Status |
2021-06-24 |
|
|
| 2184 |
Theoretical and conceptual consideration |
2021-06-23 |
|
|
| 2185 |
A Problem of Interpretation |
2021-06-23 |
|
|
| 2186 |
Additional Findings |
2021-06-23 |
|
|
| 2187 |
Theoretical principles of used model for estimates of Mean Group (MG) and Pooled Mean Group (PMG) |
2021-06-23 |
|
|
| 2188 |
Balassa Samuelsson effect |
2021-06-23 |
|
|
| 2189 |
Theoretical Foundations |
2021-06-23 |
|
|
| 2190 |
Limitation of the Study |
2021-06-22 |
|
|
| 2191 |
The Eventual Fate of Programming for Mechanical Technology |
2021-06-21 |
|
|
| 2192 |
Continued Growth of Collaborative Robot Applications |
2021-06-21 |
|
|
| 2193 |
Grasping Advances |
2021-06-21 |
|
|
| 2194 |
Model of a Collaborative Workstation |
2021-06-21 |
|
|
| 2195 |
Essential Components of Grading and Staging |
2021-06-19 |
|
|
| 2196 |
Research Problem and Methodology |
2021-06-16 |
|
|
| 2197 |
Measures and Definitions |
2021-06-16 |
|
|
| 2198 |
Theoretical Inferences |
2021-06-16 |
|
|
| 2199 |
Domestic Violence |
2021-06-16 |
|
|
| 2200 |
Specialization of Labor |
2021-06-16 |
|
|
| 2201 |
Modern Revolution |
2021-06-16 |
|
|
| 2202 |
History |
2021-06-16 |
|
|
| 2203 |
Youngster Work in Preindustrial Social Orders |
2021-06-16 |
|
|
| 2204 |
Policy Implication and Recommendations |
2021-06-15 |
|
|
| 2205 |
Sustainability and Triple-Bottom Line (TBL) Framework |
2021-06-15 |
|
|
| 2206 |
Ozone Depleting Substances(ODS) |
2021-06-15 |
|
|
| 2207 |
Chlorofluorocarbons |
2021-06-15 |
|
|
| 2208 |
Causes of Ozone Depletion |
2021-06-15 |
|
|
| 2209 |
Ozone Protective Effect:UV radiation |
2021-06-15 |
|
|
| 2210 |
Measuring Ozone Depletion |
2021-06-15 |
|
|
| 2211 |
Ozone Depletion Mechanism |
2021-06-15 |
|
|
| 2212 |
Ozone Depletion |
2021-06-15 |
|
|
| 2213 |
Ozone Hole and Global Warming |
2021-06-15 |
|
|
| 2214 |
Ozone Hole Over Antarctica |
2021-06-14 |
|
|
| 2215 |
Ozone Hole |
2021-06-14 |
|
|
| 2216 |
Ozone Layer |
2021-06-14 |
|
|
| 2217 |
Ozone |
2021-06-14 |
|
|
| 2218 |
Authorâ??s Contributions |
2021-06-14 |
|
|
| 2219 |
Core Ideas |
2021-06-14 |
|
|
| 2220 |
Study conduct implications |
2021-06-14 |
|
|
| 2221 |
Computational Advances: Using New Methods for Old Data Types |
2021-06-11 |
|
|
| 2222 |
Concepts: Using Multiple Theories |
2021-06-11 |
|
|
| 2223 |
Components of a Conceptual Model: The Importance of Symbolic vs. Functional Brands |
2021-06-11 |
|
|
| 2224 |
Context: Retail Collaborations as a Context for Research |
2021-06-11 |
|
|
| 2225 |
The Roles of Blockchain Technology on the Financial Sector |
2021-06-11 |
|
|
| 2226 |
Contribution/ Originality |
2021-06-11 |
|
|
| 2227 |
Model Estimation by Simultaneous Equation Method |
2021-06-11 |
|
|
| 2228 |
Fixed Effect Results |
2021-06-11 |
|
|
| 2229 |
Results Empirical and Discussions |
2021-06-11 |
|
|
| 2230 |
Data and Descriptive Statistics |
2021-06-11 |
|
|
| 2231 |
Empirical Literature Review |
2021-06-11 |
|
|
| 2232 |
Theoretical Literature Review |
2021-06-11 |
|
|
| 2233 |
Discussion and Recommendation |
2021-06-10 |
|
|
| 2234 |
Literature |
2021-06-10 |
|
|
| 2235 |
Fundings |
2021-06-10 |
|
|
| 2236 |
Standard Trade Theory |
2021-06-09 |
|
|
| 2237 |
Transnational Strategy |
2021-06-09 |
|
|
| 2238 |
Multidomestic Strategy |
2021-06-09 |
|
|
| 2239 |
Standardization Strategy |
2021-06-09 |
|
|
| 2240 |
Export Strategy |
2021-06-09 |
|
|
| 2241 |
Evaluating the proof |
2021-06-09 |
|
|
| 2242 |
Economies of scale |
2021-06-09 |
|
|
| 2243 |
Sorts of Robot HMIs |
2021-06-08 |
|
|
| 2244 |
Human Machine Interface (HMI) |
2021-06-08 |
|
|
| 2245 |
Graphical User Interface (GUI) |
2021-06-08 |
|
|
| 2246 |
User Interface (UI) |
2021-06-08 |
|
|
| 2247 |
Machine Arms |
2021-06-08 |
|
|
| 2248 |
Future Models |
2021-06-08 |
|
|
| 2249 |
Types of Surgery Explanation |
2021-06-08 |
|
|
| 2250 |
Most Difficult Surgery Procedures |
2021-06-08 |
|
|
| 2251 |
Types of hepatitis virus |
2021-06-07 |
|
|
| 2252 |
Refrence |
2021-06-03 |
|
|
| 2253 |
Future Perspectives of Postbiotics |
2021-06-03 |
|
|
| 2254 |
Literature Review: Postbiotics |
2021-06-03 |
|
|
| 2255 |
Ends |
2021-06-02 |
|
|
| 2256 |
Review of Case |
2021-06-02 |
|
|
| 2257 |
Paediatric Epilepsy: Clinical Uses |
2021-06-01 |
|
|
| 2258 |
Predictors of Clinical Epilepsy |
2021-06-01 |
|
|
| 2259 |
Operative Technique |
2021-05-31 |
|
|
| 2260 |
Diagnostic Analysis |
2021-05-31 |
|
|
| 2261 |
Legends |
2021-05-31 |
|
|
| 2262 |
Method of Fabrication |
2021-05-31 |
|
|
| 2263 |
Stability with Human Albumin |
2021-05-28 |
|
|
| 2264 |
Chemical Definition of Downstream Processes |
2021-05-28 |
|
|
| 2265 |
Chemically Defined Recombinant Serum Proteins as Essential Raw Materials in Vaccine and Viral Vector Production Media |
2021-05-28 |
|
|
| 2266 |
Chemical Definition of Upstream Cell Culture Processes |
2021-05-28 |
|
|
| 2267 |
Source of Funding |
2021-05-28 |
|
|
| 2268 |
What would people do to keep these cancer-causing viruses from infecting them? |
2021-05-26 |
|
|
| 2269 |
Treatment for Ebola |
2021-05-25 |
|
|
| 2270 |
Ebola is diagnosed in a variety of ways |
2021-05-25 |
|
|
| 2271 |
Ebola Symptoms |
2021-05-25 |
|
|
| 2272 |
How does one contract Ebola? |
2021-05-25 |
|
|
| 2273 |
Precautions of Airborne Diseases |
2021-05-25 |
|
|
| 2274 |
Diseases that are Spread across the Air |
2021-05-25 |
|
|
| 2275 |
Objective of this Study |
2021-05-20 |
|
|
| 2276 |
Finding |
2021-05-20 |
|
|
| 2277 |
Proposed model |
2021-05-20 |
|
|
| 2278 |
Context of Vietnam |
2021-05-20 |
|
|
| 2279 |
E-government |
2021-05-20 |
|
|
| 2280 |
6Cs Parent’s Model |
2021-05-20 |
|
|
| 2281 |
Evaluation of Current Theory and Practice |
2021-05-20 |
|
|
| 2282 |
Implications and Contributions to Knowledge |
2021-05-20 |
|
|
| 2283 |
Data Collection and Analysis |
2021-05-20 |
|
|
| 2284 |
Relevance of Literature |
2021-05-20 |
|
|
| 2285 |
Relevance and importance of the research |
2021-05-20 |
|
|
| 2286 |
Background and Context |
2021-05-20 |
|
|
| 2287 |
Conclusions and the Way Forward |
2021-05-20 |
|
|
| 2288 |
Performances of Irrigation Schemes |
2021-05-20 |
|
|
| 2289 |
Stagnant Large Scale Irrigation Developments |
2021-05-20 |
|
|
| 2290 |
Irrigation Development Plans |
2021-05-20 |
|
|
| 2291 |
Scheme Categorization |
2021-05-20 |
|
|
| 2292 |
The Aftermaths |
2021-05-20 |
|
|
| 2293 |
Institutional Capacities |
2021-05-20 |
|
|
| 2294 |
Organizational Setups |
2021-05-20 |
|
|
| 2295 |
Platforms of the Sector |
2021-05-20 |
|
|
| 2296 |
Irrigation for Ethiopia |
2021-05-20 |
|
|
| 2297 |
Description of Selected Models |
2021-05-20 |
|
|
| 2298 |
Objective of Study |
2021-05-20 |
|
|
| 2299 |
Crop Models |
2021-05-20 |
|
|
| 2300 |
Bioelectronics Applications supported Organic |
2021-05-19 |
|
|
| 2301 |
Biosensors and Bioelectronics Advanced Technology |
2021-05-19 |
|
|
| 2302 |
Significant Improvements in Mining with X-Ray Diffraction, Reduce Operating Costs, Greater Recovery of the Mineral and Reduction of the Volume of Mining Waste |
2021-05-19 |
|
|
| 2303 |
Research Methods |
2021-05-18 |
|
|
| 2304 |
The Source of Competitive Advantage: Internal Marketing |
2021-05-18 |
|
|
| 2305 |
Theoretical Background |
2021-05-18 |
|
|
| 2306 |
Suggestion |
2021-05-18 |
|
|
| 2307 |
The Impact of Agricultural Technology Adoption on Poverty |
2021-05-18 |
|
|
| 2308 |
Determinants of Agricultural Technology Adoption |
2021-05-18 |
|
|
| 2309 |
Contribution |
2021-05-18 |
|
|
| 2310 |
Application of Theory to Develop Theoretical Framework and Hypothesis |
2021-05-18 |
|
|
| 2311 |
Rethinking the Design Principles of Support Programs for Deep Tech Ventures |
2021-05-18 |
|
|
| 2312 |
Learning Trajectories and Patterns in Deep Tech Ventures |
2021-05-18 |
|
|
| 2313 |
Labor Courts |
2021-05-18 |
|
|
| 2314 |
Online Media Commitment |
2021-05-18 |
|
|
| 2315 |
Better Client Care |
2021-05-18 |
|
|
| 2316 |
Terminology |
2021-05-17 |
|
|
| 2317 |
Molecular Docking |
2021-05-16 |
|
|
| 2318 |
Declaration |
2021-05-15 |
|
|
| 2319 |
Experimental Methodology |
2021-05-14 |
|
|
| 2320 |
Applications of diffusion tensor imaging and fiber tractography |
2021-05-14 |
|
|
| 2321 |
Psychological Impact of COVID-19 |
2021-05-14 |
|
|
| 2322 |
How probably square measure children to induce Covid? |
2021-05-14 |
|
|
| 2323 |
The symptoms of Epithelioid Hemangioendothelioma |
2021-05-14 |
|
|
| 2324 |
Eosinophilic Esophagitis: Treatment |
2021-05-14 |
|
|
| 2325 |
Diagnosing leucocyte inflammation |
2021-05-14 |
|
|
| 2326 |
Diagnoising leucocyte inflammation |
2021-05-14 |
|
|
| 2327 |
Research Article |
2021-05-14 |
|
|
| 2328 |
Editorial Note for Integrative Medicine |
2021-05-13 |
|
|
| 2329 |
Declaration of Competing Interests |
2021-05-13 |
|
|
| 2330 |
Editorial Note for Cell Systems Biology |
2021-05-13 |
|
|
| 2331 |
Editorial Note for How to Treat Coronavirus at Home |
2021-05-13 |
|
|
| 2332 |
Editorial Note for Healthcare Science |
2021-05-13 |
|
|
| 2333 |
Editorial Note for Covid-19 Symptoms |
2021-05-13 |
|
|
| 2334 |
Empirical Findings |
2021-05-12 |
|
|
| 2335 |
Literature Review and Theoretical Frame Work |
2021-05-12 |
|
|
| 2336 |
Risk of Getting Infection |
2021-05-12 |
|
|
| 2337 |
Novel Approaches |
2021-05-12 |
|
|
| 2338 |
Introduction and Discussion |
2021-05-11 |
|
|
| 2339 |
Conceptual Framework and Empirical Analysis |
2021-05-11 |
|
|
| 2340 |
Summary of Findings |
2021-05-10 |
|
|
| 2341 |
Section Four: Summary, Conclusion and Recommendations |
2021-05-10 |
|
|
| 2342 |
Differences in Respondents’ Perceptions based on Sex and Educational Background |
2021-05-10 |
|
|
| 2343 |
Section Three |
2021-05-10 |
|
|
| 2344 |
Methods of Data Analysis |
2021-05-10 |
|
|
| 2345 |
Procedures for Data Collection |
2021-05-10 |
|
|
| 2346 |
Section Two: Methodological Aspect |
2021-05-10 |
|
|
| 2347 |
Conceptual and Theoretical Framework |
2021-05-10 |
|
|
| 2348 |
Section One: Introduction |
2021-05-10 |
|
|
| 2349 |
Conclusions and Discussion |
2021-05-10 |
|
|
| 2350 |
Anti-Inflammatory Activity |
2021-05-07 |
|
|
| 2351 |
Types of stocks |
2021-05-06 |
|
|
| 2352 |
Results of our Numerical Analysis |
2021-05-06 |
|
|
| 2353 |
Consumer market |
2021-05-06 |
|
|
| 2354 |
Metabolic Diseases Meet 2020 |
2021-05-04 |
|
|
| 2355 |
Scope for Future Research |
2021-05-04 |
|
|
| 2356 |
Authors Information |
2021-05-04 |
|
|
| 2357 |
Findings and Analysis |
2021-05-04 |
|
|
| 2358 |
Data Collection and Management |
2021-05-04 |
|
|
| 2359 |
Editorial Note on Hazards of Computer Viruses |
2021-04-30 |
|
|
| 2360 |
Editorial Note on Cloud Storage |
2021-04-30 |
|
|
| 2361 |
Intraoperative Epicardial Echocardiography |
2021-04-29 |
|
|
| 2362 |
Diagnosis of Right Ventricular Failure |
2021-04-29 |
|
|
| 2363 |
Tissue processing |
2021-04-29 |
|
|
| 2364 |
Gastrointestinal |
2021-04-29 |
|
|
| 2365 |
Author Discloures |
2021-04-28 |
|
|
| 2366 |
Standard Operating Procedures (SOPS) and Staff Training |
2021-04-28 |
|
|
| 2367 |
Clinical Nutrition RCT Oversight |
2021-04-28 |
|
|
| 2368 |
Documentation Unique to Diet Interventions |
2021-04-28 |
|
|
| 2369 |
Cell as a Living System |
2021-04-28 |
|
|
| 2370 |
Programmed Model Coordination Fabricate |
2021-04-26 |
|
|
| 2371 |
Proposed Strategy |
2021-04-26 |
|
|
| 2372 |
Examples and Applications |
2021-04-26 |
|
|
| 2373 |
Translating Component |
2021-04-26 |
|
|
| 2374 |
Types of Components |
2021-04-26 |
|
|
| 2375 |
Mass Identification |
2021-04-26 |
|
|
| 2376 |
Working Module |
2021-04-26 |
|
|
| 2377 |
Limitations and Conclusion |
2021-04-26 |
|
|
| 2378 |
Innovations |
2021-04-23 |
|
|
| 2379 |
Causes of Myiasis |
2021-04-23 |
|
|
| 2380 |
Epidemology |
2021-04-23 |
|
|
| 2381 |
Methods and Discussion |
2021-04-22 |
|
|
| 2382 |
Study Description |
2021-04-22 |
|
|
| 2383 |
Hypothesis |
2021-04-22 |
|
|
| 2384 |
Need of Study |
2021-04-22 |
|
|
| 2385 |
Case Representation |
2021-04-22 |
|
|
| 2386 |
Advancement |
2021-04-21 |
|
|
| 2387 |
Kinds of Exchanging Systems |
2021-04-21 |
|
|
| 2388 |
Cytology of Primary Mediastinal Rhabdomyosarcoma with Superior Vena Cava Compression and Bilateral Pleural Effusion |
2021-04-21 |
|
|
| 2389 |
Epidemiology of the Novel COVID- 19 |
2021-04-21 |
|
|
| 2390 |
Reached Results |
2021-04-21 |
|
|
| 2391 |
A Literature yet Little Bloated on the Subject |
2021-04-21 |
|
|
| 2392 |
Crucial Investigation Incorporates |
2021-04-21 |
|
|
| 2393 |
Execution Estimation |
2021-04-21 |
|
|
| 2394 |
Demand and Supply Analysis |
2021-04-21 |
|
|
| 2395 |
Discussion/Analytical |
2021-04-21 |
|
|
| 2396 |
Data Analysis and Presentation |
2021-04-16 |
|
|
| 2397 |
Effectiveness |
2021-04-16 |
|
|
| 2398 |
Data Sources and Collection Methods |
2021-04-16 |
|
|
| 2399 |
Purpose and Objectives |
2021-04-16 |
|
|
| 2400 |
The Rationale for the Study |
2021-04-16 |
|
|
| 2401 |
Findings and Discussion |
2021-04-16 |
|
|
| 2402 |
Explanation |
2021-04-16 |
|
|
| 2403 |
Call to Action |
2021-04-16 |
|
|
| 2404 |
Tourism statistics to the NSW Outback |
2021-04-16 |
|
|
| 2405 |
International Tourism statistics to Australia: an overview |
2021-04-16 |
|
|
| 2406 |
Plurality of the tourism “industries” |
2021-04-16 |
|
|
| 2407 |
The Future of Work |
2021-04-16 |
|
|
| 2408 |
Innovation in Family Businesses |
2021-04-16 |
|
|
| 2409 |
Succession in Family Business |
2021-04-16 |
|
|
| 2410 |
Author Notes |
2021-04-14 |
|
|
| 2411 |
Methodology and Strategy of Hyderabadi Biryani |
2021-04-08 |
|
|
| 2412 |
Cause and Effect Analysis |
2021-04-07 |
|
|
| 2413 |
Radiopharmaceuticals |
2021-04-07 |
|
|
| 2414 |
Tomography |
2021-04-07 |
|
|
| 2415 |
|
2021-04-07 |
|
|
| 2416 |
Reflection on the Incidence Basedon Gibbsâ?? Model |
2021-04-07 |
|
|
| 2417 |
Why Gibbsâ?? reflective mode |
2021-04-07 |
|
|
| 2418 |
Rolfeâ??s reflection model |
2021-04-07 |
|
|
| 2419 |
Johnâ??s reflective model |
2021-04-07 |
|
|
| 2420 |
Gibbsâ?? reflective model |
2021-04-07 |
|
|
| 2421 |
Gibbsâ?? reflective model |
2021-04-07 |
|
|
| 2422 |
Gibbsâ?? reflective model |
2021-04-07 |
|
|
| 2423 |
Review of the Models of Reflection Practice |
2021-04-07 |
|
|
| 2424 |
Narrative of the event |
2021-04-07 |
|
|
| 2425 |
Ecological Impact of Air Pollution |
2021-04-07 |
|
|
| 2426 |
How to Deal with Debris? |
2021-04-06 |
|
|
| 2427 |
Characteristics |
2021-04-06 |
|
|
| 2428 |
Recycling |
2021-04-06 |
|
|
| 2429 |
Disposal methods |
2021-04-06 |
|
|
| 2430 |
Kinds of Hazards |
2021-04-06 |
|
|
| 2431 |
Author’s contribution |
2021-04-02 |
|
|
| 2432 |
Rationale for HDR Brachytherapy |
2021-04-02 |
|
|
| 2433 |
Mediations to Improve Learning |
2021-04-02 |
|
|
| 2434 |
Image-based dosimetry of radionuclide therapy |
2021-04-02 |
|
|
| 2435 |
Molecular targeting radionuclide therapy (radioimmunotherapy) |
2021-04-02 |
|
|
| 2436 |
Selected therapeutic radionuclides and their clinical applications |
2021-04-02 |
|
|
| 2437 |
Clinical requirements and choice of radio-nuclide for therapy |
2021-04-02 |
|
|
| 2438 |
RADIONUCLIDES |
2021-04-02 |
|
|
| 2439 |
Circadian Nuclear Receptors |
2021-04-02 |
|
|
| 2440 |
Glucocorticoid Receptors |
2021-04-02 |
|
|
| 2441 |
Estrogen-Related Receptors |
2021-04-02 |
|
|
| 2442 |
Retinoid X receptors |
2021-04-02 |
|
|
| 2443 |
Farnesoid X receptors |
2021-04-02 |
|
|
| 2444 |
Cancer Therapy |
2021-04-02 |
|
|
| 2445 |
Changing frequency of Journal of Infectious Diseases and Medicine |
2021-04-02 |
|
|
| 2446 |
Nuclear Receptors |
2021-04-02 |
|
|
| 2447 |
Evidence Supporting the Use of Chemotherapy |
2021-04-02 |
|
|
| 2448 |
Evidence Supporting the Use of Somatostatin Analogues (SSAs) |
2021-04-02 |
|
|
| 2449 |
Neuroendocrine Tumors |
2021-04-02 |
|
|
| 2450 |
IMRT Delivery using a MLC |
2021-04-02 |
|
|
| 2451 |
IMRT planning: inverse planning |
2021-04-02 |
|
|
| 2452 |
Development of IMRT |
2021-04-02 |
|
|
| 2453 |
Radiation therapy techniques |
2021-04-02 |
|
|
| 2454 |
Intensity-modulated radiation therapy |
2021-04-02 |
|
|
| 2455 |
Radiation Therapy |
2021-04-02 |
|
|
| 2456 |
The impact of IR radiation on the induction of bystander killing by genetically engineered ovarian tumor cells: implications for clinical use of cancer vaccines |
2021-04-02 |
|
|
| 2457 |
Stem cell therapy for Crigler Najjar syndrome type I |
2021-04-02 |
|
|
| 2458 |
Human CAR-NK cells: A new non-viral method allowing high efficient transfection and target cell killing |
2021-04-02 |
|
|
| 2459 |
Stem cell, Biology and regenerative medicines is the major industry for the development of health, basic need of daily life, create employment, generate income, stronger economy, r |
2021-04-02 |
|
|
| 2460 |
Stem cell, Biology and regenerative medicines is the major industry for the development of health, basic need of daily life, create employment, generate income, stronger economy, r |
2021-04-02 |
|
|
| 2461 |
Stem cell, Biology and regenerative medicines is the major industry for the development of health, basic need of daily life, create employment, generate income, stronger economy, r |
2021-04-02 |
|
|
| 2462 |
Article Name - Stem cell, Biology and regenerative medicines is the major industry for the development of health, basic need of daily life, create employment, generate income, stro |
2021-04-02 |
|
|
| 2463 |
Stem cell and novel neurotropic factors to promote functional recovery in limb transplantation - Shashikumar K Salgar, Madigan Army Medical Center, USA |
2021-04-02 |
|
|
| 2464 |
Editorial Note on Journal of Microbiology and Pathology |
2021-04-01 |
|
|
| 2465 |
Editorâ??s Note on Journal of Microbiology and Pathology |
2021-04-01 |
|
|
| 2466 |
Editorâ??s Note on Journal of Microbiology and Pathology |
2021-04-01 |
|
|
| 2467 |
Annual Cardiologists |
2021-04-01 |
|
|
| 2468 |
Award Contents Heart Congress 2020 |
2021-04-01 |
|
|
| 2469 |
A Retrospective Study Comparing Clinical Profiles and Initial Treatments Received of Elderly and Non-Elderly Patients with Acute Coronary Syndrome at the Intensive Care Units |
2021-04-01 |
|
|
| 2470 |
Journal of Interventional and General Cardiology |
2021-04-01 |
|
|
| 2471 |
Conference Announcement-Heart Congress 2020 |
2021-04-01 |
|
|
| 2472 |
Shutting Patent Foramen Ovale (PFO) for Cryptogenic Stroke - Deeper Thoughts |
2021-04-01 |
|
|
| 2473 |
Handling Difficulties in the Diagnosis and Management of Hypertension |
2021-04-01 |
|
|
| 2474 |
Podocyte pathology and their techniques |
2021-04-01 |
|
|
| 2475 |
Bacterial Diseases |
2021-04-01 |
|
|
| 2476 |
Correlation of Type of ST Segment Elevation in Acute Anterior Wall Myocardial Infarction on ECG |
2021-04-01 |
|
|
| 2477 |
Anesthetic Monitoring of Preeclampsia |
2021-04-01 |
|
|
| 2478 |
Effectiveness of Flexyrap® Cobalt-Chromium Rapamycineluting Stents with Biodegradable Polymer in Coronary Artery Disease |
2021-04-01 |
|
|
| 2479 |
Can Non-Procedural Patient Characteristics Predict in Hospital Complications following Percutaneous Coronary Intervention? |
2021-04-01 |
|
|
| 2480 |
Can Non-Procedural Patient Characteristics Predict in Hospital Complications following Percutaneous Coronary Intervention? |
2021-04-01 |
|
|
| 2481 |
DNA Fingerprinting |
2021-03-31 |
|
|
| 2482 |
Treatment of Lung Cancer |
2021-03-31 |
|
|
| 2483 |
Stages of Lung Cancer |
2021-03-31 |
|
|
| 2484 |
Types of Lungs Cancer |
2021-03-31 |
|
|
| 2485 |
Research Gap |
2021-03-31 |
|
|
| 2486 |
Global health security: A Short communication |
2021-03-31 |
|
|
| 2487 |
Editorial Note for Special Issue on Molecular and Genetic Aspects of Covid 19 |
2021-03-30 |
|
|
| 2488 |
Amino Acids |
2021-03-30 |
|
|
| 2489 |
Results/Case Report |
2021-03-29 |
|
|
| 2490 |
AKI in Covid-19 |
2021-03-29 |
|
|
| 2491 |
Authorship Page |
2021-03-26 |
|
|
| 2492 |
Determinants of HIV/AIDS Disclosure in Pediatrics Age from 5-14 Years on ART |
2021-03-26 |
|
|
| 2493 |
Editorial Note for the Journal of AIDS & Clinical Research |
2021-03-26 |
|
|
| 2494 |
Diagnosis HIV |
2021-03-26 |
|
|
| 2495 |
Anti-Cancer Activity of Allium Sativum |
2021-03-26 |
|
|
| 2496 |
Antimicrobial Activity of Allium Sativum |
2021-03-26 |
|
|
| 2497 |
Strategies |
2021-03-25 |
|
|
| 2498 |
Policy Implications and Contributions |
2021-03-25 |
|
|
| 2499 |
Literature Review and Conceptual Framework |
2021-03-25 |
|
|
| 2500 |
Literature Review and Methodology |
2021-03-25 |
|
|
| 2501 |
Research Findings and Discussion |
2021-03-25 |
|
|
| 2502 |
The Literature Review |
2021-03-25 |
|
|
| 2503 |
Respiratory presentations |
2021-03-25 |
|
|
| 2504 |
Nerve Presentations |
2021-03-25 |
|
|
| 2505 |
Nerve Neuropathy presentations |
2021-03-25 |
|
|
| 2506 |
Effectiveness of Flexyrap® Cobalt-Chromium Rapamycineluting Stents with Biodegradable Polymer in Coronary Artery Disease |
2021-03-22 |
|
|
| 2507 |
Effectiveness of Flexyrap® Cobalt-Chromium Rapamycineluting Stents with Biodegradable Polymer in Coronary Artery Disease |
2021-03-22 |
|
|
| 2508 |
Effectiveness of Flexyrap® Cobalt-Chromium Rapamycineluting Stents with Biodegradable Polymer in Coronary Artery Disease |
2021-03-22 |
|
|
| 2509 |
Efficient and Safe Technique for Repair of Adult Re-Coarctation with Cardiovascular Pathologies |
2021-03-22 |
|
|
| 2510 |
Limitations and Concerns |
2021-03-22 |
|
|
| 2511 |
Comparative Analysis of the Hindu and Times of India Post the Abrogation of Article 370 |
2021-03-22 |
|
|
| 2512 |
Biomarkers Role of Aging |
2021-03-22 |
|
|
| 2513 |
Cancer Biomarkers |
2021-03-22 |
|
|
| 2514 |
Purpose of Genomic Study |
2021-03-22 |
|
|
| 2515 |
Vitamins and Minerals |
2021-03-22 |
|
|
| 2516 |
Quantitative Ethnobotanical Data Analysis |
2021-03-20 |
|
|
| 2517 |
Establishing a Cleansing and Sanitizing Program |
2021-03-19 |
|
|
| 2518 |
Elements of Cleansing and Sanitizing |
2021-03-19 |
|
|
| 2519 |
Sanitation Controls |
2021-03-19 |
|
|
| 2520 |
Detection and Elimination of Physical Hazards |
2021-03-19 |
|
|
| 2521 |
Physical Hazards |
2021-03-19 |
|
|
| 2522 |
Biochemical Hazards |
2021-03-19 |
|
|
| 2523 |
Chemical Hazards |
2021-03-19 |
|
|
| 2524 |
Hazards of Food |
2021-03-19 |
|
|
| 2525 |
Discussion and Analysis |
2021-03-18 |
|
|
| 2526 |
Vascular Defects |
2021-03-18 |
|
|
| 2527 |
Cardiology Bleeding Disorders |
2021-03-18 |
|
|
| 2528 |
Rheumatic Diseases |
2021-03-18 |
|
|
| 2529 |
Effects of Physical Activity |
2021-03-18 |
|
|
| 2530 |
Non-Pharmacological Approach |
2021-03-18 |
|
|
| 2531 |
Non-Pharmacological Treatment in Vascular Diseases |
2021-03-18 |
|
|
| 2532 |
Vascular Imaging |
2021-03-18 |
|
|
| 2533 |
Vascular Disease Causes and Risk Factors |
2021-03-18 |
|
|
| 2534 |
Cardiovascular System |
2021-03-18 |
|
|
| 2535 |
Subjects and laboratory analysis: An Editorial |
2021-03-18 |
|
|
| 2536 |
Diagnosis of lung cancer: An Editorial |
2021-03-18 |
|
|
| 2537 |
Comorbidity on psychiatric readmission an editorial |
2021-03-18 |
|
|
| 2538 |
Serum biomarkers in patients |
2021-03-18 |
|
|
| 2539 |
Sleep without atonia in younger age |
2021-03-18 |
|
|
| 2540 |
Neuropathy presentations in patients with COVID19 |
2021-03-17 |
|
|
| 2541 |
Respiratory care in neuromuscular disorders |
2021-03-17 |
|
|
| 2542 |
Acute bronchitis |
2021-03-17 |
|
|
| 2543 |
Acute bronchitis: An editorial |
2021-03-17 |
|
|
| 2544 |
Indolizine Pharmacophore and Pharmacological Activity |
2021-03-17 |
|
|
| 2545 |
Recent Synthetic Developments and Reactivity |
2021-03-17 |
|
|
| 2546 |
perpesctive |
2021-03-17 |
|
|
| 2547 |
Study Results |
2021-03-17 |
|
|
| 2548 |
Clinical Respiratory Diseases |
2021-03-17 |
|
|
| 2549 |
Journal highlights |
2021-03-17 |
|
|
| 2550 |
Effect on Humans |
2021-03-17 |
|
|
| 2551 |
Research Contribution and Achievement Awards |
2021-03-17 |
|
|
| 2552 |
Docking Results |
2021-03-17 |
|
|
| 2553 |
Rare Diseases and Orphan Drugs |
2021-03-17 |
|
|
| 2554 |
Importance & Scope |
2021-03-17 |
|
|
| 2555 |
Scholar Level |
2021-03-17 |
|
|
| 2556 |
Professional Level |
2021-03-17 |
|
|
| 2557 |
Women Scientist (The Women of Science Award) |
2021-03-17 |
|
|
| 2558 |
Scholar Level (The Upcoming Researcher Award) |
2021-03-17 |
|
|
| 2559 |
Professional Level (The Research Contribution Award) |
2021-03-17 |
|
|
| 2560 |
Bibliographic References |
2021-03-16 |
|
|
| 2561 |
Methods Validation |
2021-03-16 |
|
|
| 2562 |
Pulmonary Hypertension: An editorial |
2021-03-16 |
|
|
| 2563 |
Innovation |
2021-03-12 |
|
|
| 2564 |
Worldwide Work and Reasonable Exchange Developments |
2021-03-12 |
|
|
| 2565 |
Wellbeing Chances |
2021-03-12 |
|
|
| 2566 |
Work Conditions and Climate |
2021-03-12 |
|
|
| 2567 |
Worldwide Store Network |
2021-03-12 |
|
|
| 2568 |
Development Rate of Real GDP per capita |
2021-03-12 |
|
|
| 2569 |
Data and Results |
2021-03-12 |
|
|
| 2570 |
A Review of the Literature |
2021-03-12 |
|
|
| 2571 |
Benefits |
2021-03-12 |
|
|
| 2572 |
WPC 2020 Young Scientist Awards |
2021-03-12 |
|
|
| 2573 |
The different Parts of Financial Science |
2021-03-12 |
|
|
| 2574 |
Presentation of Results |
2021-03-12 |
|
|
| 2575 |
Award Announcements |
2021-03-11 |
|
|
| 2576 |
Conditions of Acceptance |
2021-03-11 |
|
|
| 2577 |
Guidelines |
2021-03-11 |
|
|
| 2578 |
Criteria |
2021-03-11 |
|
|
| 2579 |
Acknowledgement as YRF Awardee |
2021-03-11 |
|
|
| 2580 |
Privileges |
2021-03-11 |
|
|
| 2581 |
Eligibility |
2021-03-11 |
|
|
| 2582 |
Who Speak about ‘Normative Power Europe’ |
2021-03-11 |
|
|
| 2583 |
The Cotonou Partnership Agreement (CPA): The Implication for the Postcolonial EU and African Relations |
2021-03-11 |
|
|
| 2584 |
Postcolonial Approach on the Discourse of ‘Normative Power Europe’ |
2021-03-11 |
|
|
| 2585 |
Postcolonial Approach on the Discourse of ‘Normative Power Europe’ |
2021-03-11 |
|
|
| 2586 |
Orientalism |
2021-03-11 |
|
|
| 2587 |
Theoretical Framework: Post colonialism |
2021-03-11 |
|
|
| 2588 |
Intervention |
2021-03-10 |
|
|
| 2589 |
Examination |
2021-03-10 |
|
|
| 2590 |
Drug Supply Chain Regulation |
2021-03-09 |
|
|
| 2591 |
Risk Factors for Ovarian Cancer |
2021-03-06 |
|
|
| 2592 |
Types of Ovarian Cancer |
2021-03-06 |
|
|
| 2593 |
Early Symptoms of Ovarian Cancer |
2021-03-06 |
|
|
| 2594 |
Discussion of Findings |
2021-03-05 |
|
|
| 2595 |
Objectives of the Study |
2021-03-05 |
|
|
| 2596 |
Future Challenges |
2021-03-05 |
|
|
| 2597 |
Nanoparticle Incorporation into Scaffold |
2021-03-05 |
|
|
| 2598 |
Inflammatory factors |
2021-03-05 |
|
|
| 2599 |
Polymers |
2021-03-05 |
|
|
| 2600 |
Ceramics |
2021-03-05 |
|
|
| 2601 |
Bone Tissue Engineering Scaffolds |
2021-03-05 |
|
|
| 2602 |
Applications of Nanomedicine |
2021-03-05 |
|
|
| 2603 |
Medical Needs |
2021-03-05 |
|
|
| 2604 |
Nanomedicine Impacts all Fields of Drugs |
2021-03-05 |
|
|
| 2605 |
Conclusion and Discussion |
2021-03-05 |
|
|
| 2606 |
Stabilization and stabilization of Favipiravir by Magnetic Nanocomposite Magnetite |
2021-03-05 |
|
|
| 2607 |
Nitrogen Limitation Affects Hydrological Process |
2021-03-05 |
|
|
| 2608 |
Vegetation Controls the Future of Water Cycle |
2021-03-05 |
|
|
| 2609 |
Shrub Encroachment on Grasslands can Increment Groundwater Recharge |
2021-03-05 |
|
|
| 2610 |
Further Research |
2021-03-04 |
|
|
| 2611 |
Evolution and Biases of Social Media |
2021-03-04 |
|
|
| 2612 |
Evolution and Biases of Traditional Media |
2021-03-04 |
|
|
| 2613 |
Pathogenesis |
2021-03-04 |
|
|
| 2614 |
Research Methods and Data Gathering Techniques |
2021-03-04 |
|
|
| 2615 |
Media Framing |
2021-03-04 |
|
|
| 2616 |
Hydrological Implications of Rapid Global Warming |
2021-03-04 |
|
|
| 2617 |
Urbanization Reconfigures Surface Hydrology |
2021-03-04 |
|
|
| 2618 |
Geochemistry of Conventional Stable Isotopes |
2021-03-04 |
|
|
| 2619 |
Realms of hydrological science- Introductory Overview |
2021-03-04 |
|
|
| 2620 |
Editorial Note on Azo Dyes |
2021-03-04 |
|
|
| 2621 |
Hydrology of the Paleoflood Period in Quantitative Form |
2021-03-04 |
|
|
| 2622 |
Geohydrology: Watershed Hydrology |
2021-03-04 |
|
|
| 2623 |
Surface Hydrology Reconfigures Urbanization |
2021-03-04 |
|
|
| 2624 |
Retraction Note |
2021-03-03 |
|
|
| 2625 |
Citation |
2021-03-03 |
|
|
| 2626 |
Copyright |
2021-03-03 |
|
|
| 2627 |
METHOD ENGINEERING |
2021-03-02 |
|
|
| 2628 |
ENTERPRENEURSHIP |
2021-03-02 |
|
|
| 2629 |
This work is partly presented in 32 nd International Conference on Vaccines and Immunization November on 0 9 - 10, 2021 held at Atlanta, USA Vol. 10 No.1 Extended Abstract Malar |
2021-03-02 |
|
|
| 2630 |
SUPPLY CHAIN MANAGEMENT |
2021-03-02 |
|
|
| 2631 |
INDUSTRIAL ENGINEERING |
2021-03-02 |
|
|
| 2632 |
INDUSTRIAL ENGINEERING |
2021-03-02 |
|
|
| 2633 |
Vibrating Dual Bent-Share Cultivator |
2021-03-02 |
|
|
| 2634 |
Editors Note: Journal of Business & Financial Affairs : Amedeo Xu. |
2021-03-01 |
|
|
| 2635 |
Assessing the Effects of Financial Liberalization and Global Financial Crisis on Stock Market Volatility: Evidence from Smooth-Transition GARCH Models |
2021-03-01 |
|
|
| 2636 |
Editorial Note on Business marketing and Consumer market. |
2021-03-01 |
|
|
| 2637 |
The Impact of Trade Facilitation on Trade Flow in Asian Countries |
2021-03-01 |
|
|
| 2638 |
The Mediating Effect of Firm Performance on the Relationship between Ownership Structure Dimensions and Corporate Social Responsibility Disclosure by Firms Listed in Nairobi Securi |
2021-03-01 |
|
|
| 2639 |
Editorial Note for Genetic Aspects |
2021-03-01 |
|
|
| 2640 |
Editorial Note on Public Health |
2021-03-01 |
|
|
| 2641 |
Editorial Note for Medicine Aspects |
2021-03-01 |
|
|
| 2642 |
Editorial Note on Obesity and Public Health |
2021-03-01 |
|
|
| 2643 |
Cardiovascular Epidemiology |
2021-03-01 |
|
|
| 2644 |
Editorial Note on Nutritional Health and Epidemiology |
2021-03-01 |
|
|
| 2645 |
Editorial Note for Medicinal Biotechnology |
2021-03-01 |
|
|
| 2646 |
Health and Public Safety Precautions in Work |
2021-03-01 |
|
|
| 2647 |
Workplace Health and Safety Training during Covid-19 Pandemic |
2021-03-01 |
|
|
| 2648 |
Knowledge Transfer for Occupational Health |
2021-03-01 |
|
|
| 2649 |
Technologies of Safety and Health Management in Constructions |
2021-03-01 |
|
|
| 2650 |
Management of construction Safety and Health |
2021-03-01 |
|
|
| 2651 |
Editorial Note for Gene Therapeutics |
2021-03-01 |
|
|
| 2652 |
Types of Pathology |
2021-02-27 |
|
|
| 2653 |
Technology and Information |
2021-02-27 |
|
|
| 2654 |
Technology, People and Covid-19 |
2021-02-27 |
|
|
| 2655 |
Public Health |
2021-02-27 |
|
|
| 2656 |
Research Contribution |
2021-02-27 |
|
|
| 2657 |
Food Industry Application |
2021-02-27 |
|
|
| 2658 |
Data Collection Methods |
2021-02-27 |
|
|
| 2659 |
Research Statement |
2021-02-27 |
|
|
| 2660 |
Infections and Antibiotics |
2021-02-27 |
|
|
| 2661 |
Statement of Expected Research Contribution |
2021-02-26 |
|
|
| 2662 |
Research Strategy |
2021-02-26 |
|
|
| 2663 |
Research Design |
2021-02-26 |
|
|
| 2664 |
Statement of Proposed Research Methodology |
2021-02-26 |
|
|
| 2665 |
Statement of the Research Problem |
2021-02-26 |
|
|
| 2666 |
Justification of the Research |
2021-02-26 |
|
|
| 2667 |
Institutional Policies and Culture |
2021-02-26 |
|
|
| 2668 |
Social and Cultural Practices |
2021-02-26 |
|
|
| 2669 |
Balance between Family and Work |
2021-02-26 |
|
|
| 2670 |
Data Analysis and Interpretation |
2021-02-26 |
|
|
| 2671 |
Research Sample |
2021-02-26 |
|
|
| 2672 |
Research Problem and Significance |
2021-02-26 |
|
|
| 2673 |
Aim and Objectives |
2021-02-26 |
|
|
| 2674 |
Evaluate Market Potential and Resources |
2021-02-26 |
|
|
| 2675 |
Close the Rest |
2021-02-26 |
|
|
| 2676 |
Close the First Sale |
2021-02-26 |
|
|
| 2677 |
Execute Business Model |
2021-02-26 |
|
|
| 2678 |
Develop Business Model |
2021-02-26 |
|
|
| 2679 |
Intellectual Property and Patents |
2021-02-26 |
|
|
| 2680 |
Support Networks |
2021-02-26 |
|
|
| 2681 |
Human Capital/Investigator Strengths |
2021-02-26 |
|
|
| 2682 |
Pipette to Pallet: A Journey from Academia |
2021-02-26 |
|
|
| 2683 |
Roadmap |
2021-02-26 |
|
|
| 2684 |
Turn Spin Coupling |
2021-02-26 |
|
|
| 2685 |
Attractive Field Strength |
2021-02-26 |
|
|
| 2686 |
Atomic turn |
2021-02-26 |
|
|
| 2687 |
Magnetic Resonance |
2021-02-26 |
|
|
| 2688 |
Exercises and Challenges |
2021-02-26 |
|
|
| 2689 |
Atomic Medication |
2021-02-26 |
|
|
| 2690 |
Presentation |
2021-02-26 |
|
|
| 2691 |
Immunotherapy |
2021-02-26 |
|
|
| 2692 |
Bayesian Sir Modeling in the Case of Undocumented Infectious Individuals of COVID 19 |
2021-02-26 |
|
|
| 2693 |
Awareness, attitudes study during the outbreak of COVID-19: A cross-sectional survey |
2021-02-26 |
|
|
| 2694 |
Population Statistics that Contribute to COVID Mortality |
2021-02-26 |
|
|
| 2695 |
On The Record Values Property of Muth-Pareto Distribution and other Related Inference |
2021-02-26 |
|
|
| 2696 |
Editor note on Journal of Biometrics & Biostatistics |
2021-02-26 |
|
|
| 2697 |
Recommended Procedures |
2021-02-26 |
|
|
| 2698 |
Instruments Used |
2021-02-26 |
|
|
| 2699 |
Data Management |
2021-02-26 |
|
|
| 2700 |
Compliance with Ethical Standards |
2021-02-26 |
|
|
| 2701 |
Stroke Rehabilitation |
2021-02-26 |
|
|
| 2702 |
Migraine |
2021-02-26 |
|
|
| 2703 |
Ataxia |
2021-02-26 |
|
|
| 2704 |
Lumbar Disk Disease |
2021-02-26 |
|
|
| 2705 |
Ethical Statements |
2021-02-22 |
|
|
| 2706 |
Thoughts of Cell Therapy |
2021-02-22 |
|
|
| 2707 |
Present Therapy of AD |
2021-02-22 |
|
|
| 2708 |
Funding Source |
2021-02-22 |
|
|
| 2709 |
Results and Observations |
2021-02-22 |
|
|
| 2710 |
Types of Gastrulation |
2021-02-16 |
|
|
| 2711 |
The Joints |
2021-02-16 |
|
|
| 2712 |
The Upper and Lower Limb Bones |
2021-02-16 |
|
|
| 2713 |
Head |
2021-02-16 |
|
|
| 2714 |
Case Study 3: Evolutionary Relationships of Genes |
2021-02-12 |
|
|
| 2715 |
Case Study 2: Gene Copy Numbers |
2021-02-12 |
|
|
| 2716 |
Case Study 1: Presence or Absence of Genes |
2021-02-12 |
|
|
| 2717 |
Authors' contributions |
2021-02-12 |
|
|
| 2718 |
Clinical Registry |
2021-02-11 |
|
|
| 2719 |
Personality |
2021-02-10 |
|
|
| 2720 |
Trends |
2021-02-10 |
|
|
| 2721 |
Budget |
2021-02-10 |
|
|
| 2722 |
Protection |
2021-02-10 |
|
|
| 2723 |
Industrial Production |
2021-02-10 |
|
|
| 2724 |
In Household Food Processing |
2021-02-10 |
|
|
| 2725 |
Cause |
2021-02-09 |
|
|
| 2726 |
Analytical Methods |
2021-02-09 |
|
|
| 2727 |
Factors |
2021-02-09 |
|
|
| 2728 |
Mechanism |
2021-02-09 |
|
|
| 2729 |
Structure |
2021-02-09 |
|
|
| 2730 |
Types |
2021-02-09 |
|
|
| 2731 |
Optical Instruments in Spectroscopy |
2021-02-09 |
|
|
| 2732 |
Standards of Spectroscopy |
2021-02-09 |
|
|
| 2733 |
Materials |
2021-02-08 |
|
|
| 2734 |
Patient Assessment |
2021-02-06 |
|
|
| 2735 |
Clinical Implication |
2021-02-04 |
|
|
| 2736 |
Recommendation and Conclusion |
2021-02-04 |
|
|
| 2737 |
Ocular Allergy Test for ACDs |
2021-02-02 |
|
|
| 2738 |
Observations in Specific Enteroendocrine Tumors were noted |
2021-02-02 |
|
|
| 2739 |
Clinical Predictors |
2021-02-02 |
|
|
| 2740 |
Classification |
2021-02-02 |
|
|
| 2741 |
Genetics |
2021-02-02 |
|
|
| 2742 |
Codon Usage Bias in Phylogenetic Systematics |
2021-01-30 |
|
|
| 2743 |
Biological Construct of Codon Usage Bias |
2021-01-30 |
|
|
| 2744 |
Overview of Common Phylogenomic Techniques that do not Utilize Codon Usage Biases |
2021-01-30 |
|
|
| 2745 |
Codon Usage Biases Span the Tree of Life |
2021-01-30 |
|
|
| 2746 |
The Continued Importance of Phylogenetic Systematics |
2021-01-30 |
|
|
| 2747 |
Indoor Environmental Factors |
2021-01-29 |
|
|
| 2748 |
Materials and Experimental Design |
2021-01-29 |
|
|
| 2749 |
Materials and Experimental Program |
2021-01-29 |
|
|
| 2750 |
Alternative Analysis |
2021-01-29 |
|
|
| 2751 |
Description of Alternatives |
2021-01-29 |
|
|
| 2752 |
Overview of Study Approach |
2021-01-29 |
|
|
| 2753 |
Footnotes |
2021-01-19 |
|
|
| 2754 |
Article Highlights |
2021-01-19 |
|
|
| 2755 |
Coretip |
2021-01-19 |
|
|
| 2756 |
How does abdominal TB occur? |
2021-01-19 |
|
|
| 2757 |
Infectious Diseases |
2021-01-18 |
|
|
| 2758 |
Causative Agent |
2021-01-18 |
|
|
| 2759 |
Recognition |
2021-01-18 |
|
|
| 2760 |
Note in Proof |
2021-01-08 |
|
|
| 2761 |
Summary: Haplotype Switching as a Cosmic Viral Adaptation Strategy |
2021-01-08 |
|
|
| 2762 |
COVID-19 Outbreaks in Ships at Sea |
2021-01-08 |
|
|
| 2763 |
Airborne Transmission COVID-19 Formally Recognized? |
2021-01-08 |
|
|
| 2764 |
Genetic Strategy of COVID-19 is Compatible with its Putative Cosmic Origins |
2021-01-08 |
|
|
| 2765 |
The Chinese Bioweapon Release Theory |
2021-01-08 |
|
|
| 2766 |
Cosmic Origins? |
2021-01-08 |
|
|
| 2767 |
Pangolins as an Intermediate Host from Bats then to Human? |
2021-01-08 |
|
|
| 2768 |
The Bat to Human Jump Theory |
2021-01-08 |
|
|
| 2769 |
Early COVID-19 Origins and Explosive Epicentres |
2021-01-08 |
|
|
| 2770 |
Genomic Structure of COVID-19 |
2021-01-08 |
|
|
| 2771 |
Cosmic Origin Hypothesis for COVID-19 |
2021-01-08 |
|
|
| 2772 |
Authors’ Contribution |
2021-01-07 |
|
|
| 2773 |
Conclusion and Recommendation |
2021-01-07 |
|
|
| 2774 |
Evidence of seasonal deposition of micron-sized dust from the stratosphere |
2021-01-07 |
|
|
| 2775 |
Seasonal Deposition of Atmospheric Viruses |
2021-01-07 |
|
|
| 2776 |
Ships at Sea |
2021-01-07 |
|
|
| 2777 |
Discussion of COVID-19 |
2021-01-07 |
|
|
| 2778 |
Non-Therapeutic Methods |
2021-01-04 |
|
|
| 2779 |
Treatment of Diabetes |
2021-01-04 |
|
|
| 2780 |
Diagnosis of Diabetes |
2021-01-04 |
|
|
| 2781 |
Causes of Diabetes |
2021-01-04 |
|
|
| 2782 |
Diabetes insipidus |
2021-01-04 |
|
|
| 2783 |
Gestational Diabetes Mellitus (GDM) |
2021-01-04 |
|
|
| 2784 |
Other Specific Types of Diabetes |
2021-01-04 |
|
|
| 2785 |
Diabetes Mellitus |
2021-01-04 |
|
|
| 2786 |
Classification of Diabetes |
2021-01-04 |
|
|
| 2787 |
Epidemiology |
2021-01-04 |
|
|
| 2788 |
Editor |
2021-01-01 |
|
|
| 2789 |
Calculation Method |
2021-01-01 |
|
|
| 2790 |
Material Selection |
2021-01-01 |
|
|
| 2791 |
Limitations and Future Research |
2021-01-01 |
|
|
| 2792 |
Thematic Synthesis |
2021-01-01 |
|
|
| 2793 |
Critical Appraisal |
2021-01-01 |
|
|
| 2794 |
Inclusion and Exclusion Criteria |
2021-01-01 |
|
|
| 2795 |
Exploring the Impact of Individual Resilience on Entrepreneurial Success |
2021-01-01 |
|
|
| 2796 |
Testimonials |
2020-12-30 |
|
|
| 2797 |
Limitations of Study |
2020-12-30 |
|
|
| 2798 |
Ethics and Consent |
2020-12-28 |
|
|
| 2799 |
Contributions |
2020-12-28 |
|
|
| 2800 |
Organizational Learning and Entrepreneurship |
2020-12-28 |
|
|
| 2801 |
Declerations |
2020-12-28 |
|
|
| 2802 |
What Learnings Should Practitioners Consider when Utilizing this Approach? |
2020-12-28 |
|
|
| 2803 |
What are the Outcomes Associated with Using this Approach? |
2020-12-28 |
|
|
| 2804 |
What are the Limitations of this Methodology and Its Use as an Entrepreneurial Strategy? |
2020-12-28 |
|
|
| 2805 |
Relevant Organizational Learning Practices |
2020-12-28 |
|
|
| 2806 |
Characterizing Organizational Learning |
2020-12-28 |
|
|
| 2807 |
Main Innovation |
2020-12-24 |
|
|
| 2808 |
Research Findings |
2020-12-24 |
|
|
| 2809 |
Data Collection |
2020-12-24 |
|
|
| 2810 |
Construction and Development of Research Instruments |
2020-12-24 |
|
|
| 2811 |
Research Conceptual Framework |
2020-12-24 |
|
|
| 2812 |
Research Delimitation |
2020-12-24 |
|
|
| 2813 |
Expert Level (Scientific Service Achievement Award) |
2020-12-24 |
|
|
| 2814 |
We have classified our recognition category in two: |
2020-12-24 |
|
|
| 2815 |
Sampling Technique |
2020-12-23 |
|
|
| 2816 |
Abstract Citation |
2020-12-23 |
|
|
| 2817 |
Speaker Publications |
2020-12-23 |
|
|
| 2818 |
Funding and Sponsorship |
2020-12-22 |
|
|
| 2819 |
Consent to Publication |
2020-12-19 |
|
|
| 2820 |
Clinical Trial Registration |
2020-12-19 |
|
|
| 2821 |
Single Cell Assays |
2020-12-17 |
|
|
| 2822 |
Statistical Methods |
2020-12-17 |
|
|
| 2823 |
Ethics and Dissemination |
2020-12-17 |
|
|
| 2824 |
Short Note |
2020-12-16 |
|
|
| 2825 |
Ethical Approval and Consent Participate |
2020-12-15 |
|
|
| 2826 |
Grant Information |
2020-12-14 |
|
|
| 2827 |
Ethics Approval and Consent |
2020-12-13 |
|
|
| 2828 |
Strength and Limitations |
2020-12-12 |
|
|
| 2829 |
Neurological Disorders |
2020-12-07 |
|
|
| 2830 |
Head Injury |
2020-12-07 |
|
|
| 2831 |
Judging Criteria |
2020-12-04 |
|
|
| 2832 |
Guidelines for Best Poster Presentation - Best Poster Awards |
2020-12-04 |
|
|
| 2833 |
Best Poster Presentation - Best Poster Awards, Neurology 2020 |
2020-12-04 |
|
|
| 2834 |
Guidelines for Young Researchers Forum- Young Scientist Awards |
2020-12-04 |
|
|
| 2835 |
Funding Information |
2020-12-02 |
|
|
| 2836 |
Conclusion and Future Works |
2020-12-02 |
|
|
| 2837 |
Future Perspectives |
2020-12-02 |
|
|
| 2838 |
Conclusion and Relevance |
2020-12-02 |
|
|
| 2839 |
The Stages of Developing a Drug |
2020-12-02 |
|
|
| 2840 |
Bioanalysis |
2020-12-02 |
|
|
| 2841 |
Biomedicine |
2020-12-02 |
|
|
| 2842 |
Causes Epilepsy |
2020-12-02 |
|
|
| 2843 |
Seizure Medication |
2020-12-02 |
|
|
| 2844 |
Symptoms of Epilepsy |
2020-12-02 |
|
|
| 2845 |
LC-MS |
2020-12-02 |
|
|
| 2846 |
Learning Objectives |
2020-12-02 |
|
|
| 2847 |
Case Summary |
2020-12-02 |
|
|
| 2848 |
Upcoming/ Impending Strategies to improve Journal |
2020-12-02 |
|
|
| 2849 |
Severe Acute Respiratory Syndrome(Sars) |
2020-12-02 |
|
|
| 2850 |
Mechanism of Drug Resistance and Associated Mutations |
2020-12-02 |
|
|
| 2851 |
Approaches commonly used for detection of Mutations |
2020-12-02 |
|
|
| 2852 |
Tools Relevant for Identification of Drug Resistance Genes |
2020-12-02 |
|
|
| 2853 |
Whole Genome Sequencing |
2020-12-01 |
|
|
| 2854 |
Medical Genomics |
2020-12-01 |
|
|
| 2855 |
Cancer Genomics |
2020-12-01 |
|
|
| 2856 |
Patient Consent |
2020-12-01 |
|
|
| 2857 |
Music |
2020-12-01 |
|
|
| 2858 |
Polymer Composite |
2020-12-01 |
|
|
| 2859 |
Conclusion and Future Prospects |
2020-11-30 |
|
|
| 2860 |
Chitosan |
2020-11-30 |
|
|
| 2861 |
Poly Biguanides |
2020-11-30 |
|
|
| 2862 |
Quaternary Ammonium Compounds |
2020-11-30 |
|
|
| 2863 |
Nanotechnology |
2020-11-30 |
|
|
| 2864 |
Cross Linking |
2020-11-30 |
|
|
| 2865 |
Biocides |
2020-11-30 |
|
|
| 2866 |
The role of Nitric Oxide (NO) in the pathophysiology of the Myofascial Syndrome |
2020-11-27 |
|
|
| 2867 |
The role of Nitric Oxide (NO) in Gravity and Life management in the Myofascial System |
2020-11-27 |
|
|
| 2868 |
Challenges in Establishing a COVID Care Centre in Northern India |
2020-11-27 |
|
|
| 2869 |
Effectiveness of Spinal Manipulation for Treatment of Chronic Non-Specific Low Back Pain: A Systematic Review and Meta-Analysis |
2020-11-27 |
|
|
| 2870 |
Prevalence of Cardiovascular Disease and Risk Factors Among Residents of Tanga City |
2020-11-27 |
|
|
| 2871 |
Evolutionary Connections and Conclusions |
2020-11-26 |
|
|
| 2872 |
Cyclostome Hormones |
2020-11-26 |
|
|
| 2873 |
Chordate Hormones |
2020-11-26 |
|
|
| 2874 |
Hormones of the Gnathostome Adenohypophysis |
2020-11-26 |
|
|
| 2875 |
Cyclostome Development |
2020-11-26 |
|
|
| 2876 |
Chordate Development |
2020-11-26 |
|
|
| 2877 |
Development of the Gnathostome Adenohypophysis |
2020-11-26 |
|
|
| 2878 |
Morphology of the Gnathostome Pituitary |
2020-11-26 |
|
|
| 2879 |
About the Study |
2020-11-26 |
|
|
| 2880 |
Editorial Note for Journal of Phylogenetics & Evolutionary Biology |
2020-11-26 |
|
|
| 2881 |
Therapy after Brain Injury |
2020-11-25 |
|
|
| 2882 |
On an Isotropic Finslerian Manifold [9] |
2020-11-17 |
|
|
| 2883 |
Properties of the Nullity Space and the Curvature Image Space |
2020-11-17 |
|
|
| 2884 |
Properties of the Curvature ℜ of a Riemannian Manifold |
2020-11-17 |
|
|
| 2885 |
Properties of the Curvature â?? of a Riemannian Manifold |
2020-11-17 |
|
|
| 2886 |
Properties of the Curvature â?? of a Riemannian Manifold |
2020-11-17 |
|
|
| 2887 |
Canonical Connection of a Riemannian Manifold |
2020-11-17 |
|
|
| 2888 |
The Spruce Budworm with Delay and without Delay and Numerical Results |
2020-11-17 |
|
|
| 2889 |
The Bifurcation Point and Hysteresis Effect |
2020-11-17 |
|
|
| 2890 |
The Bifurcation Point and Hysteresis Effect |
2020-11-17 |
|
|
| 2891 |
Nondimentionalization |
2020-11-17 |
|
|
| 2892 |
The Spruce Budworm Model and its Analysis |
2020-11-17 |
|
|
| 2893 |
The Mathematical Tools |
2020-11-17 |
|
|
| 2894 |
Preface |
2020-11-17 |
|
|
| 2895 |
West Nile Virus |
2020-11-16 |
|
|
| 2896 |
H1N1 Flu Virus |
2020-11-16 |
|
|
| 2897 |
Objectives |
2020-11-06 |
|
|
| 2898 |
Ingredient |
2020-11-06 |
|
|
| 2899 |
Recommendations for Future Research |
2020-11-04 |
|
|
| 2900 |
Implications |
2020-11-04 |
|
|
| 2901 |
Methodology and Research Design |
2020-11-04 |
|
|
| 2902 |
Ethics Approval and Consent to Participate |
2020-11-03 |
|
|
| 2903 |
Background |
2020-11-03 |
|
|
| 2904 |
Operational Definitions and Statistical Analysis |
2020-11-03 |
|
|
| 2905 |
Literature Search |
2020-11-03 |
|
|
| 2906 |
Case History |
2020-10-31 |
|
|
| 2907 |
Limitations and Further Suggestions |
2020-10-31 |
|
|
| 2908 |
Concluding Remarks |
2020-10-29 |
|
|
| 2909 |
Numerical Experiments |
2020-10-29 |
|
|
| 2910 |
A new Finite Volume Method for Hyperbolic Conservation Laws |
2020-10-29 |
|
|
| 2911 |
WENO Methods |
2020-10-29 |
|
|
| 2912 |
Finite Volume Methods |
2020-10-29 |
|
|
| 2913 |
Analysis of Coated Fabrics |
2020-10-29 |
|
|
| 2914 |
Materials and Methodology |
2020-10-29 |
|
|
| 2915 |
Statement of Problem |
2020-10-29 |
|
|
| 2916 |
Limitations of the Study |
2020-10-29 |
|
|
| 2917 |
Hilaris |
2020-10-29 |
|
|
| 2918 |
Theory |
2020-10-28 |
|
|
| 2919 |
Materials and Instrumentation |
2020-10-28 |
|
|
| 2920 |
Learning Points |
2020-10-26 |
|
|
| 2921 |
Metabolic Syndrome Alters Immunity |
2020-10-24 |
|
|
| 2922 |
Excess Glucose: The Silent Killer |
2020-10-24 |
|
|
| 2923 |
Vitamins and Minerals: Imperative to Immunity |
2020-10-24 |
|
|
| 2924 |
Viruses: How do They Work? |
2020-10-24 |
|
|
| 2925 |
The Immune System |
2020-10-24 |
|
|
| 2926 |
Care of Diabetic Patients |
2020-10-24 |
|
|
| 2927 |
Laboratory Examination |
2020-10-24 |
|
|
| 2928 |
Research in Context |
2020-10-24 |
|
|
| 2929 |
Disclosure Statement |
2020-10-24 |
|
|
| 2930 |
Statement of Ethics |
2020-10-24 |
|
|
| 2931 |
Data |
2020-10-24 |
|
|
| 2932 |
Method Validation |
2020-10-23 |
|
|
| 2933 |
Discussions |
2020-10-23 |
|
|
| 2934 |
Organic Synthesis and Reactions |
2020-10-23 |
|
|
| 2935 |
Ethical Considerations |
2020-10-23 |
|
|
| 2936 |
Result and Discussions |
2020-10-22 |
|
|
| 2937 |
Instrumentation |
2020-10-22 |
|
|
| 2938 |
Biological Assay |
2020-10-22 |
|
|
| 2939 |
Biological Results |
2020-10-22 |
|
|
| 2940 |
Synthesis of Metal Complexes |
2020-10-21 |
|
|
| 2941 |
Computational Details |
2020-10-21 |
|
|
| 2942 |
General Remarks |
2020-10-21 |
|
|
| 2943 |
Procedures |
2020-10-21 |
|
|
| 2944 |
Experimental Animals |
2020-10-21 |
|
|
| 2945 |
Sensitivity Analysis |
2020-10-20 |
|
|
| 2946 |
Numerical Simulation and Sensitivity Analysis |
2020-10-20 |
|
|
| 2947 |
Existence of Disease free Equilibrium Point (DFE) |
2020-10-20 |
|
|
| 2948 |
Experimental Design |
2020-10-16 |
|
|
| 2949 |
Design |
2020-10-15 |
|
|
| 2950 |
Therapeutic Types and Assay Platform |
2020-10-15 |
|
|
| 2951 |
Assay Development Considerations |
2020-10-15 |
|
|
| 2952 |
Consent for Publication |
2020-10-15 |
|
|
| 2953 |
Authorship |
2020-10-15 |
|
|
| 2954 |
Editor Note |
2020-10-12 |
|
|
| 2955 |
Discussion and Findings |
2020-10-12 |
|
|
| 2956 |
Research Hypotheses |
2020-10-12 |
|
|
| 2957 |
Research Questions |
2020-10-12 |
|
|
| 2958 |
Research Objectives |
2020-10-12 |
|
|
| 2959 |
Approaches to Business Model Innovation |
2020-10-12 |
|
|
| 2960 |
Systematic Literature Reviews |
2020-10-12 |
|
|
| 2961 |
Business Model Innovation |
2020-10-12 |
|
|
| 2962 |
Assessment of a Business Model |
2020-10-12 |
|
|
| 2963 |
Types of Business Models |
2020-10-12 |
|
|
| 2964 |
Components and Frameworks |
2020-10-12 |
|
|
| 2965 |
Published Literature Review |
2020-10-12 |
|
|
| 2966 |
Business Model Definition |
2020-10-12 |
|
|
| 2967 |
Methodology of the study |
2020-10-12 |
|
|
| 2968 |
Statement of the Problem |
2020-10-12 |
|
|
| 2969 |
Background of the Study |
2020-10-12 |
|
|
| 2970 |
Summary and Conclusions |
2020-10-12 |
|
|
| 2971 |
Diagnostics and Multivariate Tools |
2020-10-12 |
|
|
| 2972 |
Funding Agency |
2020-10-09 |
|
|
| 2973 |
Research Significance |
2020-10-09 |
|
|
| 2974 |
Discussion and Inferences |
2020-10-09 |
|
|
| 2975 |
Research Methodology and Data Analysis |
2020-10-09 |
|
|
| 2976 |
Construction |
2020-10-09 |
|
|
| 2977 |
Study Area |
2020-10-09 |
|
|
| 2978 |
Young Research Forum |
2020-10-06 |
|
|
| 2979 |
Author Disclosure Statement |
2020-10-05 |
|
|
| 2980 |
Recommendations and Implications of Findings |
2020-10-03 |
|
|
| 2981 |
Aim of the Study |
2020-10-03 |
|
|
| 2982 |
Declartions |
2020-10-01 |
|
|
| 2983 |
Space Law Treaties and Principles |
2020-10-01 |
|
|
| 2984 |
Analysis |
2020-10-01 |
|
|
| 2985 |
Opinion |
2020-10-01 |
|
|
| 2986 |
CARFENTANILâ??SYNTHETIC OPIOID ANALGESIC: A REVIEW |
2020-09-30 |
|
|
| 2987 |
CARFENTANILâ??SYNTHETIC OPIOID ANALGESIC: A REVIEW |
2020-09-30 |
|
|
| 2988 |
Impact of 2019- nCoV on African Economy |
2020-09-29 |
|
|
| 2989 |
Cross-Case Analysis of Thematic Areas |
2020-09-29 |
|
|
| 2990 |
Case Study Approach |
2020-09-28 |
|
|
| 2991 |
Review of Related Literature |
2020-09-28 |
|
|
| 2992 |
Infection Prevention and Control |
2020-09-28 |
|
|
| 2993 |
Susceptible Person |
2020-09-28 |
|
|
| 2994 |
Editors |
2020-09-28 |
|
|
| 2995 |
Classification of the Journal |
2020-09-28 |
|
|
| 2996 |
Cerebral Malaria |
2020-09-28 |
|
|
| 2997 |
Bacterial Degradation |
2020-09-28 |
|
|
| 2998 |
Lumbar Plexus Block (LPB) |
2020-09-26 |
|
|
| 2999 |
Fascia Iliaca Block (FIB) |
2020-09-26 |
|
|
| 3000 |
Femoral Nerve Block (FNB) |
2020-09-26 |
|
|
| 3001 |
Patients and Methods |
2020-09-26 |
|
|
| 3002 |
Aim of Work |
2020-09-26 |
|
|
| 3003 |
Permission |
2020-09-26 |
|
|
| 3004 |
Research Perspective |
2020-09-26 |
|
|
| 3005 |
Prognosis of Esophageal Cancer |
2020-09-26 |
|
|
| 3006 |
Life Quality |
2020-09-26 |
|
|
| 3007 |
Follow Up |
2020-09-26 |
|
|
| 3008 |
Postoperative Care |
2020-09-26 |
|
|
| 3009 |
Synchronous Oligometastasis |
2020-09-26 |
|
|
| 3010 |
Salvage Concept |
2020-09-26 |
|
|
| 3011 |
Curative Therapy of Esophageal Cancer |
2020-09-26 |
|
|
| 3012 |
Primary Staging |
2020-09-26 |
|
|
| 3013 |
Observation |
2020-09-26 |
|
|
| 3014 |
A Review on Role of Breeding for Rust Disease Resistance in Soybean (Glycine max [L.] Merrill |
2020-09-25 |
|
|
| 3015 |
Safety and Challenges of Scaffold used in Tissue Engineering |
2020-09-25 |
|
|
| 3016 |
THE ROLE OF POLYMORPHISM OF THE TYROSINASE GENE - TYR IN THE MECHANISM OF DEVELOPMENT OF VITILIGO |
2020-09-25 |
|
|
| 3017 |
The visualization of hair follicles by means of ultrasound scanner and follicoscope (using 640nm red visible with polarized light filter) to reduce damage for hair follicles during |
2020-09-23 |
|
|
| 3018 |
The visualization of hair follicles by means of ultrasound scanner and follicoscope (using 640nm red visible with polarized light filter) to reduce damage for hair follicles during |
2020-09-23 |
|
|
| 3019 |
Novelties in additive manufacturing and bio-printing |
2020-09-23 |
|
|
| 3020 |
A comparison of one shape and protaper next rotary systems for elimination of enterococcus faecalis from root canal: Microbiological and sem evaluation |
2020-09-23 |
|
|
| 3021 |
Utilization of blood and its components at a tertiary care hospital in Pakistan |
2020-09-23 |
|
|
| 3022 |
Real-time Measurement of Glomerular Filtration Rate |
2020-09-23 |
|
|
| 3023 |
Studies on Short Term Performance of Mergers and Acquisitions |
2020-09-22 |
|
|
| 3024 |
Foreign Entry Modes |
2020-09-22 |
|
|
| 3025 |
History of Merger & Acquisition |
2020-09-22 |
|
|
| 3026 |
Conceptual Background of the Study |
2020-09-22 |
|
|
| 3027 |
Findings and Conclusions |
2020-09-22 |
|
|
| 3028 |
Government Initiatives |
2020-09-22 |
|
|
| 3029 |
Analysis and Interpretation |
2020-09-22 |
|
|
| 3030 |
NVG-SEE |
2020-09-22 |
|
|
| 3031 |
Business Responsibility Reporting (BRR) |
2020-09-22 |
|
|
| 3032 |
Regulation Pertaining to Corporate Social Responsibility (CSR) |
2020-09-22 |
|
|
| 3033 |
The Accounting Framework |
2020-09-22 |
|
|
| 3034 |
ICAI-ARF 2008 |
2020-09-22 |
|
|
| 3035 |
Disclosure Requirements under the Companies Act |
2020-09-22 |
|
|
| 3036 |
Companies Act, 2013 |
2020-09-22 |
|
|
| 3037 |
Securities and Exchange Board of India (SEBI) |
2020-09-22 |
|
|
| 3038 |
Factories Act, 1948 |
2020-09-22 |
|
|
| 3039 |
Environmental Regulations in India |
2020-09-22 |
|
|
| 3040 |
Regulations for Corporate Reporting in India |
2020-09-22 |
|
|
| 3041 |
Stakeholder Satisfaction |
2020-09-22 |
|
|
| 3042 |
Project success Indicators |
2020-09-22 |
|
|
| 3043 |
Scientific Research Outputs |
2020-09-18 |
|
|
| 3044 |
Corona Virus Infection |
2020-09-18 |
|
|
| 3045 |
Journal of Applied and Computational Mathematics |
2020-09-18 |
|
|
| 3046 |
Lemma |
2020-09-18 |
|
|
| 3047 |
Novel fractionation methods of injectable platelet-rich fibrin |
2020-09-18 |
|
|
| 3048 |
Appendix |
2020-09-17 |
|
|
| 3049 |
Numerical Examples |
2020-09-17 |
|
|
| 3050 |
Mathematical Modelling and Implementation of Eigenmodes |
2020-09-17 |
|
|
| 3051 |
Applications |
2020-09-17 |
|
|
| 3052 |
Examples of Star-operators |
2020-09-17 |
|
|
| 3053 |
Examples of Star-systems equivalent |
2020-09-17 |
|
|
| 3054 |
Examples of Star-function |
2020-09-17 |
|
|
| 3055 |
Examples of Star-element |
2020-09-17 |
|
|
| 3056 |
Orientation of a Star with Coefficient A and Matrix Multiplication |
2020-09-17 |
|
|
| 3057 |
Some Basic Definitions and Notations |
2020-09-17 |
|
|
| 3058 |
Numerical Simulations |
2020-09-17 |
|
|
| 3059 |
Stability Analysis of Steady States |
2020-09-17 |
|
|
| 3060 |
Equilibrium Analysis |
2020-09-17 |
|
|
| 3061 |
Model Formulation |
2020-09-17 |
|
|
| 3062 |
Submission Process |
2020-09-16 |
|
|
| 3063 |
Role of Guest Editor(s) |
2020-09-16 |
|
|
| 3064 |
Role of Guest Editor(s |
2020-09-16 |
|
|
| 3065 |
Role of EB Members |
2020-09-16 |
|
|
| 3066 |
Proposal Preparation |
2020-09-16 |
|
|
| 3067 |
Special Issue Guidelines |
2020-09-16 |
|
|
| 3068 |
Limitations and Future Recommendations |
2020-09-16 |
|
|
| 3069 |
Biography |
2020-09-16 |
|
|
| 3070 |
Modern Psychotherapeutic Tools and Satvavajaya Techniques |
2020-09-16 |
|
|
| 3071 |
Epidemiology and Prevalence |
2020-09-16 |
|
|
| 3072 |
Pathophysiology of Hypertension and Role of Mental Components |
2020-09-16 |
|
|
| 3073 |
Summary Investigation |
2020-09-16 |
|
|
| 3074 |
Dry Cough |
2020-09-16 |
|
|
| 3075 |
Oral Manifestation of Side/Adverse Effect Of Hypertensive Drugs |
2020-09-16 |
|
|
| 3076 |
Sign and Symptoms |
2020-09-16 |
|
|
| 3077 |
Assay Procedure |
2020-09-10 |
|
|
| 3078 |
Procedure for Calibration Plot |
2020-09-10 |
|
|
| 3079 |
Preparation of Solutions |
2020-09-10 |
|
|
| 3080 |
MTT Assay |
2020-09-10 |
|
|
| 3081 |
Sources of Funding |
2020-09-10 |
|
|
| 3082 |
Structural and Functional Characteristics of the Virus Sars-Cov-2 and Pathogenesis |
2020-09-10 |
|
|
| 3083 |
Antimicrobial Activity |
2020-09-10 |
|
|
| 3084 |
Declarations of Interest |
2020-09-10 |
|
|
| 3085 |
Validation of the Proposed Method |
2020-09-10 |
|
|
| 3086 |
Method Development |
2020-09-10 |
|
|
| 3087 |
Conflict of Interest Statement |
2020-09-09 |
|
|
| 3088 |
Aim of the Work |
2020-09-09 |
|
|
| 3089 |
Data and Methodology |
2020-09-07 |
|
|
| 3090 |
Novel Discoveries in Diagnosis and Treatments |
2020-09-02 |
|
|
| 3091 |
Patients |
2020-09-02 |
|
|
| 3092 |
Infliximab Uses and its Outcomes |
2020-09-02 |
|
|
| 3093 |
Complications with Proton Pump Inhibitors |
2020-09-02 |
|
|
| 3094 |
Interpretation |
2020-09-02 |
|
|
| 3095 |
2020 Conference Announcement of 4th International Conference on Craniofacial Surgery |
2020-09-01 |
|
|
| 3096 |
Neurointensive Care |
2020-09-01 |
|
|
| 3097 |
Dementia |
2020-09-01 |
|
|
| 3098 |
Mobile or Cell Phone or Smart Phone Addiction |
2020-09-01 |
|
|
| 3099 |
Occupational Therapy |
2020-09-01 |
|
|
| 3100 |
Alcohol Addiction |
2020-09-01 |
|
|
| 3101 |
Clinical Review |
2020-08-30 |
|
|
| 3102 |
Conclusion and Limitations |
2020-08-30 |
|
|
| 3103 |
Materials and Procedures |
2020-08-30 |
|
|
| 3104 |
Clinical Case Series |
2020-08-30 |
|
|
| 3105 |
Flu (Influenza Virus) |
2020-08-30 |
|
|
| 3106 |
Dengue Virus |
2020-08-30 |
|
|
| 3107 |
Hib Disease |
2020-08-30 |
|
|
| 3108 |
Report on Tuberculosis |
2020-08-30 |
|
|
| 3109 |
Declaration of Interests |
2020-08-29 |
|
|
| 3110 |
Project Demonstration |
2020-08-29 |
|
|
| 3111 |
Schedule, Tasks and Milestones |
2020-08-29 |
|
|
| 3112 |
Call for Nominations |
2020-08-29 |
|
|
| 3113 |
Conclusões |
2020-08-29 |
|
|
| 3114 |
Resultados E Discussão |
2020-08-29 |
|
|
| 3115 |
Agradecimento |
2020-08-28 |
|
|
| 3116 |
Conclusão |
2020-08-28 |
|
|
| 3117 |
Resultados Y Discusión |
2020-08-28 |
|
|
| 3118 |
Métodos |
2020-08-28 |
|
|
| 3119 |
Referencias |
2020-08-28 |
|
|
| 3120 |
Financiamiento |
2020-08-28 |
|
|
| 3121 |
Conclusiones |
2020-08-28 |
|
|
| 3122 |
Discusión |
2020-08-28 |
|
|
| 3123 |
Resultados |
2020-08-28 |
|
|
| 3124 |
Método |
2020-08-28 |
|
|
| 3125 |
Introducción |
2020-08-28 |
|
|
| 3126 |
Palabras Clave |
2020-08-28 |
|
|
| 3127 |
Upcoming Strategies to improve Journal |
2020-08-26 |
|
|
| 3128 |
Applied Strategies in 2019 |
2020-08-26 |
|
|
| 3129 |
Ethics Approval |
2020-08-26 |
|
|
| 3130 |
Overview of Cardiovascular Complications |
2020-08-26 |
|
|
| 3131 |
Experimental Work |
2020-08-26 |
|
|
| 3132 |
General Anesthesia |
2020-08-26 |
|
|
| 3133 |
Riemannian Manifolds with Regular Curvature |
2020-08-26 |
|
|
| 3134 |
Automorphisms of a Riemannian Manifold |
2020-08-26 |
|
|
| 3135 |
Conformal Infinitesimal Transformations of a Riemannian Manifold |
2020-08-26 |
|
|
| 3136 |
Properties of the Horizontal Nullity Space of Curvatures |
2020-08-26 |
|
|
| 3137 |
Properties of the Curvature  of a Riemannian Man |
2020-08-26 |
|
|
| 3138 |
Connections on Riemannian Manifolds |
2020-08-26 |
|
|
| 3139 |
Examples |
2020-08-26 |
|
|
| 3140 |
Automorphisms |
2020-08-26 |
|
|
| 3141 |
Particular Lie Algebras from Γ and S |
2020-08-26 |
|
|
| 3142 |
Properties of the Vertical Ideal of  |
2020-08-26 |
|
|
| 3143 |
Preliminaries |
2020-08-26 |
|
|
| 3144 |
Young Researchers Forum |
2020-08-25 |
|
|
| 3145 |
Market Analysis |
2020-08-25 |
|
|
| 3146 |
Methodology Adopted |
2020-08-25 |
|
|
| 3147 |
Experimental Procedures |
2020-08-25 |
|
|
| 3148 |
Block Room Documentation Standards |
2020-08-25 |
|
|
| 3149 |
Future Research Works |
2020-08-21 |
|
|
| 3150 |
Future of Soft Computing Methods |
2020-08-21 |
|
|
| 3151 |
Pros and Cons of Methods |
2020-08-21 |
|
|
| 3152 |
Delicate Computing Methods |
2020-08-21 |
|
|
| 3153 |
Material and Method |
2020-08-21 |
|
|
| 3154 |
Training Results |
2020-08-21 |
|
|
| 3155 |
ANN Learning Methodology |
2020-08-21 |
|
|
| 3156 |
Disclosure of Potential Sources of Conflict of Interest |
2020-08-20 |
|
|
| 3157 |
Vaccination and Immunization |
2020-08-19 |
|
|
| 3158 |
Statistical Modeling |
2020-08-19 |
|
|
| 3159 |
The Pirfenidone NDA |
2020-08-19 |
|
|
| 3160 |
Simulation Studies |
2020-08-19 |
|
|
| 3161 |
Parameters Estimations |
2020-08-19 |
|
|
| 3162 |
The KR Distribution |
2020-08-19 |
|
|
| 3163 |
Introduction & Aim |
2020-08-18 |
|
|
| 3164 |
Conclusive Remarks |
2020-08-18 |
|
|
| 3165 |
Conclusion and Future Directions |
2020-08-17 |
|
|
| 3166 |
Letter to Editor |
2020-08-17 |
|
|
| 3167 |
Treatments for Kidney Disease |
2020-08-14 |
|
|
| 3168 |
Symptoms |
2020-08-14 |
|
|
| 3169 |
Causes |
2020-08-14 |
|
|
| 3170 |
Prevention |
2020-08-14 |
|
|
| 3171 |
Symptoms of diabetic retinopathy |
2020-08-14 |
|
|
| 3172 |
Diabetic retinopathy includes 3 different types |
2020-08-14 |
|
|
| 3173 |
Some advantages of Pad Batch Dyeing |
2020-08-13 |
|
|
| 3174 |
Ebola Virus |
2020-08-13 |
|
|
| 3175 |
Autoimmune Disease |
2020-08-13 |
|
|
| 3176 |
Short Commentary |
2020-08-12 |
|
|
| 3177 |
Case Study |
2020-08-12 |
|
|
| 3178 |
Acknowledgements/Study funding |
2020-08-12 |
|
|
| 3179 |
Cerebral Palsy |
2020-08-12 |
|
|
| 3180 |
Molecular Genomics and Genetics |
2020-08-12 |
|
|
| 3181 |
Technologies in Genomics |
2020-08-12 |
|
|
| 3182 |
Alzheimer's |
2020-08-12 |
|
|
| 3183 |
Parkinson's Disease Note |
2020-08-12 |
|
|
| 3184 |
Multiple sclerosis |
2020-08-12 |
|
|
| 3185 |
Neurorehabilitation |
2020-08-12 |
|
|
| 3186 |
Brain rehabilitation |
2020-08-12 |
|
|
| 3187 |
Strengths and Limitations |
2020-08-10 |
|
|
| 3188 |
Final Thoughts |
2020-08-10 |
|
|
| 3189 |
Deviation from the Jet-Stream Belt |
2020-08-10 |
|
|
| 3190 |
Data from Epidemiology |
2020-08-10 |
|
|
| 3191 |
Corona-Virus Transport via Dust Pollutants |
2020-08-10 |
|
|
| 3192 |
Transfer of Virus from one Ground Location to another |
2020-08-10 |
|
|
| 3193 |
Seasonal Recurrence |
2020-08-10 |
|
|
| 3194 |
The Fall of Viruses Through the Stratosphere |
2020-08-10 |
|
|
| 3195 |
Global Dissemination |
2020-08-10 |
|
|
| 3196 |
Critical Summary of Main Facts and Popular Assumptions |
2020-08-10 |
|
|
| 3197 |
Worldwide Spread of the Virus |
2020-08-10 |
|
|
| 3198 |
Cases Reported at End of February, 2020 |
2020-08-10 |
|
|
| 3199 |
Side effects |
2020-08-07 |
|
|
| 3200 |
Quarantine |
2020-08-07 |
|
|
| 3201 |
Isolate |
2020-08-07 |
|
|
| 3202 |
Suggestions for Further Study and Research |
2020-08-07 |
|
|
| 3203 |
Potential Medical Benefits of Autologous Stem Cell Trapping Mechanism |
2020-08-07 |
|
|
| 3204 |
Related empirical studies |
2020-08-07 |
|
|
| 3205 |
Tumor Necrosis Factor(TNF) |
2020-08-07 |
|
|
| 3206 |
Chemokines |
2020-08-07 |
|
|
| 3207 |
Immune Response |
2020-08-07 |
|
|
| 3208 |
Relation to Historical Evidence |
2020-08-06 |
|
|
| 3209 |
Evidence of Viruses Reaching the Ground |
2020-08-06 |
|
|
| 3210 |
A Comparison with SARS |
2020-08-06 |
|
|
| 3211 |
Data from Epidemiology and Sequencing |
2020-08-06 |
|
|
| 3212 |
Deadwood Fire smoke |
2020-08-05 |
|
|
| 3213 |
How can they influence climate change? |
2020-08-05 |
|
|
| 3214 |
Strategies to reduce the problem |
2020-08-05 |
|
|
| 3215 |
Addressing the needs of demand and supply |
2020-08-05 |
|
|
| 3216 |
Fresh water harvesting |
2020-08-05 |
|
|
| 3217 |
Landslides and Eruption of Emotions |
2020-08-05 |
|
|
| 3218 |
Flood Causing Trauma |
2020-08-05 |
|
|
| 3219 |
Objective |
2020-08-05 |
|
|
| 3220 |
Cord blood stem cells and amnionic fluid stem cells |
2020-08-04 |
|
|
| 3221 |
Embryonic Germ Cells |
2020-08-04 |
|
|
| 3222 |
Adult stem cells |
2020-08-04 |
|
|
| 3223 |
Embryonic stem cells |
2020-08-04 |
|
|
| 3224 |
Mini Review |
2020-08-04 |
|
|
| 3225 |
Short Communication |
2020-08-04 |
|
|
| 3226 |
Extended Abstract |
2020-08-04 |
|
|
| 3227 |
Experimental Set-up |
2020-08-04 |
|
|
| 3228 |
Dear Editor, |
2020-08-04 |
|
|
| 3229 |
Conflict Of Interest |
2020-08-03 |
|
|
| 3230 |
Evaluation protocols |
2020-08-03 |
|
|
| 3231 |
Outcome and Conclusion |
2020-08-03 |
|
|
| 3232 |
Findings |
2020-08-03 |
|
|
| 3233 |
Case Description and Methods |
2020-08-03 |
|
|
| 3234 |
Letter |
2020-08-03 |
|
|
| 3235 |
Proof of Theorem 1.2 |
2020-08-03 |
|
|
| 3236 |
Proof of Theorem 1.3 |
2020-08-03 |
|
|
| 3237 |
Universality of Affine Semigroups |
2020-08-03 |
|
|
| 3238 |
Supercyclicity Subtended Universality of Affine Maps |
2020-08-03 |
|
|
| 3239 |
A Dichotomy for Supercyclic Linear Semigroups |
2020-08-03 |
|
|
| 3240 |
Statement of the Theorem |
2020-08-03 |
|
|
| 3241 |
Conclusion: Point Symmetries of Higher Order O.D.E's |
2020-08-03 |
|
|
| 3242 |
Point Symmetries of Generic Second Order Linear O.D.E's |
2020-08-03 |
|
|
| 3243 |
Main Results |
2020-08-03 |
|
|
| 3244 |
Financial Support and Sponsorship |
2020-07-31 |
|
|
| 3245 |
Conclusion and Future Perspectives |
2020-07-31 |
|
|
| 3246 |
Extraction Methodology |
2020-07-31 |
|
|
| 3247 |
Availability of Data and Materials |
2020-07-31 |
|
|
| 3248 |
Disclosure of Interest |
2020-07-31 |
|
|
| 3249 |
2020 Webinar Announcement |
2020-07-30 |
|
|
| 3250 |
Commentary |
2020-07-30 |
|
|
| 3251 |
Declaration of Patient Consent |
2020-07-30 |
|
|
| 3252 |
Severe Acute Respiratory Syndrome (Sars) |
2020-07-30 |
|
|
| 3253 |
Description of Work Techniques, Methods or Processes |
2020-07-30 |
|
|
| 3254 |
Description |
2020-07-30 |
|
|
| 3255 |
Chemical Oxygen Demand (COD) |
2020-07-29 |
|
|
| 3256 |
Anaerobic Digestion of Banana Waste |
2020-07-29 |
|
|
| 3257 |
Program Complex of VRMSHELL |
2020-07-29 |
|
|
| 3258 |
Authors Contributions |
2020-07-28 |
|
|
| 3259 |
Ethics Statement |
2020-07-28 |
|
|
| 3260 |
Perspective |
2020-07-28 |
|
|
| 3261 |
Conference Announcement |
2020-07-26 |
|
|
| 3262 |
Awards 2020 |
2020-07-26 |
|
|
| 3263 |
Employee Empowerment |
2020-07-24 |
|
|
| 3264 |
Prognosis |
2020-07-23 |
|
|
| 3265 |
Prevention of Pre Hypertension |
2020-07-23 |
|
|
| 3266 |
Biomarkers Related Prehypertension |
2020-07-23 |
|
|
| 3267 |
Risk for Progression of Prehypertension to Hypertension |
2020-07-23 |
|
|
| 3268 |
Measurement of Blood Pressure |
2020-07-23 |
|
|
| 3269 |
Prevalence of Pre-Hypertension |
2020-07-23 |
|
|
| 3270 |
Ethical Approval and Consent to Participate |
2020-07-23 |
|
|
| 3271 |
Tourism Development by Designation of a World Heritage Site |
2020-07-22 |
|
|
| 3272 |
Tourist’s Perceptions of World Heritage Site and its Designation |
2020-07-22 |
|
|
| 3273 |
Tourist’s Perceptions of World Heritage Site and its Designation |
2020-07-22 |
|
|
| 3274 |
Tourist’s Perceptions of World Heritage Site and its Designation |
2020-07-22 |
|
|
| 3275 |
Local Community Perceptions to the World Heritage Site |
2020-07-22 |
|
|
| 3276 |
Impacts of Designation a World Heritage Site |
2020-07-22 |
|
|
| 3277 |
Hashemite Kingdom of Jordan and World |
2020-07-22 |
|
|
| 3278 |
The Significance of World Heritage Sites |
2020-07-22 |
|
|
| 3279 |
The Changing Nature of World Heritage |
2020-07-22 |
|
|
| 3280 |
Disclosure |
2020-07-21 |
|
|
| 3281 |
Ethics |
2020-07-21 |
|
|
| 3282 |
How to Detect Rivaroxaban? |
2020-07-21 |
|
|
| 3283 |
Drug-Drug Interactions |
2020-07-21 |
|
|
| 3284 |
Compliance |
2020-07-21 |
|
|
| 3285 |
Remarks |
2020-07-21 |
|
|
| 3286 |
Discussion and Implications4 |
2020-07-21 |
|
|
| 3287 |
Experimental Results |
2020-07-21 |
|
|
| 3288 |
Conclusion and Future Work |
2020-07-21 |
|
|
| 3289 |
Physical Implications and Extensions |
2020-07-21 |
|
|
| 3290 |
Quantum Mechanism |
2020-07-21 |
|
|
| 3291 |
Mathematical Methodology |
2020-07-21 |
|
|
| 3292 |
Conclusion and Further Research |
2020-07-21 |
|
|
| 3293 |
COVID-19 and Vitamin D supplementation |
2020-07-21 |
|
|
| 3294 |
Clinical Take Home Message |
2020-07-20 |
|
|
| 3295 |
High Fructose Corn Syrup |
2020-07-20 |
|
|
| 3296 |
Diet and Inflammation/Inflammasomes |
2020-07-20 |
|
|
| 3297 |
Dietary Emulsifiers |
2020-07-20 |
|
|
| 3298 |
Fat |
2020-07-20 |
|
|
| 3299 |
Fiber |
2020-07-20 |
|
|
| 3300 |
Diet and Microbiome |
2020-07-20 |
|
|
| 3301 |
Opportunity for expansion of Tele-medicine |
2020-07-18 |
|
|
| 3302 |
Construction of Super PDE’s |
2020-07-17 |
|
|
| 3303 |
The Backward Time Centred Space with Nonlinear Nonlocal Boundary Conditions (BTCS-NNBC) |
2020-07-17 |
|
|
| 3304 |
The Dufort–Frankel scheme with Nonlinear Nonlocal Boundary Conditions (DFS-NNBC) |
2020-07-17 |
|
|
| 3305 |
The Forward Time Centred space with Nonlinear Nonlocal Boundary Conditions (FTCS-NNBC) |
2020-07-17 |
|
|
| 3306 |
Letter to the Editor |
2020-07-17 |
|
|
| 3307 |
Author’s Individual Contribution to Manuscript |
2020-07-17 |
|
|
| 3308 |
Aim |
2020-07-17 |
|
|
| 3309 |
Ependymoma |
2020-07-17 |
|
|
| 3310 |
Brainstem Glioma |
2020-07-17 |
|
|
| 3311 |
Cerebellar Astrocytoma |
2020-07-17 |
|
|
| 3312 |
Theory and Experimentation |
2020-07-09 |
|
|
| 3313 |
Informed Consent |
2020-07-09 |
|
|
| 3314 |
Compliance Statement |
2020-07-09 |
|
|
| 3315 |
Hydraulic Parameters of Water Moving along the Furrows |
2020-07-07 |
|
|
| 3316 |
Biological Activity |
2020-07-07 |
|
|
| 3317 |
Materials and Experimental Method |
2020-07-07 |
|
|
| 3318 |
Editorial Highlights |
2020-07-07 |
|
|
| 3319 |
Ethical Guidelines |
2020-07-07 |
|
|
| 3320 |
Experimental Procedure |
2020-07-07 |
|
|
| 3321 |
Pathogenesis and Pathology |
2020-07-07 |
|
|
| 3322 |
Transmission |
2020-07-07 |
|
|
| 3323 |
Host Range |
2020-07-07 |
|
|
| 3324 |
Etiology |
2020-07-07 |
|
|
| 3325 |
The Way Forward |
2020-07-06 |
|
|
| 3326 |
Review of Literature |
2020-07-06 |
|
|
| 3327 |
Future Research |
2020-07-03 |
|
|
| 3328 |
Problem statement |
2020-07-03 |
|
|
| 3329 |
Abstract |
2020-07-03 |
|
|
| 3330 |
Future Studies |
2020-07-01 |
|
|
| 3331 |
Methods and Materials |
2020-07-01 |
|
|
| 3332 |
How to Build Maintenance Management System? |
2020-06-30 |
|
|
| 3333 |
Maintenance Management System |
2020-06-30 |
|
|
| 3334 |
Possible Responses |
2020-06-29 |
|
|
| 3335 |
Problems and Threats |
2020-06-29 |
|
|
| 3336 |
The Role Played by Irrigated Agriculture |
2020-06-29 |
|
|
| 3337 |
Conceptual Framework |
2020-06-29 |
|
|
| 3338 |
Result and Analysis |
2020-06-26 |
|
|
| 3339 |
Calculations |
2020-06-26 |
|
|
| 3340 |
Ethical Statement |
2020-06-25 |
|
|
| 3341 |
Funding Statement |
2020-06-17 |
|
|
| 3342 |
Data Availability |
2020-06-17 |
|
|
| 3343 |
Conclusions and Recommendations |
2020-06-17 |
|
|
| 3344 |
Past Conference Report |
2020-06-16 |
|
|
| 3345 |
No heading |
2020-06-16 |
|
|
| 3346 |
Further Studies |
2020-06-15 |
|
|
| 3347 |
The instrumentation for molecular hydrogen |
2020-06-15 |
|
|
| 3348 |
Molecular hydrogen |
2020-06-15 |
|
|
| 3349 |
Theoretical Findings |
2020-06-15 |
|
|
| 3350 |
Key Messages |
2020-06-12 |
|
|
| 3351 |
Highlights |
2020-06-12 |
|
|
| 3352 |
The FICB |
2020-06-09 |
|
|
| 3353 |
Case Presentation |
2020-06-09 |
|
|
| 3354 |
Case Series |
2020-06-09 |
|
|
| 3355 |
Financial Disclosure |
2020-06-08 |
|
|
| 3356 |
Contributorship Statement |
2020-06-08 |
|
|
| 3357 |
Financial Support |
2020-06-08 |
|
|
| 3358 |
Case Report |
2020-06-08 |
|
|
| 3359 |
Result |
2020-06-08 |
|
|
| 3360 |
Conflicts of Interest |
2020-06-08 |
|
|
| 3361 |
Consent of Publication |
2020-06-08 |
|
|
| 3362 |
Declaration of Conflict of Interest |
2020-06-08 |
|
|
| 3363 |
Cytogenetic analysis |
2020-06-08 |
|
|
| 3364 |
Application |
2020-06-04 |
|
|
| 3365 |
Control of AI |
2020-06-04 |
|
|
| 3366 |
Eccentricities |
2020-06-04 |
|
|
| 3367 |
Editor’s Note |
2020-05-25 |
|
|
| 3368 |
Editor’s Note |
2020-05-25 |
|
|
| 3369 |
Others |
2020-05-25 |
|
|
| 3370 |
Study Limitations |
2020-05-25 |
|
|
| 3371 |
VR and Neurorehabilitation Outcomes |
2020-05-25 |
|
|
| 3372 |
VR and Neuropsychological Outcomes |
2020-05-25 |
|
|
| 3373 |
Associations Between VR Variables and Demographic and Clinical Variables |
2020-05-25 |
|
|
| 3374 |
Associations Between VR Variables and Demographic and Clinical Variables. |
2020-05-25 |
|
|
| 3375 |
Outcome Measures |
2020-05-25 |
|
|
| 3376 |
Devices |
2020-05-25 |
|
|
| 3377 |
Intervention Measures |
2020-05-25 |
|
|
| 3378 |
Intervention Schedule |
2020-05-25 |
|
|
| 3379 |
Participants |
2020-05-25 |
|
|
| 3380 |
Brain Neoplasm |
2020-05-25 |
|
|
| 3381 |
Virtual Reality and Rehabilitation |
2020-05-25 |
|
|
| 3382 |
Funding |
2020-05-25 |
|
|
| 3383 |
Psychometric Tools [1] |
2020-05-20 |
|
|
| 3384 |
Recommendations |
2020-05-18 |
|
|
| 3385 |
Limitations |
2020-05-18 |
|
|
| 3386 |
Subjects and Methods |
2020-05-18 |
|
|
| 3387 |
Material and Methods |
2020-05-18 |
|
|
| 3388 |
Ethical Approval |
2020-05-18 |
|
|
| 3389 |
"Whack A Mole" (WAM) model |
2020-05-18 |
|
|
| 3390 |
Authors’ Contributions |
2020-05-16 |
|
|
| 3391 |
Authors’ Contributions |
2020-05-16 |
|
|
| 3392 |
Authors’ Contributions |
2020-05-16 |
|
|
| 3393 |
Conflicts of Interest Statement |
2020-05-16 |
|
|
| 3394 |
Theoretical Framework |
2020-05-16 |
|
|
| 3395 |
Technical Proposal and Advantages |
2020-05-15 |
|
|
| 3396 |
Space to Think – Again |
2020-05-15 |
|
|
| 3397 |
Space to Think – Again |
2020-05-15 |
|
|
| 3398 |
The Emergence of the Quantum Mechanical Table |
2020-05-15 |
|
|
| 3399 |
The Emergence of the Roberts-Janet Nuclear Periodic Table |
2020-05-15 |
|
|
| 3400 |
Questions |
2020-05-15 |
|
|
| 3401 |
Historic and Current Framework |
2020-05-15 |
|
|
| 3402 |
Editorial Note |
2020-05-15 |
|
|
| 3403 |
Case Description |
2020-05-15 |
|
|
| 3404 |
Prevention and Control |
2020-05-15 |
|
|
| 3405 |
Treatment |
2020-05-15 |
|
|
| 3406 |
Differential Diagnosis |
2020-05-15 |
|
|
| 3407 |
Diagnosis |
2020-05-15 |
|
|
| 3408 |
Economic Impact of BLV |
2020-05-15 |
|
|
| 3409 |
BLV Transmission |
2020-05-15 |
|
|
| 3410 |
Clinical Signs and Symptoms |
2020-05-15 |
|
|
| 3411 |
Classification and Pathogenesis of Virus |
2020-05-15 |
|
|
| 3412 |
Prevalence of BLV |
2020-05-15 |
|
|
| 3413 |
Historical Background |
2020-05-15 |
|
|
| 3414 |
Clinical Image |
2020-05-15 |
|
|
| 3415 |
noheading |
2020-05-15 |
|
|
| 3416 |
Notes on Using the Charts |
2020-05-14 |
|
|
| 3417 |
Methods for Sample Size Determination |
2020-05-14 |
|
|
| 3418 |
Additional Details on Methods |
2020-05-14 |
|
|
| 3419 |
Tools to Describe Practice Patterns |
2020-05-14 |
|
|
| 3420 |
Research Methodology |
2020-03-16 |
|
|
| 3421 |
Conclusion and Recommendations |
2020-03-16 |
|
|
| 3422 |
Data Availability Statement |
2020-03-16 |
|
|
| 3423 |
Suggestions |
2020-03-16 |
|
|
| 3424 |
Literature Review |
2020-03-16 |
|
|
| 3425 |
Biological Evaluation |
2020-03-12 |
|
|
| 3426 |
Conflict of Interests |
2020-03-05 |
|
|
| 3427 |
Competing Interests |
2020-03-05 |
|
|
| 3428 |
Author Contributions |
2020-03-05 |
|
|
| 3429 |
Limitations and Recommendations for Future Studies |
2020-03-04 |
|
|
| 3430 |
Acknowledgments |
2020-03-02 |
|
|
| 3431 |
Conclusions |
2020-02-29 |
|
|
| 3432 |
Chronotherapeutic Drug Delivery System |
2020-02-29 |
|
|
| 3433 |
Chronotherapy in Treatment of Peptic Ulcer Disease |
2020-02-29 |
|
|
| 3434 |
Applications of Chronotherapy |
2020-02-29 |
|
|
| 3435 |
Treatment of Peptic Ulcer |
2020-02-29 |
|
|
| 3436 |
Pathogenesis of Peptic Ulcer |
2020-02-29 |
|
|
| 3437 |
Result and Discussion |
2020-01-13 |
|
|
| 3438 |
Required Statements |
2019-10-29 |
|
|
| 3439 |
Declarations |
2019-07-15 |
|
|
| 3440 |
Some definitions and literature survey |
2019-05-27 |
|
|
| 3441 |
Abbreviations |
2019-05-06 |
|
|
| 3442 |
Antimicrobials Screening |
2019-05-03 |
|
|
| 3443 |
Analytical Tools and Techniques Employed |
2019-05-03 |
|
|
| 3444 |
Discussion and Conclusion |
2019-05-02 |
|
|
| 3445 |
Methods |
2019-05-02 |
|
|
| 3446 |
Data Analysis |
2019-05-01 |
|
|
| 3447 |
Method |
2019-05-01 |
|
|
| 3448 |
Statistical Analysis |
2019-04-30 |
|
|
| 3449 |
Editorial |
2019-04-10 |
|
|
| 3450 |
Acknowledgment |
2019-04-10 |
|
|
| 3451 |
Limitation |
2019-04-10 |
|
|
| 3452 |
Experimental |
2019-03-28 |
|
|
| 3453 |
Time Flow |
2019-03-26 |
|
|
| 3454 |
Future Scope |
2019-02-26 |
|
|
| 3455 |
Methodology |
2019-02-05 |
|
|
| 3456 |
Materials and Method |
2019-01-30 |
|
|
| 3457 |
Definition of Occupational Hazard |
2019-01-30 |
|
|
| 3458 |
Area of Infection Control |
2019-01-30 |
|
|
| 3459 |
Personal Protective Equipment |
2019-01-30 |
|
|
| 3460 |
Sterilization |
2019-01-30 |
|
|
| 3461 |
Genetics and Oral Health |
2019-01-30 |
|
|
| 3462 |
Management of Chromosomal Abnormalities |
2019-01-30 |
|
|
| 3463 |
Chromosomal Abnormalities |
2019-01-30 |
|
|
| 3464 |
Law of segregation |
2019-01-30 |
|
|
| 3465 |
Basic information related to Genetics |
2019-01-30 |
|
|
| 3466 |
Summary |
2019-01-30 |
|
|
| 3467 |
Public Health Significance |
2019-01-30 |
|
|
| 3468 |
Defluoridation – Studies in India |
2019-01-30 |
|
|
| 3469 |
Current status of defluoridation in India |
2019-01-30 |
|
|
| 3470 |
Defluoridation techniques |
2019-01-30 |
|
|
| 3471 |
Characteristics of defluoridation |
2019-01-30 |
|
|
| 3472 |
Definition of Defluoridation |
2019-01-30 |
|
|
| 3473 |
Conflict of Interest |
2019-01-30 |
|
|
| 3474 |
Acknowledgements |
2019-01-30 |
|
|
| 3475 |
Recommendation |
2019-01-29 |
|
|
| 3476 |
Field Method |
2019-01-29 |
|
|
| 3477 |
Role of Different Types of Microbes |
2019-01-29 |
|
|
| 3478 |
Biofertilizers |
2019-01-29 |
|
|
| 3479 |
Discussion |
2019-01-29 |
|
|
| 3480 |
Results |
2019-01-29 |
|
|
| 3481 |
Acknowledgment |
2019-01-29 |
|
|
| 3482 |
Experimental Section |
2019-01-29 |
|
|
| 3483 |
References |
2019-01-23 |
|
|
| 3484 |
Conclusion |
2019-01-23 |
|
|
| 3485 |
Results and Discussions |
2019-01-23 |
|
|
| 3486 |
Materials and Methods |
2019-01-23 |
|
|
| 3487 |
Introduction |
2019-01-23 |
|
|
| 3488 |
Keywords |
2019-01-23 |
|
|